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Abstract
A series of Re(I) complexes was synthesised and investigated as optical imaging agents.
Fundamental studies provided insight into how structural modifications influenced
their chemical, photophysical and biological properties.
The synthesis, structural and photophysical properties of a series of fac-[Re(diim)(CO)3(L)]
complexes has been reported, where diim is either 1,10-phenanthroline (phen) or 2,2’-
bipyridine (bipy) and L is one of a series of 5-substituted aryl tetrazoles. NMR and
X-ray crystallography indicated that all of the complexes coordinate to the tetrazolato
ligand through the N2 atom. Phosphorescent emission was characterised as originating
from a 3MLLCT state. Structural changes to the diimine ligand from bipy to phen led
to an improvement in the photoluminescence quantum yield (φ ) and an elongation of
lifetime (τ). Changes to the electron withdrawing para substituents on the aryl tetra-
zolato ligand allowed fine tuning of the complexes τ , φ and, to a lesser extent, the
maximum emission wavelengths.
The photophysical properties of the prepared neutral Re(I) complexes were reversibly
modulated upon protonation of the tetrazolato ligand. The cationic complexes of the
form fac-[Re(diim)(CO)3(LH)]+ exhibited increased emission intensity, a blue shifted
emission maxima and increased τ and φ , compared to their neutral analogues. Dif-
ferent photophysical modulation was observed upon protonation of Ir(III) and Ru(II)
tetrazolato complexes. The iridium emission was red shifted whilst the ruthenium
emission was significantly quenched. These changes were reversible upon addition of
triethylamine. To harness the enhanced photophysical output of the protonated Re(I)
complexes in an irreversible way, methylation reactions were carried out to yield com-
plexes of the form fac-[Re(diim)(CO)3(LCH3)]+. The photophysical output was again
increased with longer τ and improved φ , with respect to the neutral species. Crys-
tal structures revealed the formation of both Re-N2 and Re-N1 linkage isomers. The
stability of the Re(I) complexes was lost upon methylation as evidenced by the detach-
ment of the tetrazolato ligand in coordinating solvents.
xx
In an attempt to improve the water solubility of the fac-[Re(phen)(CO)3(L)] com-
plexes, a small polyethylene glycol chain was functionalised onto the phen ligand.
Analysis of the n-octanol/water distribution coefficient revealed that the PEG chain
was of insufficient length to modify the lipophilicity of the complexes. However, upon
structural change to the phen ligand, photophysical output was not appreciably altered.
To extend applications of the Re(I) complexes, fac-[Re(phen)(CO)3(Talk)] was syn-
thesised. The terminal alkyne group on the tetrazolato ligand can be functionalised
utilising “click” chemistry. Studies revealed that the para substituent is not signifi-
cantly involved in the HOMO and so further modification here should not considerably
alter photophysical output.
Live HeLa cell imaging revealed that the neutral complexes fac-[Re(phen)(CO)3(Tph)],
fac-[Re(phen)(CO)3(Tbz)] and fac-[Re(phen-S-PEG)(CO)3(Tph)] showed good cel-
lular uptake with perinuclear localisation. This was confirmed through spectral imag-
ing and analysis. fac-[Re(phen)(CO)3(Tph)] and fac-[Re(phen)(CO)3(Tbz)] were
non toxic during incubation and imaging. Upon continual illumination (for approx-
imately three minutes, as in a z-stack experiment) these complexes became cytotoxic
as evidenced by the rounding up of cells and formation of membrane blebs. fac-
[Re(phen-S-PEG)(CO)3(Tph)] had a strong emission within HeLa cells but was the
most phototoxic complex imaged. The phototoxic nature of the Re(I) complexes was
rationalised by their ability to produce singlet oxygen upon excitation to their triplet
excited state.
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Chapter 1
Introduction
1.1 Medical Imaging Modalities
Medical imaging techniques have greatly advanced since the 19th century. Improve-
ments in technology have allowed for the whole body, including anatomical structures
and/or physiological function, to be imaged for medicinal purposes.1 These develop-
ments translate to a more rapid response to disease detection and therefore early and
more efficient treatment of patients. The progression of the medical imaging field
has seen the reduction of potentially risky and invasive diagnostic techniques, such as
exploratory surgery.1,2 A number of imaging procedures are established in medicine
including X-ray imaging (including computed tomography [CT] scans), magnetic res-
onance imaging (MRI) and ultrasound, as shown in Figure 1.1.3–5
Figure 1.1: Medical images (left to right); MRI, ultrasound and X-ray.3–5
More recent developments include positron emission tomography (PET) and single
photon emission computed tomography (SPECT) imaging techniques.
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1.1.1 Radiography
Radiography uses X-rays to image internal structures of the patient, producing an over-
all 2D image. Patients are placed in front of a detector as X-rays are pulsed through
the body or area of interest. Bones are efficient at absorbing X-rays, whereas tissue
and muscle allow more X-rays to pass through to the detector. This difference makes
bones appear white while soft tissue shows up in shades of grey on a developed X-ray
image. Radiography can be used to image the whole body and is commonly used to
image anatomical structures, for example teeth and the skeletal system.6 It is one of the
most widespread technologies used in medical imaging but has fairly poor resolution
and only produces 2D images.7 To increase the information gained from radiography,
contrast agents (particularly iodine based) have been employed. Contrast agents im-
prove image quality and allow further functional information to be gained.6 X-rays are
a form of ionising radiation and therefore exposure must be monitored as excessive
levels can be harmful.8
1.1.2 X-ray Computed Tomography (CT)
CT scans use X-rays to produce multiple 2D images which are then digitally recon-
structed to give a 3D view of the area. This technique revolutionised medical imaging9
and is now the most commonly used technique for evaluating cancer patients.10 Con-
trast agents are also used in X-ray CT imaging to help improve the level of information
gained from each image.6 Unlike the whole body capability of simple X-ray imaging,
CT scans can only image a limited area and are not used to image the whole body at
one time.7
1.1.3 Magnetic Resonance Imaging (MRI)
During an MRI scan the subject is placed inside a strong magnetic field which aligns
the protons in the body (most commonly found in water) in a predominantly low en-
ergy state. A radio frequency pulse will excite the protons to a higher energy state.
Once the pulse is switched off, protons relax and the energy released upon relaxation
is used to produce the final MR image.11 Contrast in tissues is achieved by the dif-
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ferent relaxation times of protons, depending on their location. T1 and T2 describe
the relaxation time constants along the z axis and in the x-y planes respectively.12,13
Whole body imaging can be achieved using MRI and it is commonly used in diagnostic
medicine. As with CT scans, MRIs have the potential to produce 3D images to increase
the amount of information gained from the process. Exogenous contrast agents (para-
magnetic substances such as Gd3+ complexes) are commonly used to improve image
output.14
1.1.4 Ultrasound
Ultrasound can not be detected by the human ear. This imaging technique is most
commonly associated with the imaging of foetuses in pregnant women but it can also
be used as a diagnostic tool. Generally, ultrasound imaging uses a transducer which
produces small pulses of ultrasound waves (echoes) into the body. Some of these will
penetrate deeper while others are reflected back to the transducer, eventually producing
an image.15 Ultrasound does not use ionising radiation, can image in real time and
is generally portable. These factors are some of the advantages of ultrasound over
other imaging modalities. Similar to other techniques, technology has allowed the
production of 3D ultrasound images.9
1.1.5 Radioimaging
Radioimaging involves the use of radioactive tracers, for example 18F and 99mTc la-
beled compounds. These are introduced into the body to assist in the visualisation of
structures (eg: organs) at more of a molecular and functional level than the techniques
discussed above. The tracer is usually attached to a biologically relevant molecule
that has specificity for an organ/region of interest. The radiotracer emits gamma rays,
detected by a camera to produce a 2D or 3D image of the organ inside the patient.16
The most common forms of radioimaging are PET and SPECT. They are similar tech-
niques however PET is more sensitive, whereas SPECT is cheaper and more widely
available. The radionuclides commonly used in PET include 18F, 11C, 13N and 15O
whereas 99mTc is predominantly used for SPECT imaging.17 SPECT can give infor-
mation about blood flow and metabolism. The radiotracers used in SPECT generally
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have a longer half-life compared to those used in PET. Therefore SPECT is commonly
used in cardiology cases where scans can take hours.16
1.1.6 Multimodal Imaging
Multimodal imaging can be used to describe the acquisition of images with multiple
techniques and digitally combining them or, the simultaneous acquisition of different
image types. The combination of different imaging techniques can give rise to im-
proved diagnostic outputs which has seen their employment in medicine increase over
the last two decades.10,18,19 The first type of multimodal imaging was the combination
of CT and SPECT in 1966. In 1998 both SPECT-CT and PET-CT became commer-
cially available and are commonly used today.20
The techniques discussed above in sections 1.1.1-1.1.5, are all non-invasive however,
they do not have the power of subcellular resolution achievable through optical imag-
ing. Optical imaging can be used as a stand alone technique or as a complementary
procedure to those mentioned above, leading to an increase in the power of diagnostic
medicine.
1.1.7 Optical Imaging
Optical imaging, often referred to as fluorescence imaging, is a technique utilising
ultraviolet to near infrared (NIR) wavelengths of light to visualise chemical and bio-
logical moieties. It is a rapidly developing area in the medical imaging field as it is
non-invasive, utilises non-ionising radiation and can produce high resolution images at
a sub-cellular level.21 There are various ways optical imaging is employed in medicine
however fluorescence microscopy is one of the most common techniques utilised. It
can be used to image cell cultures in vitro or to analyse tissue samples ex vivo. The
high resolution achieved through fluorescence microscopy is illustrated in Figure 1.2,
where subcellular co-staining of the DNA (blue) and microtubules (red) is shown.22
Different fluorescent labels have been used in the HeLa cells (Figure 1.2) to target dif-
ferent organelles. Fluorescence microscopy is well established in research and is also
employed in diagnostic clinical applications.23
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Figure 1.2: Fluorescence staining of cancerous cells.22
Fluorescence imaging in vivo (on animal models) has become one of the most com-
monly used tools in pre-clinical research. Whole body in vivo imaging is still not
routinely used and research is still in its infancy.21,24,25 Fluorescence image-guided
surgery is another technique emerging in the area of optical imaging.26 Current limita-
tions of fluorescence imaging include the interference of small structures within tissue,
the level of light penetration achievable and the overall contrast produced. Despite
these limitations, the progress of optical imaging (including whole body and surgi-
cal imaging) is rapid and will soon be commonly employed in a range of research,
diagnostic and even therapeutic applications. For this advancement, continued devel-
opment of specialised instrumentation is required. However, just as important is the
development of suitable probes, commonly required for optical imaging. These probes
are luminescent and are used to target and therefore image particular components of
the body and/or tissues.
It is possible to carry out label-free imaging on certain samples and it is always de-
sirable to avoid the introduction of exogenous chemicals to the body and biological
samples. Some optical imaging techniques make this possible. For example, confocal
Raman spectroscopy has been used to analyse samples at a cellular level.27 A recent
example has demonstrated the ability to image brain activity patterns in animal models,
label free, by harnessing the endogenous fluorescence from flavins.28 It would be ideal
to conduct all optical imaging without the introduction of labels however, to achieve
high specificity and high contrast imaging, probes are often necessary.
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1.2 Probes for Optical Imaging and the Principles of
Fluorescence
In order to carry out the optical imaging techniques discussed above, there is a need for
optimised probes to ensure maximum image contrast and specificity. This will lead to
improved diagnosis and patient outcomes as well as advances in pre-clinical research.
A range of dyes are commercially available and are routinely used in optical imaging
to assist in the visualisation of cellular structure and function.29,30 These probes can
be used alone or can be conjugated to specific biomolecules (such as antibodies, pro-
teins etc). The structure of the probe or the conjugated biomolecule is used to control
uptake and specificity or to selectively sense chemical species in a biological environ-
ment. The most commonly available commercial probes are small organic fluorescent
molecules, for example the Alexa Fluor dyes, Fluorescein and DAPI (46 and 47, Fig-
ure 1.3). Over the past three decades research into their development has progressed
rapidly.25 The use of fluorescent proteins, for example the commonly known green
fluorescent protein, in conjunction with genetic engineering has also been exploited in
both imaging and sensing applications.31–33
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Figure 1.3: Fluorescent labels Fluorescein and 4’,6-diamidino-2-phenylindole (DAPI)
used in optical imaging.
1.2.1 Fluorescence
Fluorescence is a form of luminescence that is characterised by the emission of light
from an electronically excited state to a ground state of the same spin multiplicity. The
Jablonski diagram,34 illustrated in Figure 1.4, is used to represent the processes that
occur when a molecule interacts with light (hv).
Light is required to excite an electron from the highest occupied molecular orbital
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Figure 1.4: Simplified Jablonski diagram, illustrating fluorescence.
(HOMO) to the lowest unoccupied molecular orbital (LUMO) of a compound, when
the transition is S0→S1. The absorbance of light promotes the compound from its
ground state (eg: S0) into an electronically excited state (eg: S1, S2), considering the
ground state as a singlet. The excited electron will be in the opposite spin to its partner
in the ground state. Therefore the multiplicity of this excited state is termed a sin-
glet, based on the equation: 2S+1. S is the is the total spin angular momentum for all
electrons and in this case will equal zero, therefore 2S + 1 = 1. Upon excitation of
a molecule, many vibrational excited states will be populated. Vibrational relaxation
(VR) occurs between vibrational levels of the same excited state whereas internal con-
version (IC) occurs between different electronic levels. Both VR and IC are rapid
radiationless processes that occur in the order of 10-14-10-13 seconds.35,36
The population of many vibronic levels upon excitation is directly related to the Franck-
Condon principle, an important concept in relation to all luminescent molecules. The
Franck-Condon principle is based around the Born-Oppenheimer approximation which
states that electronic transitions are very fast compared to nuclear motions, due to the
relative light weight of electrons compared to nuclei. Therefore, vertical electronic
transitions will be favoured when there is a minimal change in the position of the nu-
clei.37 This concept is illustrated in Figure 1.5. Kasha’s rule states that emission occurs
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Figure 1.5: Franck-Condon principle for electronic transitions.
from the lowest lying excited state.35 This emission will then occur to various vibra-
tional levels of the ground state, some which are more likely than others, according to
Franck-Condon considerations (Figure 1.5). It can be thought that the emission band
is the sum of all emission from v = 0 in the excited state, to each vibronic level in the
ground state. Emission to a vibrational level is preferred when it corresponds to a min-
imal change in the position of the nuclear coordinates.37 From any vibrational level,
the molecule will relax to the lowest energy ground state. Kasha’s rule also provides
an explanation as to why the excitation energy is higher than the emission energy. The
Jablonski diagram also shows that the energy of emission is less than that of excitation.
This difference is known as the Stokes shift,38 commonly represented as λem - λex.39
The probability of a transition is governed by a set of selection rules which relate to
the multiplicity and symmetry of the ground and excited states. The spin conservation
selection rule states that transitions are only allowed between states of the same spin
multiplicity. For example, a singlet to singlet transition is allowed whereas a triplet to
singlet transition is forbidden.40 An electronic transition must also involve a change
in parity, which is the basis of the Laporte selection rule. This selection rule applies
to centrosymmetric molecules or ions where parity is either symmetric (gerade, g) or
antisymmetric (ungerade, u), with respect to the inversion centre. Therefore g→g and
u→u transitions are forbidden.41
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In the Jablonski diagram (Figure 1.4) emission from S1 to the ground state is spin
allowed as the excited and ground state posses the same multiplicity.35 As the transition
is spin allowed, the emission of light is usually fast, in the order of 10-8 seconds. The
average time a molecules spends in the excited state, before returning to its ground
state, is known as the lifetime (τ). The radiative lifetime (τ r) is the time it takes for the
excited state to depopulate, assuming non-radiative decay pathways are not possible.
The radiative decay constant can be defined by; kr = 1τr , and assumes no contribution
from non-radiative decay. However, relaxation from the lowest energy state to the
ground state can occur either radiatively, by the emission of a photon or non-radiatively,
such as vibrational relaxation. Therefore lifetime (τ) is usually measured, which takes
into account the radiative and non-radiative decay constants; τ= 1knr+kr .
Quantum yield (φ ) is another parameter used to characterise luminescent materials and
is described as the ratio of photons the molecule emits versus the number of photons
absorbed.35,39 The equations below outline the relationships between φ , knr, kr and τ .
kr = φτ knr =
1−φ
τ
φ= krknr+kr
1.2.2 Drawbacks of Fluorescent Probes
Certain organic fluorophores are known to be able to possess high molar extinction
coefficients (ε) and φ meaning that they are efficient at absorbing and emitting light.42
However, in certain situations they can suffer from a range of issues reducing image
quality and resolution hence limiting the imaging potential of the label. Due to their
relatively short lived fluorescence lifetimes and small Stokes shifts, they can suffer in-
terference from autofluorescence. Autofluorescence originates from endogenous fluo-
rophores such as aromatic amino acids, including tryptophan, tyrosine (48, Figure 1.6)
and phenylalanine.43,44 Enzyme cofactors, such as nicotinamide adenine dinucleotide
(NADH), pyridoxal phosphate (49, Figure 1.6) and flavin adenine dinucleotide (FAD)
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Figure 1.6: Examples of autofluorescent compounds, tyrosine and pyridoxal phos-
phate.
are also endogenous fluorophores.44 Typically, endogenous species involved in aut-
ofluorescence also exhibit small Stokes shifts (tens of nm) and relatively short lived
lifetimes (<<10 ns). Interference occurs because signals from both the applied label
and endogenous biological species are detected. Overlapping of emission and absorp-
tion profiles (small Stokes shift), can also cause self-quenching of molecules in close
proximity to each other due to reabsorption of emitted photons.43 This is a major is-
sue when the dye is used to image a specific organelle or protein. The molecules
accumulate, increasing the chance of self-quenching which can reduce the signal in-
tensity of the probe dramatically. Finally, many of these organic labels can undergo
photobleaching. Photobleaching is the loss of fluorescence intensity caused by contin-
ual imaging.45 The excited state of the organic probe is unstable and might undergo
chemical transformations, causing photochemical destruction of the fluorophore into a
species that no longer possess luminescent properties.46
In order for optical imaging techniques to be successfully exploited in diagnostic
medicine there is a crucial need for the development of superior labels. Currently,
as fluorescent probes have been used for so many years, much of the instrumentation
employed in optical imaging is customised to their particular photophysical properties
(short τ , small Stokes shift etc). Despite this, investigation into luminescent heavy
metal complexes for optical imaging has recently increased. In conjunction with these
studies has been the development of specialised instrumentation and techniques to ac-
commodate and take advantage of the unique photophysical properties exhibited by
metal complexes.
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1.3 Metal Complexes in Optical Imaging
Phosphorescent heavy metal complexes have been gaining increased attention as alter-
native probes for optical imaging. They often exhibit the desired properties needed to
overcome the issues associated with organic fluorophores.
1.3.1 Photophysics of d6 Metal Complexes
The photophysical processes of heavy metal complexes with a low spin d6 configura-
tion are different to those exhibited by organic fluorescent molecules. Metal complexes
are often characterised by emission from a triplet excited state (2S + 1 = 3) down to
the ground singlet state.
Figure 1.7: Generalised partial molecular orbital diagram for d6 transition metals, co-
ordinated to equivalent π-accepting ligands. This case represents a situation where the
metal centre is a second or third row transition metal and the surrounding ligands have
low energy pi* orbitals. aOnly the T2g combination is considered for simplicity.
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The molecular orbital diagram, Figure 1.7, is a representation of a d6 heavy metal
complex (as the focus of this research), showing some of the possible electronic tran-
sitions. For simplicity, in the construction of the diagram all of the ligands around the
metal are assumed to be equivalent and only the pi* ligand orbitals of T2g symmetry
are shown forming molecular orbitals with the metal. Figure 1.7 illustrates the stabil-
ity of low spin d6 metal complexes as they have completely filled bonding orbitals and
empty anti-bonding orbitals. The frontier orbitals (HOMO-LUMO) correspond to t2g,
and t2g* respectively, while the eg* orbital is positioned at a higher energy than the
t2g*. Many of the d6 heavy metals belong to the second and third transition rows and
therefore experience a stronger crystalline field from the surrounding ligands, from in-
creased metal-ligand interaction, raising the energy of eg* . The relative position of the
t2g is determined by the presence and specific energies of the pi* orbitals of the ligands.
The higher energy of the eg* is an important requirement for the metal complexes to be
luminescent, as decay from metal centred states is usually non-radiative. The t2g and
eg* orbitals are mainly metal in character and therefore transitions between them are
known as d-d, metal-centred (MC) transitions.
One possible transition for d6 metal complexes, shown in Figure 1.7, is the metal-to-
ligand charge transfer (MLCT). It is generally the transition between the HOMO and
LUMO, to form the 1MLCT state (t2g5t2g*1). It is important to know that in order to
maximise the emission of light, the MLCT state must be sufficiently distanced from
the MC state, to avoid thermal population of the latter. At the same time, a wide
HOMO-LUMO gap is necessary to avoid high values of knr according to the energy
gap law.47–49 In metal complexes, an increase in the energy gap between the t2g and
t2g* orbitals will lead to a decrease in the non-radiative decay constant, knr which in
turn leads to an increase in τ and φ .
Intraligand (IL) transitions are not shown in Figure 1.7 but are possible within the
ligand and are known as pi − pi* transitions. If the surrounding ligands are not all
equivalent and have pi-accepting abilities, then there is also the possibility of having
ligand-to-ligand charge transfers (LLCTs). These however are not shown in Figure 1.7
but again involve a transition from the filled pi system of one ligand to the empty pi*
system of another.
Figure 1.8 is a Jablonski diagram, illustrating both fluorescent and phosphorescence.
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Figure 1.8: Simplified Jablonski diagram, illustrating fluorescence and phosphores-
cence.
The radiative emission from a triplet to singlet state is known as phosphorescence. The
main difference for the Jablonski diagram of a phosphorescent molecule is a process
known as intersystem crossing (ISC). ISC is a radiationless transition from the singlet
excited state to the more stable triplet state (T1 in Figure 1.8). Spin orbit coupling,
which is more efficient in molecules containing a heavy atom, allows the ISC transition
due to the mixing of the singlet and triplet states.50,51 As relaxation from the 3MLCT
to the ground singlet state requires a change of spin, the transition is spin forbidden
and hence the τ of metal complexes are generally longer than observed in (fluorescent)
organic molecules.
1.3.1.1 Singlet Oxygen
It is well known that molecular oxygen can quench the emission from the triplet excited
states of metal complexes.52 Molecular oxygen has a triplet ground state configuration.
As the emission from the triplet states of metal complexes is spin forbidden, it is gen-
erally long lived. This allows oxygen, which can diffuse fast through solution due
to its small size, to quench this excited state through intermolecular interactions.53,54
Figure 1.9 shows a simplified view of how the ground state of molecular oxygen is
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excited to its triplet state, through triplet-triplet energy transfer. The energy transfer
is spin allowed and can therefore occur more rapidly than radiative decay from the
complex. Emission from the lowest lying excited state of oxygen (1∆g) has a charac-
teristic emission band around 1270 nm which can be directly detected54,55, using an
NIR detector.
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Figure 1.9: Simplified Jablonski diagram demonstrating how molecular oxygen can
quench the emission from the triplet states of metal complexes.
It is important to be aware of the production of singlet oxygen, especially in biological
systems. Singlet oxygen can be cytotoxic as it undergoes redox reactions which can
oxidise important cellular species including proteins, DNA and lipids. It can also lead
to apoptosis (programmed cell death) of cells which is the basis of cancer treatment
using photodynamic therapy.56
1.3.1.2 Multiphoton Excitation
Many heavy metal complexes have demonstrated the ability to be able to undergo
multiphoton excitation (MPE).41,57–59 MPE is a non-linear process which occurs when
a molecule simultaneously absorbs two or more photons.57,60 These two photons of
lower energy will combine and have the energy required for the molecule to undergo
one photon excitation, see Figure 1.10.57,60 This means that longer wavelengths of
light (commonly in the NIR region) are used to facilitate the process of excitation from
the ground to excited state.57,60
To achieve two or multiphoton excitation of a molecule, high intensity pulsed lasers are
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Figure 1.10: Simplified Jablonski diagram showing two-photon excitation.
used so that the molecule can simultaneously absorb two (longer wavelength) photons,
to be excited to a singlet excited state. The emission profile of the complex in general,
will be the same as if it had undergone single photon excitation at a lower wavelength,
see Figure 1.10. The advantage of complexes that can undergo multiphoton excitation
is described in section 1.3.2.2.
1.3.2 General Requirements for the Application of Metal Com-
plexes in Bioimaging
There are a range of desirable properties that optical imaging probes must exhibit to be
successful. It is important that heavy metal complexes exhibit most, if not all of these
properties in order to be applicable in biological imaging applications.
1.3.2.1 Physical and Chemical Properties
Probes must exhibit good solubility in aqueous environments, specifically cellular me-
dia, to be useful for optical imaging. For the probe to easily cross the cellular mem-
brane, lipophilicity is required.61,62 Therefore, it is important to have a balance be-
tween aqueous solubility and lipophilicity. Depending on the precise application of
the probe, they must exhibit specific localisation within a cell or have the ability to be
conjugated to a biological molecule that can induce this specificity.61 If the probe is
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also to be used for sensing, then it must have a preferential repose to a specific change
in the environment (eg: pH or concentration of Ca2+) that can be easily monitored
and measured.62 The biodistribution of the probe must also be considered if eventually
applied in vivo.
High stability and kinetic inertness are required to reduce photobleaching and poten-
tial toxic effects the probe might exhibit. The probe cannot exhibit toxicity to the bi-
ological environment at any time during an imaging experiment.6,62 This includes the
generation of singlet oxygen (1O2) to a toxic concentration upon irradiation (discussed
below). Generation of 1O2 is often difficult to avoid and therefore careful planning is
required to ensure that the concentration of 1O2 is kept to a minimum, so that the cell
is not impacted.
1.3.2.2 Photophysical Properties: Tissue Penetration
For biological imaging (ex vivo/in vivo), it is vital that the light used to excite the
applied dye penetrates the tissue easily. Svoboda et al. describe a “window of trans-
parency” for biological materials where certain wavelengths of light can easily pene-
trate the tissue. This translates to more efficient excitation and detection of the dye,
into deeper tissues.63
Figure 1.11: Graph illustrating the relative transparency of biological material.63
Biological chromophores such as haemoglobin and other abundant cytochromes ab-
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sorb increasingly less light towards the NIR region of the spectrum.64 On the other
hand, water becomes less transparent to light further into the IR and so these opposing
patterns of light absorption form a window of transparency: ~ 600-1250 nm as seen
in Figure 1.11.63 Therefore the probe should be optimised in order to absorb and emit
radiation within this region, for maximum tissue penetration. UV radiation can cause
damage to live tissue and so excitation in this region should be avoided.65,66 Probes
with the potential for two photon absorption can overcome this issue as longer wave-
lengths of light (close to the red/NIR region of the spectrum) are used for excitation.67
1.3.2.3 Photophysical Properties: Stokes Shift and Lifetime
Large Stokes shifts are required to overcome the problems associated with self-quenching
and interference from autofluorescence.61 Endogenous cellular species typically have
Stokes shifts in the order of tens of nm. If the applied dye has an appreciably differ-
ent excitation and emission wavelength to the endogenous species, autofluorescence
can be minimised through specific excitation of the dye and/or the use of various fil-
ters to block out autofluorescence. Figure 1.12 shows a basic schematic of a fluores-
cence microscope, including the location of excitation and emission filters.68 If the
applied dye has an appreciably longer lifetime compared to the endogenous species
(lifetimes of typically <10 ns), then time gated imaging techniques can be employed
to reduce/remove the autofluorescent signal. Time gating components can be placed
before the detecor (Figure 1.12), to ensure significant time delay, before detection.
The endogenous species will only fluoresce for a short time and once the excitation
source is removed, the probe should continue to luminescence for a longer period61,68
as illustrated in Figure 1.13.
Many conventional epifluorescence microscopes have filter cubes (Figure 1.12) from
the UV to visible spectrum where the excitation and emission bands allowable for each
filter is fairly narrow. This can be an issue in regards to the large Stokes shifts of many
metal complexes as the excitation may require a filter cube in the UV region but emis-
sion will be far away in the green. Specialised filter cube systems can be employed to
avoid this issue however they are not common and usually require specific manufacture
or purchase.
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Figure 1.12: Basic schematic of a fluorescence microscope.
Figure 1.13: Schematic showing the advantage of time gated techniques in conjunction
with phosphorescent probes.
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Another option is to use laser excitation in confocal microscopy where emission can
be detected across multiple channels at once allowing for the use of probes with large
Stokes shifts.
It is not trivial to design a probe optimised in all of the areas listed above. Therefore
it is important to consider all of these aspects in their design to ensure a reasonable
balance between the physical, chemical and photophysical properties.
1.3.3 Advantages of Heavy Metal Complexes in Optical Imaging
Heavy metal complexes have the potential to exhibit the desirable photophysical and
chemical properties discussed above, making them attractive candidates for biologi-
cal imaging.25 The d6 metal complexes have become widely studied in this field but
also d8 platinum(II) and d10 gold(I) complexes. Lanthanide complexes have also been
studied in bioimaging applications.69–73 The emergence of the application of d6 metal
complexes in optical imaging has occurred due to their highly favourable photophysi-
cal properties and coordination chemistry.74 Heavy metal complexes generally exhibit
large Stokes shifts, (up to hundreds of nm) and long luminescence lifetimes (hundreds
of ns to ms) which can open up the opportunity to carry out time gated imaging tech-
niques which are not possible with many commercially available organics.25,68 In their
low spin d6 state, they are kinetically inert, which helps prevent photobleaching. This
stability can also translate to a reduced toxicity. A problem associated with phos-
phorescent metal complexes (emission from the triplet state) is that they are prone to
quenching by 3O2. This reduces the luminescence intensity from the sample and also
produces 1O2 which can be harmful to the biological sample.68,75 Another advantage
of heavy metal complexes is that their synthesis can be more straight forward com-
pared to organic molecules; it can be easier to change and modify ligands. There is
also the opportunity for a range of ancillary ligands to be used with these metals which
can be a way to alter their physical, chemical and photophysical properties.25,68 There
has been a surge in the number of publications and reviews surrounding the use of d6
metal complexes as luminescent optical imaging agents, with a strong emphasis on
tuning their chemical and photophysical properties.
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1.4 Brief Review of Metal Complexes in Optical Imag-
ing
Metal complexes are already routinely used in clinical applications of MRI, PET and
SPECT, however, the use of luminescent d6 metal complexes in optical imaging is still
not well established. Research into their use as alternative optical imaging probes is
expanding. A short overview covering the development of Ir(III), Ru(II) and Re(I)
metal complexes in optical imaging is presented below. Evidence of the expanding
field is noted in the wide variety of optical imaging applications investigated. Some
studies focus on the metal complexes alone, relying on the properties of the molecule
to exhibit localisation, whereas other research has looked at complexes conjugated
to a biomolecule to confer uptake or specificity.25 Confocal microscopy is the main
technique used to evaluate the biological behaviour of these complexes. Some studies
also employ two-photon absorption microscopy or time gated imaging.
1.4.1 Iridium
Ir(III) complexes of the form Ir[(C^N)2Ir(L^L)] are the most commonly studied type of
iridium complexes in luminescent imaging applications; where C^N is a monoanionic
cyclometallating ligand and L^L is a chelating neutral ligand, which combine to give
an overall cationic complex.61,62,68 The first report on the use of iridium complexes
in luminescent cell imaging was in 200876 where two fluorinated Ir complexes were
shown to stain the cytoplasm of HeLa cells. The complexes were also found to be non
toxic to these cells. Yu’s complexes, 50 and 51 (Figure 1.14) exhibited green and red
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Figure 1.14: Iridium complexes reported in 2008.
emission respectively.76
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Although mostly cationic iridium species have been investigated, a recent study by
Zhou et al.77 has demonstrated that a series of neutral iridium carbene complexes stain
the cytoplasm of cells without the need for extra functionalisation.
The first report using time-resolved emission imaging with iridium complexes in cells
was in 2010 by Murphy et al.78 The investigation showed the potential of Ir(III) com-
plexes to be imaged without interference from autofluorescence. Time gated imag-
ing was also used to discriminate emission of the Ir(III) from other dyes with shorter
lifetimes. The complex studied is in the typical form for an Ir(III) probe, as seen in
Figure 1.15.78
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Figure 1.15: Iridium complex used in time gated cellular imaging.
Figure 1.16: Fluorescence microscopy of CHO cells stained with Ir complex (52) and
Hoechst using time gated imaging. (a) no delay between laser pulse and aquisition and
(b) image recorded after 10 ns delay.
Figure 1.16 shows the incubation of CHO cells with 52 and Hoechst (an organic nu-
clear stain), from the study of Murphy et al.78 Image a is flooded with the blue emis-
sion from the Hoechst, whereas image b taken 10 ns after the laser pulse, shows pre-
dominantly the green emission from 52.
The extreme colour tunability of Ir(III) complexes was demonstrated in a recent pub-
lication by Zhang and co-workers who developed a cationic, NIR-emitting complex
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Figure 1.17: NIR emitting Iridium complex.
which stains the cytoplasm of living cells (Figure 1.17).79 By modifying both the
cyclometallating and diimine ligand from their basic formations, Zhang et al. was able
to tune the emission properties of the complex, with 53 exhibiting a structured emis-
sion (typical of Ir complexes) at 698, 760 nm.79 This emission wavelength is desirable
as it is in the red/NIR region of the spectrum.
Iridium complexes have also been explored as phosphorescent sensors for biological
ions. A report from You et al.80 investigated the detection of a range of metal ions by
introducing metal-chelating receptors onto the Ir(III) complexes. Figure 1.18 shows an
example of a complex synthesised, demonstrating the ability to sense Zn2+.
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Figure 1.18: Iridium complex exhibiting increasesd emission intensity upon coordina-
toin to Zinc ions.
The study was also extended to sense Zn2+ in mammalian cells. Despite the success of
their probes, You et al. raise the issue of 1O2 generation in biological samples, leading
to high cytotoxicity of the complex.
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1.4.2 Ruthenium
The most common form that Ru(II) imaging agents take is based around the [Ru(bpy)n]2+
core with a total of three diimine ligands coordinated to the metal centre.68 Two of
these three ligands may be a simpler diimine unit such as bipyridine or phenanthro-
line and the third is often a substituted version conferring specific properties to the
complex.62 Ruthenium has been studied for applications as both imaging and sens-
ing agents.62 One of the most commonly known uses in biology, for these types of
ruthenium complexes is the sensing of molecular oxygen.81,82 This is done through
monitoring the lifetime of the Ru complex as the luminescence notably decreases due
to quenching from oxygen.83–85 DNA detection is also well studied using Ru com-
plexes containing extended diimine ligands such as dipyridophenazine and in these
cases, the emission of the Ru complex increases upon binding to DNA.86–89
Biotinylation of complexes has been exploited as a common strategy to aid in cellu-
lar uptake68 or for developing sensitive luminescent probes for detecting avidin (as
biotin-avidin binding is known to be strong).90 Lo et al.91,92 have synthesised a series
of Ru(II) amidodipyridoquinoxaline biotin complexes which show strong binding to
avidin, for example 55 (Figure 1.19). Interestingly the emission intensity and lifetime
of this complex (and others similar) is fairly weak under ambient conditions however
upon binding to avidin, the photophysical output of the complex is enhanced. This
study, along with others similar, show the potential for metal complexes to be used as
sensing probes for avidin.93,94
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Figure 1.19: Luminescent ruthenium(II) amidodipyridoquinoxaline biotin complex.
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1.4.3 Rhenium
Phosphorescent Rhenium(I) complexes for imaging are most commonly based around
the fac-[Re(diim)(CO)3]+ core, where diim is usually a diimine ligand such as 1,10-
phenathroline or 2,2’-bipyridine however, other ligands such as quinolines and N-
heterocyclic carbenes have also been studied. The ancillary ligand can exist in its
simplest form as a halogen (Cl, Br) but is commonly a pyridyl based ligand. A review
of d6 metal complexes in biological imaging was published in 2010 by Fernández-
Moreira et al.68 and at the time, there had only been six publications of luminescent
Re(I) complexes in cellular imaging. The first report of rhenium complexes with an
optical imaging focus was from Zubieta et al. in 2004. They looked at designing a
pair of isostructural probes based around Re(I) and 99mTc, to be used in radio- and lu-
minescent imaging, to “bridge the gap” between in vivo and in vitro imaging.95 These
complexes were based around the Re(I) tricarbonyl core, utilising the quinoline lig-
ands.
In 2007, a series of Re(I) complexes were synthesised and incubated with parasitic
flagellate (Spironucleus vortens). This study was the fist report of Re(I) phosphores-
cent complexes incubated with a biological sample and imaged using microscopy.96
The Re(I) complexes consisted of bipyridine and substituted phenanthroline ligands
with a range of pyridyl ancillary ligands, for example 56 (Figure 1.20).96 Confocal mi-
croscopy studies revealed that the complexes retained their fluorescence in biological
systems. The conclusions of the study indicated that [Re(diim)(CO)3(L)]+ complexes
may be viable probes for luminescent imaging. Interestingly, a follow up publication
from the same group showed that derivatives of 56 exhibited mitochondrial accumula-
tion in MCF-7 cells.97
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Figure 1.20: One of the first Re(I) bipyridine complexes used in luminescent cellular
imaging studies.
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Lo and co-workers98 were the next group to publish studies of Re(I) complexes as lu-
minescent cellular imaging agents. The complexes synthesised were chemically more
elaborate than in the report of Amoroso et al. in 2007,96 as they were conjugated to
biotin and contained an isothiocyanate group, which was shown to react with amines
to give the corresponding thiourea. An example of this product is complex 57 (Fig-
ure 1.21)98, which was applied to a HeLa cell line and showed passive uptake into the
cytoplasm of the cells (no co-localisation experiments were undertaken).
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Figure 1.21: A Re(I) biotin isothiocyanate complex used in luminescent cellular imag-
ing studies.
In 2009 Louie and co-workers published the synthesis of a rhenium complex with a
functionalised ancillary pyridine ligand which demonstrated sensitivity to the environ-
ment.99 For example, increased pH generally quenched the emission however in the
presence of Zn2+ and Cd2+ ions, τ increased and emission was enhanced. Cellular
imaging experiments with these complexes revealed cytoplasmic localisation. These
were the first examples of rhenium metal complexes showing a photophysical response
toward Zn2+ and Cd2+ ions (also in vitro). Despite this, the probe is not optimised and
exhibits fairly poor sensitivity to the particular cations. The probe also exhibits toxic-
ity greater than cisplatin. Nonetheless, the fundamental study showed the potential for
further development of Re(I) complexes as biological sensors.
1.4.4 Summary
Ruthenium d6 metal complexes have been more heavily investigated as specific O2
sensors or for DNA intercalators in the context of biological imaging. There does
not appear to be the same focus on Ru(II) complexes as stand alone optical probes,
as there is with Ir(III) and Re(I). Many studies surrounding ruthenium complexes are
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aimed towards applications as therapeutic anti-cancer agents.100–102 Iridium d6 metal
complexes are photophysically desirable for imaging applications as their emission is
highly tunable. Their cationic and relatively lipophilic nature makes their uptake into
cells efficient. Localisation of Ir(III) complexes has generally been observed in the
cytoplasm of cells with many reports observing non-specific uptake. The majority of
rhenium complexes reported for applications in optical imaging have demonstrated the
to be easily substituted, altering photophysical output but also cellular uptake. There
have been examples of rhenium complexes localising in various cellular organelles,
including membranes,103 mitochondria97,104 and also the nucleoli.103 Despite the rise
in publications, the field of metal complexes for optical imaging is still in its infancy
and there is a lot to understand in relation to their behaviour in biological environments;
including localisation, responsiveness and toxicity. Optical imaging is a technique
with both clinical diagnostic and research applications and therefore the development
of improved probes is vital for the advancement of the field
1.5 Rationale and Overview of the Project
Many complexes, specifically utilising Ir(III), Ru(II) and Re(I) have been developed
with the intent for being used as optical imaging and/or sensing probes. Several of
these complexes do in fact show many of the desired properties required for these
applications. However, it is still not a trivial task to optimise all aspects of optical
probes, including the chemical structure (for solubility and stability) and photophysi-
cal properties. Even more of a challenge is understanding how to control the uptake
and localisation of the complexes in cells. Many of the attempts discussed above have
been serendipitous, without complete knowledge of what particular structural proper-
ties govern uptake and specific localisation. Even minor changes to the chemical struc-
ture, charge or lipophilicity can greatly influence the localisation of the complexes in
cells.105
To further expand the knowledge in this field, the study herein investigates a series
of rhenium complexes, of the type fac-[Re(diim)(CO)3(L)], where diim is either 1,10-
phenanthroline (phen) or 2,2’-bipyridine (bipy) and L is one of a series of 5-substituted
aryl tetrazoles, as shown in Figure 1.22.
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Figure 1.22: Re(I) tetrazolato complexes of the type; fac-[Re(diim)(CO)3(L)].
1.5.1 Tetrazoles
Tetrazoles are a class of aromatic heterocyclic compounds, consisting of a five mem-
bered ring with four nitrogen atoms and one carbon atom. They are carboxylic acid
isosteres106 exhibiting a similar pKa.107 Tetrazoles are used in medicinal chemistry as
a metabolically stable analogue of the carboxylic acid moiety.108,109 They also demon-
strate enhanced biological stability. Tetrazoles exist in two tautomeric forms, as illus-
trated in Scheme 1.1.
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Scheme 1.1: The N1 and N2 tautomers of tetrazoles.
The first known study of the coordination of a tetrazolate anion to a rhenium metal
centre was by Szczepura et al. in 2007 where 5-methyl-tetrazolate was coordinated
to a hexanuclear Re6Se82+ cluster core.110 The synthesis involved the addition of N3-
to a coordinated molecule of acetonitrile to produce the first example of a tetrazolato
rhenium complex.
Studies have also shown the sensitivity of tetrazolate ligands coordinated to various
metal centres including, iron111,112 iridium113 and ruthenium.114 When these com-
plexes undergo reactions with electrophiles structural and/or photophysical changes
are observed. Despite the use of tetrazolato ligands in a range of coordination com-
plexes, up until 2014, there had been no reports of rhenium tetrazolato complexes in
biological imaging.115 The sensitivity of tetrazoles is exploited herein, as part of the
fundamental research into the fac-[Re(diim)(CO)3(L)], to not only be applied in opti-
cal imaging but also as responsive probes (sensing agents).
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1.5.2 Structure Property Relationship
Up until 2010 the number of reports of Re(I) complexes in optical imaging were mini-
mal and it is still the least investigated out of the metal d6 complexes mentioned above.
Rhenium complexes have also shown the ability to respond to their environment to
produce a detectable photophysical repose.99,116–120 The aim of this multidisciplinary
research is to increase the understanding of how small changes to the structure of fac-
[Re(diim)(CO)3(L)] complexes affect their chemical and photophysical properties as
well as uptake and localisation in a biological environment. By making small structural
modifications to the core fac-[Re(diim)(CO)3(L)] complex, a structure-property rela-
tionship can be established. As part of this, the sensing potential of these complexes is
explored in a fundamental manner. Figure 1.23 provides an overview of the types of
structural modifications made to the Re(I) tetrazolato complexes throughout this study.
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Figure 1.23: Structural modifications to Re(I) complexes.
1.5.2.1 Analysis
Various techniques are employed to gain an insight into the structure-property relation-
ship of the fac-[Re(diim)(CO)3(L)] complexes. Infrared spectroscopy and NMR are
used to gain a basic understanding of structure. These techniques will also be used to
indirectly determine the change/movement of electron density on the complexes upon
structural modification. This also assists the interpretation of photophysical measure-
ments. X-ray crystallography is also used in the structural identification of the Re(I)
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complexes in the solid state. X-ray crystal analyses were done in collaboration with
Dr. Brian Skelton from the University of Western Australia and Associate Professor
Stefano Zacchini from the University of Bologna. Photophysical characterisation was
carried out to determine how the excitation and emission energies, as well as φ and τ
of the complexes are altered through changes to structure and overall charge.
To further interpret the photophysical measurements of the Re(I) complexes, time-
dependent density functional theory (TD-DFT) was employed. DFT is a theory which
represent electrons as a density “cloud” and is based on optimisation of this electron
density. Earlier molecular orbital theories (such as the Hartree-Fock method) are based
on the optimisation of wavefunctions.121,122 TD-DFT is an extension of DFT and is
necessary to use when external, time dependent potentials are taken into considera-
tion.123 This is of particular relevance when looking at the excitation of molecules
with light. TD-DFT was used to simulate the absorption spectra whereas DFT was
used to determine the minimised geometry for the complexes in the ground state and
to produce the orbital diagrams. The calculations were all done in collaboration with
Mr. Philip Wright and Dr. Paolo Raiteri from Curtin University.
Confocal imaging experiments were conducted to assess the uptake, localisation and
toxicity of a range of the synthesised rhenium complexes.
The combination of each technique described above was used to recognise how struc-
tural changes to the complexes affect the chemical and photophysical properties, as
well as their behaviour in a biological environment.
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Chapter 2
Synthesis, Structural and
Photophysical Investigation of Neutral
Rhenium Tetrazolato Complexes
2.1 Abstract
The synthesis, structural and photophysical properties of a series of fac-[Re(diim)(CO)3(L)]
complexes are reported, where diim is either 1,10-phenanthroline (phen) or 2,2’-
bipyridine (bipy) and L is one of a series of 5-substituted aryl tetrazolates. NMR
and X-ray crystallography revealed that all of the tetrazolato ligands coordinated to
the Re centre through the N2 atom. The absorption profiles indicated the presence
of high energy pi −pi* transitions and lower energy transitions which were assigned
to admixtures of metal-to-ligand charge transfer (MLCT) and ligand-to-ligand charge
transfer (LLCT) bands. The mixed nature of these bands lends their assignment to a
metal-ligand-to-ligand charge transfer (MLLCT), which was also supported by TD-
DFT. The photophysical output of the phen complexes were superior to that of the
bipy analogues in terms of τ and φ . The electron withdrawing para substituents on the
phenyltetrazolato ligand allowed fine tuning of the complexes photophysical proper-
ties, including their τ and φ , and to a lesser extent the maximum emission wavelengths.
31
2.2 Introduction
Wrighton and Morse first studied the luminescent properties of fac-[Re(phen)(CO)3(Cl)]
in 1974 and identified that the observed emission was from a 3MLCT state and was
therefore classified as phosphorescence.124 Since then, a number of studies have been
published investigating the interesting photophysical and photochemical properties
demonstrated by complexes based around the fac-[Re(diim)(CO)3]+
core.49,125–147 In recent years the applications of rhenium complexes have expanded
to organic light emitting devices (OLEDs)148–150 and photocatalysis.151–153 More re-
cently, their investigation as optical imaging and/or sensing agents has
increased,68,95,103,105,154–158 due to their highly favourable photophysical properties in
comparison to the commonly used fluorescent probes. Many studies on rhenium com-
plexes as optical imaging agents have investigated them as a simple molecules68,95,103,154
or as extended systems conjugated to biologically relevant compounds157,159–161 (to
confer uptake and specificity).
Important to the development of metal complexes as optical imaging agents is the
fundamental understanding of how small structural changes to the molecule will ef-
fect the chemical, photophysical and biological properties. The specific properties
include stability and solubility, λ ex, λ em, φ and τ as well uptake, localisation and tox-
icity of the complexes in a biological environment. Development of optical imaging
probes/sensors is a multidisciplinary area of research requiring extensive fundamental
studies to completely understand each aspect of the potential probe. Optimisation of
the chemical, photophysical and biological properties is not a trivial task. Therefore,
an increased understanding of what structural changes govern different properties, is
vital for progression of the field.
Previous research has shown the great potential for rhenium complexes to be developed
either as stand alone imaging probes or sensors as well as the ability to be bioconju-
gated to confer specificity. The work described in this chapter is based on the design,
synthesis and photophysical investigation of a series of neutral fac-[Re(diim)(CO)3(L)]
complexes where the diimine ligand is either 1,10-phenanthroline (phen) or 2,2’-
bipyridine (bipy) and L is one of a series of para functionalised 5-aryltetrazolates.
These ancillary ligands (L) are 5-phenyl-1H-tetrazole (TphH), 4-(1H-tetrazol-5-yl)-
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benzaldehyde (TbzH), Methyl-4-(1H-tetrazol-5-yl)-benzoate (TmebH), 4-(1H-tetrazol-
5-yl)cyanobenzene (TcyaH), 5-(4-iodophenyl)-1H-tetrazole (TIodH) and 5-(4-bromophenyl)-
1H-tetrazole (TBrH). Scheme 2.1 shows the Re(I) complexes described in this chapter
and their associated abbreviations.
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Scheme 2.1: The neutral Re(I) complexes reported in Chapter Two and their abbrevia-
tions.
Positively charged rhenium analogues typically exhibit blue shifted emissions and su-
perior photophysical properties (τ and φ ), according to the energy gap law.47,48,162 The
tetrazole ancillary ligand will form an overall neutral complex once coordinated to rhe-
nium but is used here for its biological compatibility.107 Moreover, tetrazole ligands
are generally strong σ donors but also pi acceptors,111 which should aid in increasing
the HOMO-LUMO energy gap of these Re(I) complexes and therefore their lumines-
cent output compared to those where the ancillary ligand is a halogen or other pi donor
ligand. Complexes containing a proton as the para substituent (Scheme 2.1) will act
as the fundamental probes in establishing a structure-property relationship between the
complexes. It is necessary to understand how changing to the nature of the ancillary
ligand (various para functional groups) or diimine ligand (phen versus bipy) will af-
fect the properties of the Re(I) complexes. The para substituent on the tetrazole ligands
will not only aid in determining a structure-property relationship but can act as a point
of conjugation to biomolecules.
33
2.3 Results and Discussion
2.3.1 Synthesis and Spectroscopic Characterisation of the 5-aryl-
1H-tetrazoles
The synthesis of the 5-aryl-1H-tetrazoles was carried out using a relatively safe, high
yielding and straightforward procedure developed by Koguro et al.109 as outlined in
Scheme 2.2.
NC R R
H
NN
N N
+ NaN3
1. Et3NHCl
Toluene
Reflux, 24 h
2. H2O/HCl
Scheme 2.2: Synthesis of the 5-aryl-1H-tetrazoles.
Triethylammoniumchloride is formed in situ and once the azide is added, the interme-
diate [Et3N•HN3], is formed. This is only approximately 1% soluble in toluene but
is polarised as [Et3NH]δ+[N3]δ - , which is not solvated in toluene. It therefore has
increased reactivity towards the nitrile, compared to using solvents which can solvate
this intermediate (for example dimethylformamide).109 [Et3NH]δ+[N3]δ - reacts with
the triple bond of the nitrile to produce the triethylammonium salt of the final product
via a 1,3-dipolar cycloaddition. There is still debate in regards to the exact mechanis-
tic pathway for these types of reactions. One is the concerted cycloaddition pathway
and the other is a two-step mechanism where the azide first acts as a nucleophile and
reacts with the nitrile, followed by ring closure.163 A study by Himo et al. indicates
that these two mechanistic pathways are essentially the same. The transition state for
the concerted 1,3-dipolar cycloaddition is the same as the ring closing state for the two
step pathway.164
The final tetrazole product was isolated as a white to off-white solid through the ad-
dition of acid, precipitating out the neutral tetrazole ligand. Melting points were at-
tempted however in all cases decomposition was observed instead due to the high
percentage of nitrogen atoms. The decomposition points for the tetrazoles synthe-
sised vary from literature values, up to 16 °C, however difficulties in obtaining consis-
tent data have been previously reported.163 The spectroscopic characterisation of the
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products agrees with the proposed structures. The yields of the various tetrazoles are
reported in Table 2.3.1.
Table 2.3.1: Yields obtained for each of the prepared aryl tetrazoles.
Tetrazole R Yield (%)
5-phenyl-1H-tetrazole (TphH, 1) H 50
4-(1H-tetrazol-5-yl)-benzaldehyde (TbzH, 2) CHO 89
methyl 4-(1H-tetrazol-5-yl)-benzoate (TmeH, 3) COOCH3 59
4-(1H-tetrazol-5-yl)cyanobenzene ( TcyaH, 4) CN ~ 43
5-(4-bromophenyl)-1H-tetrazole (TBrH, 6) Br 63
5-(4-iodophenyl)-1H-tetrazole (TIodH, 5) I 57
The spread in the yields can be attributed to the different para functional groups on the
organonitrile. The reactivity of the nitrile is increased when the -R group is electron
withdrawing, as it polarises the nitrile making the carbon atom more susceptible to
nucleophilic addition. The prepared tetrazole species were further characterised using
IR and NMR.
The main IR bands indicative of tetrazole formation are the aromatic C=N and NH
stretches, observed at approximately 1600 and 3400 cm-1 respectively. These peaks are
not observed in the organonitrile starting material and their presence in the products
supports formation of the tetrazole ring. The disappearance of the sharp nitrile band
(C≡N) around 2260-2240 cm-1 also supports consumption of the starting material.
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Scheme 2.3: The N1 and N2 tautomers of tetrazoles.
Tetrazoles exist in two tautomeric forms, with the tetrazolic proton residing on either
the N1 or N2 atom (Scheme 2.3). NMR studies by Butler et al. on analogous N1
and N2 methylated 5-aryl tetrazoles has determined that chemical shifts for the tetra-
zolic carbon (Ct) ranging from 156-152 ppm indicate the predominant presence of
the N1 tautomer; whereas values in the range of 165-162 ppm correspond to the N2
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tautomer.165–167 In studies looking at 5-substituted phenyl tetrazoles, Butler also pro-
posed that the Ct can be used to probe the extent of interannular conjugation between
the tetrazole and phenyl rings. The tetrazole ring can exhibit an inductive withdrawal
effect (-I) on the phenyl ring as shown in Scheme 2.4 a. There is also the possibility
for the tetrazole ring to mesomerically withdraw (-M) or donate (+M) electron density,
as shown in Scheme 2.4. The effect that the tetrazole ring exhibits greatly depends
on the substituents on the phenyl ring. The higher resonances observed for the Ct in
the N2 tautomer supports an increase in the interannular conjugation between the aryl
and tetrazole rings as there is an increase in +M from the tetrazole to the phenyl ring
(Scheme 2.4 b-c). This requires the 2p orbitals of the tetrazole and phenyl rings to be
parallel (ie: the two rings must be coplanar).
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Scheme 2.4: Inductive withdrawal (-I), mesomeric donation (+M) and mesomeric
withdrawal (-M) effects of the tetrazole ring. *c and e are not the only resonance
formulae that are possible for +M and -M respectively.
Resonance formulae of the c and e type in Scheme 2.4 suggest that the two rings are
coplanar in the N2 tautomer, whereas the shielded Ct of the N1 tautomer indicates
a more twisted ring system.165–167 The steric hindrance present in the N1 tautomer
causes out of plane rotation of the rings (Scheme 2.5).166 The twisted ring config-
uration reduces interannular conjugation and the intensity of possible +M donation,
resulting in the predominance of -I (Scheme 2.4).
In DMSO-d6, all of the prepared aryl tetrazoles (1, 2, 3, 4, 5 and 6) exhibit Ct signals
around 155 ppm. The NMR values of the tetrazole compounds are further discussed
in section 2.3.2.2 and shown in Table 2.3.3. According to the studies of Butler, the
Ct value of 155 ppm observed here, indicates the presence of the N1 tautomer. In fact,
the N1 tautomer is more polar and is therefore favoured in polar DMSO.167
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Scheme 2.5: Twisted and planar structures of the N1 and N2 substituted tetrazoles.
2.3.2 Synthesis and Spectroscopic Characterisation of the Neutral
Re(I) complexes
The neutral Re(I) complexes of the form fac-[Re(diim)(CO)3(L)] were synthesised
using a range of methods, outlined below. Commercially available [Re(CO)5(X)]
(where X is Cl or Br) was heated at reflux with phen or bipy in toluene producing fac-
[Re(diim)(CO)3(X)] in high yields, according to previously published methods.168,169
Complexes fac-[Re(phen)(CO)3(Tph)](11), fac-[Re(bipy)(CO)3(Tph)] (12),
fac-[Re(phen)(CO)3(Tbz)] (13), fac-[Re(bipy)(CO)3(Tbz)] (14), fac-[Re(phen)(CO)3(Tcya)]
(17), fac-[Re(bipy)(CO)3(Tcya)] (18), fac-[Re(phen)(CO)3(TBr)] (19)
and fac-[Re(phen)(CO)3(TIod)] (20) were synthesised according to the method out-
lined in Scheme 2.6. To a suspension of fac-[Re(diim)(CO)3(X)] in ethanol/water (3:1
v/v), the corresponding tetrazole ligand with triethylamine was added. After heating
at reflux for 20 hours, the final complex was filtered off and did not require further
purification. The exception was 17, purified by column chromatography.
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Scheme 2.6: Synthesis of the neutral rhenium tetrazolato complexes using an
ethanol/water solvent system, where X is Cl or Br.
This method does not rely on first forming a solvato170 or triflato171–173 rhenium com-
plex and subsequently the halogen ligand is directly substituted by the deprotonated
tetrazole alone. Any unreacted starting material, fac-[Re(diim)(CO)3(X)], remains
dissolved in the ethanol/water (3:1 v/v) solvent system and the product forming pre-
cipitates out for a convenient isolation. In some cases, if there was no solid present
in the reaction upon cooling, some of the ethanol was evaporated off until the first
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presence of solid was observed. At this point, no more solvent was removed and the
reaction was placed in an ice bath to encourage precipitation.
The synthesis of fac-[Re(bipy)(CO)3(Tme)] (16) was carried out using a previously
published method, as outlined in Scheme 2.7.154,170 AgBF4 and fac-[Re(bipy)(CO)3(Cl)]
(8) were heated at reflux in acetonitrile to form the acetonitrile solvate,
fac-[Re(bipy)(CO)3(NCCH3)]+ (43). 43 was not isolated but filtered off from a white
precipitate (AgCl) and immediately used. Methyl-4-(1H-tetrazol-5-yl)-benzoate (3)
was deprotonated using triethylamine, added to the yellow solution of 43 and heated
at reflux for 60 hours. The complex was purified by reprecipitation with acetoni-
trile/dichloromethane (1:4) and excess diethyl ether.
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Scheme 2.7: Synthesis of 16 via halogen abstraction.
The synthesis of fac-[Re(phen)(CO)3(Tme)] (15) was carried out according to a previ-
ously published method.174 fac-[Re(phen)(CO)3(Cl)] (7) and the methyl-4-(1H-tetrazol-
5-yl)-benzoate (3) (deprotonated using triethylamine) were heated at reflux in acetoni-
trile for 60 hours. The final complex was purified via column chromatography on
neutral alumina using ethyl acetate (100%) as the eluent (second product, yellow).
Out of all the methods used, the one employing ethanol/water as the solvent system
was the most straightforward. Generally no further purification was required and good
yields were achieved in a 24 hour period, which is shorter than the time required for
the other methods (48 h).174 The starting material was not recovered however the
high overall yields (63-82 %) were satisfactory. This method was trialled with both
fac-[Re(phen)(CO)3(Cl)] (7) and fac-[Re(phen)(CO)3(Br)] (9) however the reaction
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seemed to proceed better with the bromo analogue. This could be ascribed to the more
labile nature of Br over Cl, making it easier to be displaced by the tetrazolate anion.
The silver abstraction method, employing acetonitrile as the solvent generally pro-
duced a mixture of starting and final complexes.174 Column chromatography was used
to purify the product and recover the starting material. The silver abstraction method
produced high yields, unless a column was employed for purification. The yield of
fac-[Re(bipy)(CO)3(Tme)] (16) was 90 % and purification was achieved through a
simple reprecipitation. In general, whenever a column was used for purification, over-
all yields were significantly lower. However, the advantage of purification via column
chromatography was the recovery of the starting material, fac-[Re(diim)(CO)3(X)].
2.3.2.1 Infrared Spectroscopy Analysis
The Re(I) diimine complexes were all isolated as the facial isomers (fac-[Re(diim)(CO)3(X)]),
confirmed by IR (and X-ray crystallography). The meridional isomer is not formed
due to the trans effect of the CO ligands.175 Once the diimine has been coordinated,
no further substitution of carbonyl ligands will occur. This is based on the stability of
the complex formed and the increased electron density on the rhenium centre strength-
ening the remaining rhenium-carbonyl bonds via backbonding (Figure 2.1). The CO
ligands in the tetrazolato complexes were also confirmed to be in a facial arrangement.
Re C ORe C O
δ+ δ-
a b
Figure 2.1: pi backbonding of rhenium to a carbonyl ligand.
IR was used to probe the progress of reactions from the halogen precursors, fac-
[Re(diim)(CO)3(X)], to the formation of the rhenium tetrazolato complexes. Table 2.3.2
shows the changes to the stretching frequencies of the intense carbonyl bands in the
complexes. Free carbon monoxide has a bond order of three and a stretching frequency
of approximately 2143 cm-1.176 Conversely, when coordinated to a metal centre, the
stretching frequency is reduced by an amount that depends on the extent to which the
metal donates electron density into the anti-bonding orbitals of the carbonyl ligand.177
The CO ligand is a weak σ donor and good pi acceptor ligand. The σ donation occurs
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through the σ orbital on the carbon of carbon monoxide (HOMO) which contains an
electron pair. This weakly donates electron density to the rhenium metal centre form-
ing the sigma bond. Carbon monoxide also has two empty pi* orbitals, predominantly
localised on the carbon which will accept electron density from the rhenium metal
centre (LUMO). The combined effect is illustrated in Figure 2.2.
Table 2.3.2: CO stretching frequency values (cm-1) of the prepared neutral rhenium
complexes.
CO stretching frequency (cm-1)a A´(1) A´(2) A´´
fac-[Re(phen)(CO)3(Cl)] (7) 2014 1923 1885
fac-[Re(bipy)(CO)3(Cl)] (8) 2013 1891 1872
fac-[Re(phen)(CO)3(Br)] (9) 2015 1925 1882
fac-[Re(bipy)(CO)3(Br)] (10) 2011 1901 1865
fac-[Re(phen)(CO)3(NCCH3)][BF4] 2040 1938
fac-[Re(bipy)(CO)3(NCCH3)][BF4]b 2031 1909
fac-[Re(phen)(CO)3(Tph)] (11) 2019 1909 1881
fac-[Re(bipy)(CO)3(Tph)] (12) 2018 1893
fac-[Re(phen)(CO)3(Tbz)] (13) 2020 1916 1892
fac-[Re(bipy)(CO)3(Tbz)] (14) 2021 1885
fac-[Re(phen)(CO)3(Tme)] (15) 2020 1912 1887
fac-[Re(bipy)(CO)3(Tme)] (16) 2020 1902
fac-[Re(phen)(CO)3(Tcya)] (17) 2017 1912 1896
fac-[Re(bipy)(CO)3(Tcya)] (18) 2018 1923 1899
fac-[Re(phen)(CO)3(TIod)] (20) 2023 1908
fac-[Re(phen)(CO)3(TBr)] (19) 2025 1913
a; solid state FT-IR measurements, b; Previously published data obtained from an ace-
tonitrile solution.178
Rhenium complexes of the formula fac-[Re(diim)(CO)3(L)] exhibit a Cs symmetry
and therefore three separate CO bands are expected: i) A´(1), totally symmetric in
phase stretching, ii) A´(2), totally symmetric out of phase stretching and iii) A´´, asym-
metric stretching of the equatorial carbonyl ligands. The relative energies of these
bands were assigned based on previous reports.179 In the starting halogen complexes
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piRe σ C O
Figure 2.2: σ and pi interactions of the CO ligand with rhenium.
fac-[Re(diim)(CO)3(X)] (7, 8, 9, 10) the A´(1) stretch is found between 2011-2015
cm-1. In some instances, the A´(2) and the A´´ CO bands can collapse to form one
broader peak, which has been previously reported.178 Upon coordination of the tetra-
zolato ligand, the A´(1) stretching frequency increases by approximately 10 cm-1. This
can be ascribed to the increase in pi accepting abilities of the tetrazolato ligands, com-
pared to the chloro or bromo. Strong pi donation of the ancillary ligand favours reso-
nance structure “b” in Figure 2.1. This explains why the Re(I) complex exhibits lower
CO stretching frequencies when the ancillary ligand is the halogen (ie: the bond order
of the CO has been reduced, lowering the force constant). In the tetrazolato complexes,
the reduction of electron density on the rhenium centre translates to a decreased back-
bonding from the rhenium to the CO ligands, ie: “b” in Figure 2.1 is less favoured.
The intermediate products (fac-[Re(diim)(CO)3(NCCH3)]+) formed in situ as part of
the silver abstraction method, have the highest CO stretching frequencies of all com-
plexes synthesised, Table 2.3.2. This is due to the even greater reduction in electron
density on the rhenium centre as the complex has an overall positive charge, reduc-
ing the amount of backbonding to the CO ligands. A higher stretching frequency is
therefore observed as the bond order remains closer to that of a triple bond.
Studies by Palazzi et al. indicate that aryl tetrazolato ligands coordinated to [FeCp(CO)2]+
fragments show fairly strong pi accepting character.108,111 In contrast, the strength of
the rhenium back bonding onto the tetrazole seems to be much weaker in the prepared
rhenium complexes. This is noted in the IR by the relatively small increase in the CO
stretching frequencies upon coordination of the tetrazole ligand. One possible expla-
nation to this could be that there is a less favourable overlap between the diffuse 5d
rhenium orbitals and the 2p orbitals from the tetrazolic nitrogen. This is in comparison
to the more favourable overlap between the 3d and 2p orbitals of the iron and nitrogen,
respectively.
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2.3.2.2 NMR Characterisation
1H and 13C NMR studies have been carried out on all of the rhenium tetrazolato com-
plexes and the spectra match with the proposed structures. 2D HMBC experiments
were used to determine the assignment of the Hortho and Hmeta protons on the aryl
tetrazolato ligand (see Scheme 2.8 for the NMR referencing).
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Scheme 2.8: NMR referencing layout.
HMBC shows cross peaks between protons and carbons that are two or three bonds
away (in some cases, up to five bonds away). One bond cross peaks are not shown
and this is what HSQC experiments are utilised for. HSQC shows the cross peak
of a carbon and directly bonded hydrogen. HMBC experiments were used herein
to identify the Hortho, which forms a cross signal with the Ct resonance (in both the
ligand and Re(I) complexes). Where the para substituent on the tetrazolato ligand
contains a carbon, HMBC was used to identify the Hmeta. The HMBC spectra of fac-
[Re(phen)(CO)3(Tbz)] (13) in DMSO-d6 is shown in Figure 2.3. This representative
example illustrates the cross sections of the signals used to verify the relative positions
of the Hortho and Hmeta resonances.
NMR was not only useful for structure determination but was also used to assess the
structure property relationships of these complexes. The relative positions of the Ct,
Hortho and Hmeta significantly change once the tetrazole ligand is coordinated to the
rhenium centre (Table 2.3.3).
In all of the 5-substituted aryl tetrazole ligands alone, the signal of the Hortho is always
more downfield with respect to the Hmeta, except in 5-(4-iodophenyl)-1H-tetrazole (5)
where the situation is reversed. Upon coordination to the rhenium metal centre, the
Hortho and Hmeta resonances become more shielded.
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Figure 2.3: HMBC spectrum of fac-[Re(phen)(CO)3(Tbz)] (13) in DMSO-d6.
Table 2.3.3: NMR chemical shift data of the Ho, Hm and Ct for the tetrazole ligand
before and after complexation.
Rhenium complex Corresponding aryl tetrazole
(δ, ppm, Acetone-d6) (δ, ppm, DMSO-d6)
R Ho Hm Ct Ho Hm Ct
-H (11) 7.63 7.22−7.20a,b 163.4 8.05-8.03a 7.61-7.58a,b 155.2
-H (12) 7.82−7.79a 7.32−7.24a,b 163.7
-CHO (13) 7.80 7.84 162.8 8.25 8.11 155.5
-CHO (14) 7.87 8.01 163.0
-COOH (15) 7.45 7.88 162.9 8.17 8.13 155.3
-COOH (16) 7.91 7.95 163.0
-CN (17) 7.65 7.81 162.4 8.21 8.08 155.4
-CN (18) 7.72 7.96 162.5
-Br (19) 7.57 7.42 162.8 7.98 7.83 155.1
-I (20) 7.43 7.62 162.9 7.81 7.98 155.2
R: see Scheme 2.8,a; multiplet range, b; the peak includes the resonances of the Hm
and Hp.
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In all of the rhenium complexes where the tetrazolato ligand contains an EWG in the
para position, the relative signals of the Hortho and Hmeta are reversed with respect to
the starting tetrazole ligand (ie: the Hortho is now more upfield). This can be ratio-
nalised by the fact that coordination to the Re centre triggers an increased mesomeric
donation (+M) from the tetrazole compared to the predominant inductive withdrawal
(-I) effect it was having in the free ligands. The only exception to this is the fac-
[Re(phen)(CO)3(TBr)] (19) where the relative position of the signals (Ho and Hm )
remains the same. The inconsistent behaviour of the halogen containing compounds
could be explained by their competing -I and +M effects. Their electronegative nature
leads to -I whereas lone pairs of electrons facilitate +M.
The chemical shift of the Ct in the rhenium complexes has been deshielded by ap-
proximately 7-8 ppm with respect to the uncoordinated tetrazole ligands. The free
tetrazole ligands have Ct values at 155 ppm and upon coordination the Ct resonance
is observed between 165-162 ppm (Table 2.3.3). This shift can again be rationalised
in the same way used to describe the change in the Hortho and Hmeta signals. The
observed +M effect of the tetrazole ring upon coordination is suggestive of extended
interannular conjugation and coplanarity between the phenyl and tetrazole rings.166,167
The Ct resonances between 162-165 ppm also suggest that coordination of the tetrazo-
lato ligand to the rhenium centre is regioselective for the N2 position108,111,112,165 (ie:
Re-N2 linkage isomer). This assignment is also supported in the solid state by X-ray
crystallography (section 2.3.3).
Two signals around 198-194 ppm are observed in the 13C NMR of the complexes which
correspond to the CO ligands of the fac-[Re(diim)(CO)3(L)] complexes. According
to the Cs symmetry of the rhenium tetrazolato complexes, two of the three carbonyl
ligands are equivalent as they are trans to the diimine ligand and the other carbonyl
group is trans to the tetrazolato ligand. These signals are fairly weak and not well
resolved in the NMR of all complexes.
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2.3.3 X-ray Crystallography of the Neutral Re(I) Complexes
Figure 2.4: X-ray crystal structures of fac-[Re(phen)(CO)3(Tph)] (11, A),
fac-[Re(bipy)(CO)3(Tph)] (12, B), fac-[Re(phen)(CO)3(Tbz)] (13, C) and fac-
[Re(bipy)(CO)3(Tbz)] (14, D) where thermal ellipsoids have been drawn at 50% prob-
ability.
Single crystals were obtained for all of the neutral Re(I) tetrazolato complexes. X-ray
crystallographic analysis illustrates formation of the Re-N2 linkage isomer in the solid
state, as shown in Figure 2.4, Figure 2.5 and Figure 2.6. The solid state data supports
the conclusions drawn from analysis of the 13C NMR. Formation of the N1 linkage
isomer was not observed in solution nor in the solid state. This is not surprising given
the steric bulk of the fac-[Re(diim)(CO)3]+ fragment, favouring coordination of the
(also bulky) aryl tetrazolato ring at the N2 position. The three carbonyl ligands are
observed to be in a facial arrangement, consistent with the IR data.
pi-pi interactions are a relatively weak non-covalent intermolecular force however their
existence can contribute to the way a molecule packs in the solid state. pi interactions
usually occur at distances between 3.3 and 3.5 Å.
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Figure 2.5: X-ray crystal structures of fac-[Re(phen)(CO)3(Tme)] (15, A), fac-
[Re(bipy)(CO)3(Tme)] (16, B), fac-[Re(phen)(CO)3(Tcya)] (17, C) and fac-
[Re(bipy)(CO)3(Tcya)] (18, D) where thermal ellipsoids have been drawn at 50%
probability.
Figure 2.6: X-ray crystal structures of fac-[Re(phen)(CO)3(TIod)] (20, A) and fac-
[Re(phen)(CO)3(TBr)] (19, B) where thermal ellipsoids have been drawn at 50%
probability.
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Distances between aromatic molecules more than 3.8 Å are generally not consid-
ered.180 The level of intermolecular interactions throughout the lattices varies signif-
icantly between the complexes. fac-[Re(phen)(CO)3(Tph)] (11) is arranged in the
lattice to favour pi stacking of the phen units, with an average distance of 3.7 Å. fac-
[Re(phen)(CO)3(Tme)] (15), fac-[Re(phen)(CO)3(TBr)] (19) and fac-[Re(phen)(CO)3(TIod)]
(20) show evidence of moderate pi intermolecular interactions between the phen units
and the tetrazolato ligands, with an average distance of 3.6 Å calculated. The rest of
the complexes (12, 14, 16, 17 and 18) do not exhibit any evidence of pi stacking.
Table 2.3.4: Deviation from coplanarity between the aryl and tetrazole rings in the
neutral Re(I) tetrazolato complexes.
Rhenium Complex
Deviation from
Coplanarity (˚)
fac-[Re(phen)(CO)3(Tph)] (11) 2.03
fac-[Re(bipy)(CO)3(Tph)] (12) 3.26
fac-[Re(phen)(CO)3(Tbz)] (13) 6.83
fac-[Re(bipy)(CO)3(Tbz)] (14) 20.53
fac-[Re(phen)(CO)3(Tme)] (15) 10.62
fac-[Re(bipy)(CO)3(Tme)] (16) 13.17
fac-[Re(phen)(CO)3(Tcya)] (17) 26.47
fac-[Re(bipy)(CO)3(Tcya)] (18) 12.16
fac-[Re(phen)(CO)3(TIod)] (20) 11.06
fac-[Re(phen)(CO)3(TBr)] (19) 2.39
As discussed in relation to the NMR studies, Re-N2 coordination relates to extended
interannular conjugation and therefore an extended coplanar arrangement of the aryl
and tetrazole rings.111,112 The torsion angle between these rings can indicate the ex-
tent of coplanarity observed in the solid state. An absolute value for the torsion angle
close to 0° or 180° indicates coplanarity, whereas significant deviation indicates twist-
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ing. Table 2.3.4 lists the deviation from coplanarity for the complexes. Unexpectedly,
there is some deviation from coplanarity observed in the solid state, as indicated by
torsion angles between 2.03 and 26.47 º. This disagreement with the NMR data can
be rationalised by the twisted arrangement of the rings relaxing to coplanarity in solu-
tion. Also, the observed torsion angle in the crystal structures may be caused by crystal
packing interactions.170 Previously reported computational studies indicate that as in-
termolecular interactions are reduced (as in a relatively dilute solution), the torsion
angles tend to values close to zero.170
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2.3.4 Photophysical Investigation
Table 2.3.5: Absorption data for the rhenium tetrazolato complexes at 10-5 M in DCM.
Rhenium Absorption
Complex λ max/nm (ε /104M-1cm-1)
fac-[Re(phen)(CO)3(Tph)] (11) 259 (4.90), 363 (0.455)
fac-[Re(bipy)(CO)3(Tph)] (12) 251 (3.45), 285 (1.91), 373 (0.329)
fac-[Re(phen)(CO)3(Tbz)] (13) 272 (3.25). 366 (0.411)
fac-[Re(bipy)(CO)3(Tbz)] (14) 296 (3.75), 372 (0.407)
fac-[Re(phen)(CO)3(Tme)] (15) 275 (3.83), 370 (0.428)
fac-[Re(bipy)(CO)3(Tme)] (16) 252 (2.30), 288 (2.82), 370 (0.294)
fac-[Re(phen)(CO)3(Tcya)] (17) 274 (4.36), 360 (0.549)
fac-[Re(bipy)(CO)3(Tcya)] (18) 251 (2.91), 285 (3.51), 373 (0.331)
fac-[Re(phen)(CO)3(TBr)] (19) 263 (4.62), 367 (0.422)
fac-[Re(phen)(CO)3(TIod)] (20) 267 (5.15), 365 (0.500)
The absorption spectra of the neutral rhenium complexes were measured in dilute
DCM solutions at approximately 10-5 M and the absorption data is shown in Ta-
ble 2.3.5. All of the profiles (Figure 2.7 to Figure 2.9) exhibit high intensity transitions
in the UV region between 250-300 nm and a broad, lower intensity transition between
340-400 nm. Computational calculations were used to further interpret the photophysi-
cal results. The energetics and absorption spectra of (some) complexes were simulated
through TD-DFT, using GAUSSIAN09.181 The computational calculations indicate
that the high energy transitions can be assigned to pi −pi* IL transitions, which is in
agreement with reports of similar rhenium complexes.182,183 DFT indicated that for the
prepared complexes in the singlet state, the HOMO-type orbitals are mainly localised
on the rhenium metal centre but also delocalised over the entire tetrazole component
of the ancillary ligand. The LUMO type orbitals are clearly localised only on the di-
imine ligand (phen or bipy). Figure 2.10 and Figure 2.11 show the localisation of the
HOMO and LUMO, for a selection of the synthesised Re(I) complexes.
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Table 2.3.6: Photophysical data for the rhenium tetrazolato complexes at 10-5 M in
DCM. φ measured against rhodamine 101, unless otherwise stated.
Rhenium Emission 298 K
Complex λ max(nm) τ (µs)a τ (µs)b φ a φ b
fac-[Re(phen)(CO)3(Cl)] (7)d 602 0.173 0.288 - 0.036
fac-[Re(bipy)(CO)3(Cl)] (8)d 615 - 0.050 0.005
fac-[Re(phen)(CO)3(Tph)] (11) 592 0.268 0.517 0.045 0.072
fac-[Re(bipy)(CO)3(Tph)] (12) 606 0.085 0.092 0.028 0.085
fac-[Re(phen)(CO)3(Tbz)] (13) 584 0.343 0.775 0.043 0.070
fac-[Re(bipy)(CO)3(Tbz)] (14) 596 0.105 0.124 0.015 0.025
fac-[Re(phen)(CO)3(Tme)] (15)c 586 0.285 0.552 0.027 0.109
fac-[Re(bipy)(CO)3(Tme)] (16)c 600 0.092 0.118 0.011 0.015
fac-[Re(phen)(CO)3(Tcya)] (17) 584 0.382 0.518 0.060 0.053
fac-[Re(bipy)(CO)3(Tcya)] (18) 598 0.107 0.139 0.021 0.021
fac-[Re(phen)(CO)3(TBr)] (19)c 586 0.258 0.708 0.031 0.113
fac-[Re(phen)(CO)3(TIod)] (20)c 590 0.262 0.591 0.028 0.083
a; air-equilibrated samples, b; degassed (O2 free) samples, c; φ measured against
quinine sulfate, d; previously published data.48,124,169
Figure 2.7: Absorption of fac-[Re(phen)(CO)3(Tph)] (11, green), fac-
[Re(phen)(CO)3(Tbz)] (13, red), fac-[Re(phen)(CO)3(Tme)] (15, purple) and
fac-[Re(phen)(CO)3(Tcya)] (17, blue) in DCM.
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Figure 2.8: Absorption of fac-[Re(bipy)(CO)3(Tph)] (12, green), fac-
[Re(bipy)(CO)3(Tbz)] (14, red), fac-[Re(bipy)(CO)3(Tme)] (16, purple) and
fac-[Re(bipy)(CO)3(Tcya)] (18, blue) in DCM.
Figure 2.9: Absorption of fac-[Re(phen)(CO)3(TIod)] (20, red) and fac-
[Re(phen)(CO)3(TBr)] (19, blue) in DCM.
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Based on the localisation of the HOMO and LUMO type orbitals, the broad absorption
band can be assigned to a mixture of MLCT (Re→diimine) and LLCT (tetrazole→diimine)
transitions.
The close proximity of these bands has been previously described as a metal-ligand-
to-ligand charge transfer (MLLCT).145,182,184–186 For fac-[Re(phen)(CO)3(Tph)] (11)
and fac-[Re(bipy)(CO)3(Tph)] (12) the HOMO is delocalised over the complete aryl
tetrazolato ligand. For those complexes containing an EWG in the para position of
the ligand, the contribution of the aryl ring to the HOMO is reduced. By adding an
EWG to the phenyl ring, the contribution of LLCT to the MLLCT state is reduced.
The broad nature of the MLLCT band in the absorption spectra can make the identifi-
cation of the maximum difficult to assign, as has been previously reported by Villegas
et al.182 The phen complexes exhibit higher molar absorptivities (ε) compared to their
bipy analogues (Table 2.3.5), which is expected due to their increased conjugation.
Figure 2.10: Localisation of the HOMO and LUMO for the neutral phen complexes
(left to right); fac-[Re(phen)(CO)3(Tph)] (11), fac-[Re(phen)(CO)3(Tbz)] (13) and
(fac-[Re(phen)(CO)3(Tme)] (15).
The MLLCT absorption band for the complexes containing bipy are at lower energies
compared to those containing the phen ligand. According to theoretical calculations
the LUMO type orbitals are localised on the diimine ligand for all of the complexes.
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Figure 2.11: Localisation of the HOMO and LUMO for the neutral bipy complexes
(left to right); fac-[Re(bipy)(CO)3(Tph)] (12), fac-[Re(bipy)(CO)3(Tbz)] (14) and
(fac-[Re(bipy)(CO)3(Tme)] (16).
Therefore the blue shifted MLLCT observed for the phen complexes is counterintu-
itive, considering the increased conjugation of this ligand. Extended conjugation in a
LUMO system usually translates to stabilisation of the empty pi* orbitals and there-
fore a red shift is expected. However, according to the DFT, the LUMO on the 1,10-
phenanthroline ligand is not fully conjugated over the three rings as seen in Figure 2.10.
This diimine ligand actually mimics a bipyridine system with two methyl groups at-
tached (ie: 2,2’-bipyridine-3,3’-dimethyl). The additional “methyl” groups are induc-
tively electron donating and therefore destabilise the LUMO even more than the simple
2,2’-bipyridine ligand. This destabilisation causes an increase in the HOMO-LUMO
gap for the phen complexes which translates to a blue shift in the absorption, excitation
and emission spectra.
Assignment of the pi−pi* and MLLCT absorption bands was further confirmed through
the solvatochromic nature of the latter. Solvatochromism describes the stabilisation
of the excited state dipole upon change of solvent. Solvatochromism is observed
when there is a significant shift in electron density, resulting from a transition in the
molecule.187 The transition causes a change in the dipole, which is more commonly
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observed in charge transfer transitions (eg: LLCT, MLCT), rather than pi −pi* (IL) or
metal centred (MC) transitions. If the solvent has a permanent dipole then it will orient
itself with the molecule (being excited) and cause stabilisation effects.188 In particular
a bathochromic shift describes a red shift in the absorption band upon increasing the
solvent polarity and a hypsochromic shift (negative solvatochromism) corresponds to a
blue shifted transition.189 A hypsochromic shift of the MLCT band has been previously
reported for the phen and bipy parent halogen complexes.169 Upon measurement of
the absorption spectra in DCM and DMSO, a hypsochromic shift190 of approximately
14-16 nm was observed for the MLLCT bands of the prepared rhenium complexes.
The assigned IL bands were essentially unaffected by this change in solvent. The blue
shift in DMSO (a more polar solvent than DCM) suggests that the ground state of the
complexes is more polar than the excited states.
Table 2.3.7: Emission data for the rhenium tetrazolato complexes at 77 K in DCM.
Rhenium Complex Emission 77K
λ (nm) τ (µs)
fac-[Re(phen)(CO)3(Tph)] (11) 534 6.75
fac-[Re(bipy)(CO)3(Tph)] (12) 528 2.97
fac-[Re(phen)(CO)3(Tbz)] (13) 516 8.0
fac-[Re(bipy)(CO)3(Tbz)] (14) 528 3.55
fac-[Re(phen)(CO)3(Tme)] (15) 530 3.08 (21%), 8.29 (79%)
fac-[Re(bipy)(CO)3(Tme)] (16) 530 2.27 (44%), 5.59 (56%)
fac-[Re(phen)(CO)3(Tcya)] (17) 528 6.75
fac-[Re(bipy)(CO)3(Tcya)] (18) 526 3.64
fac-[Re(phen)(CO)3(TBr)] (19) 530 3.94 (30%), 9.70 (70%)
fac-[Re(phen)(CO)3(TIod)] (20) 526 3.58 (28%), 9.07 (72%)
The emission profiles of the Re(I) complexes were obtained from DCM solutions and
each complex can be characterised by a broad structureless emission band around 584-
606 nm. This profile is characteristic of emission from an MLLCT state.145,186,191
Emission from the neutral rhenium complexes originates from a 3MLLCT excited
state, accounting for their phosphorescent nature.182,190 Evidence supporting emission
from a triplet state can be found in Table 2.3.6, as the synthesised complexes exhibit
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sensitivity to molecular oxygen. It is known that molecular oxygen can quench the
triplet excited states of complexes.52 This occurs due to energy transfer from the triplet
excited state of the complex to the triplet ground state of oxygen52,54 (as outlined in
section 1.3.1.1). Upon removal of oxygen, this quenching no longer occurs, explaining
the observed increase in τ and φ upon de-oxygenating the Re(I) solutions before mea-
surement. There is also luminescence rigidochromism observed passing from room
temperature to 77 K (Table 2.3.7). The rigidochromic effect is usually indicative of
emission from a charge transfer state.127,192,193 As mentioned above, (in a fluid en-
vironment) solvent molecules can cause stabilisation of the complex by orienting to
accommodate the change in dipole occurring upon excitation. In a more rigid envi-
ronment, such as a frozen matrix, the solvent can no longer rearrange to stabilise the
complex, resulting in destabilisation of the triplet charge transfer state. This explains
the blue shifted emission observed.127 pi −pi* transitions are usually insensitive to the
medium rigidity as the transition does not involve a large change in dipole moment.193
All of the lifetime measurements at 298 K are mono-exponential (Table 2.3.6) how-
ever, as shown in Table 2.3.7, some of the complexes exhibit a bi-exponential de-
cay at 77 K. The bi-exponetial lifetime decay observed at 77 K could be attributed
to the co-existence of chemically identical species with different structural arrange-
ments/packing in the frozen matrix. Similar effects have been observed in other stud-
ies of metal complexes,194 however further strucutral analysis would be required to
confirm this hypothesis.
All of the complexes display large Stokes shifts, illustrated in the excitation and emis-
sion plots; Figure 2.12, Figure 2.13 and Figure 2.14.
The Stokes shifts are within the range of 212-234 nm which is slightly higher than
some previously reported fac-[Re(diim)(CO)3(L)]+ complexes.97,154
A slight blue shift in the absorption and emission maxima is observed when the tetra-
zolato ligand bears an electron withdrawing group (EWG). It can be rationalised that
EWGs increase the HOMO-LUMO gap by stabilising HOMO type orbitals. The
HOMO, as demonstrated through DFT (Figure 2.10 and Figure 2.11) is delocalised
over the Re 5d orbitals and also the tetrazolato ligand. Excitation of an electron from
HOMO to LUMO type orbitals therefore requires increased energy.
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Figure 2.12: Excitation and emission profiles of fac-[Re(phen)(CO)3(Tph)] (11,
green), fac-[Re(phen)(CO)3(Tbz)] (13, red), fac-[Re(phen)(CO)3(Tme)] (15, purple)
and fac-[Re(phen)(CO)3(Tcya)] (17, blue) in DCM.
Figure 2.13: Excitation and emission profiles of fac-[Re(bipy)(CO)3(Tph)] (12,
green), fac-[Re(bipy)(CO)3(Tbz)] (14, red), fac-[Re(bipy)(CO)3(Tme)] (16, purple)
and fac-[Re(bipy)(CO)3(Tcya)] (18, blue) in DCM.
56
Figure 2.14: Excitation and emission profiles of fac-[Re(phen)(CO)3(TIod)] (20, red)
and fac-[Re(phen)(CO)3(TBr)] (19, blue) in DCM.
The relatively small change observed between different EWGs can be rationalised by
the fact that they are only having an indirect effect as the HOMO is not delocalised
over the entire aryl ring of the aryltetrazolato ligand.
When comparing the lifetimes of the complexes (Table 2.3.6) it is clear that the fac-
[Re(phen)(CO)3(L)] complexes exhibit significantly longer τ than the corresponding
fac-[Re(bipy)(CO)3(L)] complexes. The phen complexes have τ in the range of 0.262-
0.382 µs whereas the bipy are in the range of 0.085-0.107µs (air-equilibrated). This
difference can be rationalised by the rigidity of phen compared to bipy, which is
known to induce vibrational quenching.195 The quantum yields for the neutral Re(I)
complexes are between 1.5-6%. When comparing complexes with the same EWG on
the tetrazolato ligand, those containing the phen always exhibit higher quantum yields.
Table 2.3.8 shows the radiative and non-radiative decay constants of the prepared neu-
tral Re(I) complexes; refer to page 9 for the equations used to calculate these constants.
The values obtained for the synthesised Re(I) complexes are within the range observed
for similar complexes.145 The phen complexes have a significantly lower knr (four to
six times) compared to their bipy analogues. A lower knr is directly related to higher
φ and elongated τ .47 Refer to 9 for the equations used to calculate the involving the
calculations
The photophysical output (φ and τ ) of the synthesised fac-[Re(diim)(CO)3(L)] com-
plexes are greatly improved compared to their parent halogen complexes48,124,169 (Ta-
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ble 2.3.6). The absorption and emission energies of the synthesised Re(I) tetrazolato
complexes are blue shifted with respect to the halogen analogues.136,151 This blue shift
along with the increased φ and τ can be accounted for by the pi accepting nature of the
tetrazolato ligands (although fairly weak as confirmed by IR) compared to the strong
pi donating nature of the halogen ligands. The pi donating nature of the halogen lig-
ands will destabilise the metal orbitals (HOMO), reducing the HOMO-LUMO gap and
increasing the knr, according to the energy gap law.47–49
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Table 2.3.8: Radiative and non-radiative decay constants (kr and knr) for the neutral
rhenium complexes calculated for the degassed (O2 free) solutions.
Rhenium Complex kr(106 s-1) knr(106 s-1)
fac-[Re(phen)(CO)3(Tph)] (11) 0.139 1.79
fac-[Re(bipy)(CO)3(Tph)] (12) 0.924 9.95
fac-[Re(phen)(CO)3(Tbz)] (13) 0.090 1.20
fac-[Re(bipy)(CO)3(Tbz)] (14) 0.202 7.86
fac-[Re(phen)(CO)3(Tme)] (15) 0.197 1.61
fac-[Re(bipy)(CO)3(Tme)] (16) 0.127 8.35
fac-[Re(phen)(CO)3(Tcya)] (17) 0.102 1.83
fac-[Re(bipy)(CO)3(Tcya)] (18) 0.151 7.04
fac-[Re(phen)(CO)3(TBr)] (19) 0.160 1.25
fac-[Re(phen)(CO)3(TIod)] (20) 0.140 1.55
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2.4 Conclusion
A series of neutral rhenium fac-[Re(diim)(CO)3(L)] complexes, where diim is either
1,10-phenanthroline or 2,2’-bipyridine and L is a 5-aryltetrazolato ligand, have been
synthesised and characterised structurally and photophysically. NMR and X-ray crys-
tallography studies confirm that all of the prepared complexes exist exclusively as the
Re-N2 linkage isomer. This allows the two rings of the ancillary ligand to have max-
imum interannular conjugation, even though some ring distortion was observed in the
solid state.
The tetrazolato ligand is a good σ donor and a partial pi acceptor (as indicated by IR),
which results in a slight reduction in electron density on the rhenium metal centre,
compared to the parent fac-[Re(diim)(CO)3(X)] complexes (where X is Cl or Br).
The lowest energy absorption transition for the Re(I) tetrazolato complexes has been
assigned to a mixed MLLCT state, as supported by theoretical calculations.
This study has given insight into how simple modifications to the diimine and ancillary
ligands effect the overall photophysical output. Those complexes where structural
modification has been made to the diimine, ie: from bipy to phen, has seen an increase
in the photophysical performance of the complex. Changing the para substituent on
the aryltetrazolato ligand does not greatly alter the photophysical properties of the
complex but can offer a way to fine tune φ and τ and, to a lesser extent the excitation
and emission energies.
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2.5 Experimental
2.5.1 General Procedures
All reagents were purchased from Sigma Aldrich or Alfa Aesar and used as received,
without further purification. All procedures involving rhenium complexes were car-
ried out under nitrogen using standard Schlenk techniques, although not necessarily
required.
Nuclear magnetic resonance spectra (consisting of 1H, 13C, 1D NOE, 2D HMBC and
HSQC experiments) were recorded using a Bruker Avance 400 spectrometer (400.1
MHz for 1H, 100 MHz for 13C) at room temperature. 1H and 13C chemical shifts were
referenced to residual solvent resonances. The assignment of peaks for the tetrazole
compounds, and their derivatives, is based on the referencing outlined in Scheme 2.8.
Infrared spectra were recorded either in the solid or solution state, as specified. Solid
state measurements were carried out using an attenuated total reflectance Perkin Elmer
Spectrum 100 FT-IR with a diamond stage. Compounds were scanned from 650 to
4000 cm-1. The intensities of the IR bands were reported as strong (s), medium (m) or
weak (w), with broad (br) bands and shoulders (sh) also indicated. IR spectra recorded
as DCM solutions were done using a NaCl (5 mm) disc on a Perkin-Elmer Spectrum
2000 FT-IR spectrometer.
Elemental analyses were performed by Chemical and MicroAnalytical Services Pty
Ltd. Victoria, Melbourne, or by Dr Thomas Rodemann at the Central Science Labo-
ratory, University of Tasmania or by Robert Herman at the Department of Chemistry,
Curtin University. All analysis were run on the desolvated bulk samples.
Melting points were determined using a BI Barnsted Electrothermal 9100 apparatus
and are uncorrected.
Photophysics
Absorption spectra were recorded at room temperature using a Perkin Elmer Lambda
35 UV/Vis spectrometer. Uncorrected steady state emission and excitation spectra
were recorded on an Edinburgh FLSP980-S2S2-stm spectrometer equipped with: i)
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a temperature-monitored cuvette holder; ii) 450 W Xenon arc lamp; iii) double ex-
citation and emission monochromators; iv) a Peltier cooled Hamamatsu R928P pho-
tomultiplier tube (spectral range 200-870 nm). Emission and excitation spectra were
corrected for source intensity (lamp and grating) and emission spectral response (de-
tector and grating) by a calibration curve supplied with the instrument. According to
the approach described by Demas and Crosby,196 luminescence quantum yields (φ )
were measured in optically dilute solutions (O.D. < 0.1) at the excitation wavelength
(nm) obtained from absorption spectra and compared to the reference emitter by the
following equation:
φx = φr[Ar(λ r)Ax(λ x)][
Ir(λ r)
Ix(λ x)][
n2x
n2r
][Dx
Dr
]
where A is the absorbance at the excitation wavelength (λ ), I is the intensity of the ex-
citation light at the excitation wavelength (λ ), n is the refractive index of the solvent,
D is the integrated intensity of the luminescence and φ is the quantum yield. The sub-
scripts r and x refer to the reference and the sample, respectively. The quantum yield
determinations were performed at identical excitation wavelengths, for the sample and
the reference, therefore canceling out the Ir(λr)/Ix(λx) term in the above equation.40
The quantum yields of the complexes were either measured against an air-equilibrated
0.1 M H2SO4 solution of quinine sulfate (φ r = 0.53) or an air-equilibrated solution of
rhodamine 101 in ethanol (φ r = 1),40 as specified.
Emission lifetimes (τ) were determined with the time correlated single photon count-
ing technique (TCSPC) with the same Edinburgh FLSP980-S2S2-stm spectrometer us-
ing pulsed picosecond LEDs (EPLED/EPL 377 nm, FHWM < 800 ps) as the excitation
source and the above-mentioned photomultiplier tube as the detector. The goodness of
fit was assessed by minimising the reduced χ2 function and by visual inspection of the
weighted residuals.
To record the 77 K luminescence spectra, the samples were placed in quartz tubes (2
mm diameter) and inserted in a special quartz dewar filled with liquid nitrogen.
Degassed solutions were prepared by gently bubbling nitrogen gas into the prepared
sample for 15 min before measurement.
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Experimental uncertainties are estimated to be ±8% for lifetime determinations, ±20%
for quantum yields, ±2 nm and ±5 nm for absorption and emission peaks, respectively.
2.5.2 Synthesis
2.5.2.1 General methodology for the synthesis of 5-aryl-1H-tetrazoles.
The synthesis of 5-aryl-1H-tetrazoles was adapted from a previously reported proce-
dure by Koguro et al.109 Unless otherwise stated, the following conditions were used.
Triethylamine (1.2 eq) was added to toluene (~ 40 mL) and the solution was cooled
to 0 ºC. 32% HCl (1.2 eq) was added to the reaction and the flask was immediately
stoppered. After 15 minutes, the corresponding nitrile (1 eq) and sodium azide (1.2
eq) were added to the reaction and heated at reflux for 24 hours. After cooling to room
temperature, water (~ 25 mL) was added to the reaction mixture. The aqueous phase
was then collected and acidified to ~ pH 3 with HCl (32%), to produce a white solid
which was filtered to yield the corresponding tetrazole.
5-phenyl-1H-tetrazole
H
H
NN
N N
1
Yield of 1: 0.706 g, 50%. M.p. 217-218 ºC (dec.) (literature value 215-216 ºC).163
νmax (ATR)/cm-1: 3130 w, 3055 w, 2981 m, 2907 m, 2835 m, 2686 s, 2539 s, 2480 s,
1860 m br, 1609 m (tetrazole CN), 1564 s, 1486 m , 1465 m, 1410 m, 1289 w, 1257
w, 1163 w, 1085 m, 1056 m, 1034 m, 1016 m, 989 m, 790 m, 725 m, 703 m, 686 m.
1H NMR (δ, ppm, DMSO-d6): 8.05-8.03 (m, 2H, CN4-C6H5 Hortho), 7.61-7.58 (m,
3H, CN4-C6H5Hmeta, para). 13C NMR (δ, ppm, DMSO-d6): 155.2 (CN4-C6H5), 131.2,
129.4, 126.9, 124.2.
4-(1H-tetrazol-5-yl)-benzaldehyde
C
H
NN
N N
O
H
2
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Yield of 2: 1.19 g, 89%. M.p. 186.8-187.5ºC (dec.) (literature value 182-184 ºC).197
νmax (ATR)/cm-1: 3403 s (NH), 3275 m, 3080 m, 3019 m, 2675 m, 2611 m, 1940 w,
1687 m, 1667 s (aldehyde CO), 1617 w, 1580 s (tetrazole CN), 1505 w, 1445 w, 1405
w, 1357 w, 1305 m, 1289 w, 1239 w, 1214 s, 1167 w, 1148 w, 1124 w, 1088 w, 1015 w,
993 m, 934 w br, 842 m, 833 m, 744 m, 697 w. 1H NMR (δ, ppm, DMSO-d6): 10.09
(s, 1H, CHO), 8.25 (d, 2H, J = 8.0 Hz, CN4-C6H4-CHO Hortho), 8.11 (d, 2H, J = 8.8
Hz, CN4-C6H4 -CHO Hmeta). 13C NMR (δ, ppm, DMSO-d6): 192.7 (aldehyde CO),
155.5 (CN4-C6H4CHO), 137.6, 130.4, 129.6, 127.64.
Methyl-4-(1H-tetrazol-5-yl)-benzoate
C
H
NN
N N
O
OCH3
3
Yield of 3: 0.748 g, 59%. M.p. 237.9-238.4ºC (dec.) (literature value 225.7 ºC).198
νmax (ATR)/cm-1: 3503 s (NH), 3312 m br, 3227 m br, 2650 m br, 1704 s (ester CO),
1654 w, 1570 m (tetrazole CN), 1504 w, 1470 w, 1442 m, 1427 m, 1310 m, 1281 s,
1191 m, 1180 m, 1151 w, 1111 m, 1068 m, 1010 w, 997 m, 955 m, 860 m, 831 w,
778 w, 732 m, 709 m, 689 w. 1H NMR (δ, ppm, DMSO-d6): 8.17 (d, 2H, J = 8.4
Hz, CN4-C6H4 -COOCH3 H ortho), 8.13 (d, 2H, J = 8.8 Hz, CN4-C6H4 -COOCH3
H meta), 3.88 (s, 3H, COOCH3). 13C NMR (δ, ppm, DMSO-d6): 165.5 (ester CO),
155.3 (CN4-C6H4COOCH3), 131.6, 130.1, 128.6, 127.2, 52.4.
5-(4-iodophenyl)-1H-tetrazole
I
H
NN
N N
5
The synthesis of 5 employed a slight excess of reagents compared to the general
methodology reported. In particular 1.5 eq of triethylamine, 32% HCl and sodium
azide were used with 1 eq of iodobenzonitrile .
Yield of 5: 0.506 g, 57%. M.p. 268-269 ºC (dec.) (literature value 269-271ºC
(dec.))199 νmax (ATR)/cm-1: 2964 w, 2816 w, 2668 w, 2514 m, 2445 m, 1906 m,
1602 s, 1557 m, 1492 w, 1478 m, 1431 s, 1405 w, 1364 w, 1272 w, 1252 w, 1165 m,
1117 w, 1088 w, 1055 m, 1025 w, 1005 w, 981 s, 826 s, 742 m, 711 w, 693 w. 1H
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NMR (δ, ppm, DMSO-d6): 7.98 (2H, d, J = 8.4 Hz, CN4-C6H4 -I Hmeta), 7.81 (2H, d,
J = 8.4 Hz, CN4-C6H4 -I Hortho). 13C NMR (δ, ppm, DMSO-d6): 155.2 (CN4-C6H4-I
), 138.3, 128.7, 123.8, 98.4.
5-(4-bromophenyl)-1H-tetrazole
Br
H
NN
N N
6
The synthesis of 6 employed a slight excess of reagents compared to the general
methodology reported. In particular 1.5 eq of triethylamine, 32% HCl and sodium
azide were used with 1 eq of bromobenzonitrile.
Yield of 6: 0.367 g, 63%. M.p. 267-270 ºC (dec.) (literature value 278-279 ºC
(dec.)).200 νmax (ATR)/cm-1: 3092 w, 2973 w, 2902 w, 2848 w, 2728 w, 2638 w, 1605
s, 1562 w, 1483 s, 1431 s, 1279 w, 1255 w, 1158 m, 1077 m, 1054 m, 1019 m, 990 m,
869 m, 876 s, 742 s, 709 w, 692 w. 1H NMR (δ, ppm, DMSO-d6): 7.98 (2H,d, J = 6.8
Hz, CN4-C6H4 -Br Hortho), 7.83 (2H, d, J = 6.6 Hz, CN4-C6H4 -Br Hmeta). 13C NMR
(δ, ppm, DMSO-d6): 155.1 (CN4-C6H4 -Br), 132.5, 128.9, 124.7, 123.6.
4-(1H-tetrazol-5-yl)cyanobenzene
C
H
NN
N N
N
4
The synthesis of 4 used no excess of the reagents, compared to the general method-
ology reported. In particular 1 eq of triethylamine, 32% HCl, 1,4-dicyanobenzene
and sodium azide (1 eq) were used. The pure form of the compound was not iso-
lated. A small amount (less than 8%) of bis-tetrazole compound, 5-[4-(1H-tetrazol-5-
yl-phenyl]-1H-tetrazole, was present in the NMR (singlet at 8.26 ppm) but the com-
pound was used in further reactions without purification.
Yield of 4: 0.253 g, ~ 43 %. M.p. 181-183 ºC (dec.) (literature value 188-189 ºC)167
νmax (ATR)/cm-1: 3433 s, 3357 s, 3246 m, 3095 m, 2537 m, 2241 and 2232 s (nitrile),
1644 w, 1619 w (C=N), 1577 m, 1564 m, 1499 m, 1437 m, 1371 w, 1281 w, 1255 w,
1245 w, 1153 w, 1124 w, 1072 w, 1060 w, 990 (947 sh) s, 848 s, 751 s, 703 w. 1H NMR
(δ, ppm, DMSO-d6): 8.21 (2H, d, J = 8.4 Hz, CN4-C6H4 -CN Hortho), 8.08 (2H, d, J
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= 8.8 Hz, CN4-C6H4 -CN Hmeta). 13C NMR (δ, ppm, DMSO-d6): 155.4 (CN4-C6H4
-CN ), 133.4, 128.8, 127.7, 118.2, 113.5.
2.5.2.2 General methodology for the synthesis of
fac-[Re(diim)(CO)3(X)]
The preparation of fac-[Re(diim)(CO)3(X)] (diim = 1,10-phenanthroline or 2,2’- bipyri-
dine) was carried out following procedures adapted from previously published work.168,169
Rhenium pentacarbonyl chloride or bromide (1 eq) and the corresponding diimine
(bipy or phen) (1.1 eq) were added to toluene and heated at reflux for 4 hours. A
yellow solid was filtered off and washed with cold toluene to yield the final complex.
fac-[Re(phen)(CO)3(Cl)]
Re
CO
OC
OC
Cl
N
N
7
Yield of 7: 0.651 g, 90%. M.p. 300 °C (dec.). νmax (ATR)/cm-1: 3897 w, 3749 w,
3088 w, 2014 s (CO, A´(1)), 1923 s (CO, A´(2)), 1885 s br (CO, A´´), 1629 w, 1602 w,
1584 w, 1518 w, 1492 w, 1425 m, 1409 m, 1340 w, 1315 w, 1302 w, 1210 w, 1196 w,
1143 w, 1108 w, 1098 w,1063 w, 961 w, 850 m, 782 w, 722 m.
fac-[Re(bipy)(CO)3(Cl)]
Re
CO
OC
OC
Cl
N
N
8
Yield of 8: 0.643 g (98%). M.p. 330 °C (dec.). νmax (ATR)/cm-1: 3749 w, 3085 w,
2013 s (CO, A´(1)), 1891 s (CO, A´(2)), 1872 s br (CO, A´´), 1601 m, 1571 w, 1491
w, 1470 m, 1443 m, 1314 w, 1246 w, 1162 w, 1122 w, 1105 w, 1070 w, 967 w, 764 m,
732 m.
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fac-[Re(phen)(CO)3(Br)]
Re
CO
OC
OC
Br
N
N
9
Yield of 9: 0.598, 92 %. M.p. 336 °C (dec.). νmax (ATR)/cm-1: 3084 w, 2015 s (CO,
A´(1)), 1925 s (CO, A´(2)), 1882 (1863 sh) s (CO, A´´), 1629 w, 1584 w, 1517 w, 1424
m, 1407 w, 1342 w, 1314 w, 1300 w, 1259 w, 1210 w, 1142 w, 1096 w, 957 w, 850 m,
782 w, 722 w.
fac-[Re(bipy)(CO)3(Br)]
Re
CO
OC
OC
Br
N
N
10
Yield of 10: 0.239 g, 92 %. M.p. 331-332 °C (dec.). νmax (ATR)/cm-1: 3067 w, 2516
w, 2397 w, 2011 s (CO, A´(1)), 1901 m (CO, A´(2)), 1865 (1851 sh) s (CO, A´´), 1603
m, 1573 w, 1493 w, 1471 m, 1442 m, 1442 (1429 sh) m, 1314 w , 1245 w, 1223 w,
1155 w, 1120 w, 1072 w, 1047 w, 959 w, 768 m, 731 w.
2.5.2.3 General methodology for the synthesis of
fac-[Re(diim)(CO)3(L)]
fac-[Re(diim)(CO)3(L)] : Where (diim = 1,10-phenanthroline or 2,2’-bipyridine) and
L is a 5-aryl-1H-tetrazole.
To a 20 mL ethanol/water solvent system (3:1 v/v) under an argon atmosphere 7, 8, 9
or 10 (1 eq) was added. The corresponding tetrazole ligand (1.6 eq) with triethylamine
(1.6 eq) in a 5.0 mL portion of ethanol/water (3:1 v/v) was added. The resulting sus-
pension was heated at reflux for 20 h. After this time, the mixture was cooled to room
temperture and filtered over a glass frit, affording the desired complexes as yellow mi-
crocrystalline powders. The product complexes did not require any further purification
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process, except for fac-[Re(phen)(CO)3(Tcya)] (17). All of complexes of the form;
fac-[Re(diim)(CO)3(L)] were synthesised according to this method, unless otherwise
stated.
Elemental analysis was carried out for all new complexes (not previously published),
otherwise characterisation was in agreement with previously published data.170,174
fac-[Re(phen)(CO)3(Tph)]
Re
CO
OC
OC
N
N N
N
H
N
N
11
Yield of 11: 0.085 g, 75%. M.p. 284 °C (dec.). ESI-MS (m/z) = 619 [M + Na]+. νmax
(IR)/cm-1, DCM, rt: 2029 s (CO, A´(1)), 1922 s br (CO, A´(2)/A´´ ), 1606 w (tetrazole
C=N). 1H NMR (δ, ppm, Acetone-d6): 9.65 (2H, d, J = 4.8 Hz, phen H2,9), 8.96 (2H,
d, J = 8.2 Hz, phen H4,7), 8.30 (2H, s, phen H5,6), 8.19−8.15 (2H, m, phen H3,8), 7.63
(2H, d, J = 7.2 Hz, CN4-C6H5 Hortho), 7.22−7.20 (3H, m, CN4-C6H5 Hmeta, para). 13C
NMR (δ, ppm, Acetone-d6): 163.4 (CN4-C6H5), 155.1, 148.3, 140.3, 131.7, 131.3,
129.1, 128.9, 128.7, 127.4, 126.6.
fac-[Re(bipy)(CO)3(Tph)]
Re
CO
OC
OC
N
N N
N
H
N
N
12
Yield of 12: 0.072 g, 63%. M.p. 253 °C (dec.). ESI-MS (m/z) = 595 [M + Na]+. νmax
(IR)/cm-1, DCM, rt: 2029 s (CO, A´(1)), 1924 s br (CO, A´(2)/A´´ ), 1606 w (tetrazole
C=N). 1H NMR (δ, ppm, Acetone-d6): 9.25 (2H, d, J = 5.2 Hz, bipy H6,6’), 8.69 (2H,
d, J = 8.0 Hz, bipy H3,3’), 8.35 (2H, t, J = 7.2 Hz, bipy H4,4’), 7.82−7.79 (4H, m, bipy
H5,5’ and CN4-C6H5 Hortho), 7.32−7.24 (3H, m, CN4-C6H5 Hmeta, para). 13C NMR
(δ, ppm, Acetone-d6): 163.7 (CN4-C6H5), 157.5, 154.7, 141.2, 131.5, 129.2, 128.9,
128.7, 126.8, 124.7.
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fac-[Re(phen)(CO)3(Tbz)]
Re
CO
OC
OC
N
N N
N
C
N
N
O
H
13
Yield of 13: 0.097 g, 82%. M.p. 268 °C (dec.). ESI-MS (m/z) = 647 [M + Na]+. νmax
(IR)/cm-1, DCM, rt: 2029 s (CO, A´(1)), 1923 br (CO, A´(2)/A´´ ), 1699 s (aldehyde
CO), 1610 w (tetrazole C=N). 1H NMR (δ, ppm, Acetone-d6): 9.96 (1H, s,CN4-C6H4-
CHO), 9.67 (2H, d, J = 5.2 Hz, phen H2,9), 8.98 (2H, d, J = 8.4 Hz, phen H4,7), 8.32
(2H, s, phen H5,6), 8.20− 8.17 (2H, m, phen H3,8), 7.84 (2H, d, J = 8.8 Hz, CN4-
C6H4 -CHO Hmeta), 7.80 (2H, d, J = 8.4 Hz, CN4-C6H4 -CHO Hortho). 13C NMR (δ,
ppm, Acetone-d6): 192.4, 162.8 (CN4-C6H4-CHO), 155.2, 148.2, 140.4, 137.1, 136.6,
131.7, 130.5, 128.7, 127.4, 127.0.
fac-[Re(bipy)(CO)3(Tbz)]
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Yield of 14: 0.102 g, 83%. M.p. 265 °C (dec.). ESI- MS (m/z) = 623 [M + Na]+. νmax
(IR)/cm-1, DCM, rt: 2029 s (CO, A´(1)), 1922 br (CO, A´(2)/A´´ ), 1699 s (aldehyde
CO), 1607 w (tetrazole C=N). 1H NMR (δ, ppm, Acetone-d6): 10.01 (1H, s, CN4-
C6H4-CHO), 9.27 (2H, d, J = 5.5 Hz, bipy H6,6’), 8.71 (2H, d, J = 8.4 Hz, bipy H3,3’),
8.37 (2H, t, J = 7.8 Hz, bipy H4,4’), 8.01 (2H, d, J = 8.0 Hz, CN4-C6H4 -CHO Hmeta),
7.87 (2H, d, J = 8.4 Hz, CN4-C6H4 -CHO Hortho), 7.83 (2H, t, J = 5.6 Hz, bipy H5,5’).
13C NMR (δ, ppm, Acetone-d6): 192.4, 163.0 (CN4-C6H4-CHO), 157.5, 154.7, 141.3,
137.2, 136.7, 130.6, 128.7, 127.1, 124.7.
fac-[Re(phen)(CO)3(Tme)]
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The synthesis of 15 was carried out using previously published methods by Wright
et al.174 fac-[Re(phen)(CO)3(Cl)] 7 (1 eq, 0.21 mmol) was added to acetonitrile (10
mL) under a nitrogen atmosphere. To this suspension, methyl-4-(1H-tetrazol-5-yl)-
benzoate 3 (1.6 eq, 0.34 mmol) with triethylamine (1.6 eq, 0.34 mmol) in acetonitrile
(3 mL) was added. The reaction was heated at reflux for 4 nights. The complex was
purified via neutral alumina-filled column chromatography using ethyl acetate (100%)
as the eluent (second product, yellow).
Yield of 15: 0.085 g, 63%. M.p. 243 °C (dec.). νmax (ATR)/cm-1: 3049 w, 2957 w,
2020 s (CO, A´(1)), 1912 s (CO, A´(2)), 1887 (CO, A´´ ), 1722 s (ester CO), 1678 w,
1615 m (tetrazole CN), 1584 w, 1534 w, 1519 w, 1449 w, 1427 m, 1307 w, 1277 m,
1226 w, 1212 w, 1190 w, 1174 w, 1150 w, 1141 w, 1108 w, 1098 w, 1037 w, 1005
w, 975 w, 864 w, 851 m, 829 w, 777 w, 737 m, 721 m, 698 m. 1H NMR (δ, ppm,
Acetone-d6): 9.66 (2H, d, J = 5.0 Hz, phen H2,9), 8.97 (2H, d, J = 10.2 Hz, phen
H4,7), 8.30 (2H, s, phen H5,6), 8.19-8.16 (2H, m, phen H3,8), 7.88 (2H, d, J = 7.4 Hz,
CN4-C6H4-COOCH3 Hmeta), 7.75 (2H, d, J = 7.4 Hz, CN4-C6H4-COOCH3 Hortho),
3.84 (3H, s, -OCH3). 13C NMR (δ, ppm, Acetone-d6): 197.9 (CO), 166.9 (COCH3),
162.9 (CN4-C6H4-COOCH3), 155.2, 148.3, 140.4, 135.5, 131.7, 130.5, 130.4, 128.7,
127.4, 126.5, 52.3 (-OCH3).
fac-[Re(bipy)(CO)3(Tme)]
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The synthesis of 16 was carried out using previously published methods by Werrett et
al.170 fac-[Re(bipy)(CO)3(Cl)], 8 (1 eq, 0.50 mmol) and AgBF4 (1.2 eq, 0.60 mmol)
were combined in dry acetonitrile (15 mL) and heated at reflux, in the dark for 4 hours
70
under a nitrogen atmosphere. The white solid was filtered off through Celite, to yield a
yellow solution, containing, fac-[Re(bipy)(CO)3(NCCH3)][BF4] which was used im-
mediately. To this yellow solution, methyl-4-(1H-tetrazol-5-yl)-benzoate 3, (1.2 eq,
0.60 mmol) with triethylamine (1.2 eq, 0.60 mmol) in acetonitrile (3 mL), was added
and heated under reflux for 24 hours. The complex was purified via reprecipitation
from acetonitrile/dichloromethane and diethylether.
Yield of 16: 0.287 g, 90 %. M.p. 275 °C (dec.). νmax (ATR)/cm-1: 3075 w, 3035
w, 2949 w, 2020 s (CO, A´(1)), 1902 s br (CO, A´(2)/A´´), 1721 s (ester CO), 1603
m (tetrazole CN), 1573 w, 1496 m, 1474 m, 1447 m, 1433 m, 1379 m, 1306 w, 1271
m, 1175 m, 1123 m, 1094 m, 1036 w, 1005 w, 863 w, 779 m, 740 m, 732 m, 694 w.
1H NMR (δ, ppm, Acetone-d6): 9.26 (2H, d, J = 5.5 Hz, bipy H6,6’), 8.71 (2H, d, J
= 8.0 Hz, bipy H3,3’), 8.37 (2H, t, J = 8.0 Hz, bipy H4,4’), 7.95 (2H, d, J = 7.4 Hz,
CN4-C6H4-COOCH3 Hmeta), 7.91 (2H, d, J = 7.4 Hz, CN4-C6H4-COOCH3 Hortho),
7.84-7.80 (2H, m, bipy H5,5’), 3.86 (3H, s, -OCH3). 13C NMR (δ, ppm, Acetone-
d6): 167.0 (COCH3), 163.0 (CN4-C6H4-COOCH3), 157.5, 154.7, 141.3, 135.6, 130.6,
130.4, 128.7, 126.7, 124.7, 52.3 (-OCH3).
fac-[Re(phen)(CO)3(Tcya)]
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The complex was purified via neutral alumina-filled column chromatography using
acetonitrile (100%) as the eluent (second fraction, yellow).
Yield of 17: 0.050 g, 42%. M.p. 242-243 °C (dec.). ESI-MS (m/z) = 644 [M + Na]+.
νmax (IR)/cm-1, DCM, rt: 2229 w (CN), 2030 s (CO, A´(1)), 1923 br (CO, A´(2)/A´´ ),
1606 w (tetrazole C=N). 1H NMR (δ, ppm, Acetone-d6): 9.67 (2H, d, J = 4.0 Hz, phen
H2,9), 8.97 (2H, d, J = 7.2 Hz, phen H4,7), 8.31 (2H, s, phen H5,6), 8.20−8.16 (2H,
m, phen H3,8), 7.81 (2H, d, J = 6.4 Hz, CN4-C6H4 -CN Hmeta), 7.65 (2H, d, J = 4.0
Hz, CN4-C6H4 -CN Hortho). 13C NMR (δ, ppm, Acetone-d6): 162.4 (CN4-C6H4-CN),
155.2, 148.2, 140.4, 135.3, 133.2, 131.7, 128.7, 127.4, 127.1, 119.3, 112.2.
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Yield of 18: 0.090 g, 75%. M.p. 283-284 °C (dec.) Elemental analysis for C21H12N7O3Re:
calculated: C 42.28, H 2.03, N 16.43; found: C 42.25, H 1.88, N 16.26. ESI-MS (m/z)
= 620 [M + Na]+. νmax (IR)/cm-1, DCM, rt: 2229 w (CN), 2029 s (CO, A´(1)), 1923 br
(CO, A´(2)/A´´ ), 1606 w (tetrazole C=N). 1H NMR (δ, ppm, Acetone-d6): 9.27 (2H, d,
J = 5.5 Hz, bipy H6,6’), 8.71 (2H, d, J = 8.40 Hz, bipy H3,3’), 8.37 (2H, t, J = 8.0 Hz,
bipy H4,4’), 7.96 (2H, d, J = 9.2 Hz, CN4-C6H4 -CN H meta), 7.83−7.79 (2H, m, bipy
H5,5’), 7.72 (2H, d, J = 7.5 Hz, CN4-C6H4 -CN Hortho). 13C NMR (δ, ppm, Acetone-
d6): 162.5 (CN4-C6H4-CN), 157.4, 154.7, 141.3, 135.5, 133.3, 128.7, 127.3, 124.7,
119.3, 112.3. Crystals suitable for X-ray analysis (identified as 18, C21H12N7O3Re)
were obtained by slow diffusion of diethyl ether into a DCM solution of the complex
in dichloromethane.
fac-[Re(phen)(CO)3(TBr)]
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Yield of 19: 0.150 g, 83 %. M.p.282-283 ºC (dec.). Elemental analysis for C22H12Br
N6O3Re: calculated: C 39.18, H 1.79, N 12.46; found: C 38.99 , H 1.84 , N 12.60.
νmax (ATR)/cm-1: 3062 w, 2996 w, 2025 s (CO, A´(1)), 1913 s, (CO, A´(2)/A´´ ), 1632
w, 1602 w, 1584 w, 1517 w, 1427 m, 1414 m, 1340 w, 1270 w, 1229 w, 1178 w, 1140
w, 1120 w, 1096 w, 1068 w, 1038 w, 1003 w, 849 m, 827 m, 780 w, 750 w, 722 m.1H
NMR (δ, ppm, Acetone-d6): 9.65 (2H, d, J = 5.2 Hz, phen H2,9), 8.97 (2H, d, J = 8.2
Hz, phen H4,7), 8.30 (2H, s, phen H5,6), 8.19-8.16 (2H, m, phen H3,8), 7.57 (2H, d, J
= 8.8 Hz, CN4-C6H4 -Br Hortho), 7.42 (2H, d, J = 8.8 Hz, CN4-C6H4 -Br Hmeta). 13C
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NMR (δ, ppm, Acetone-d6): 162.8 (CN4-C6H4-Br), 155.2, 148.2, 140.4, 132.3, 131.7,
130.5, 128.7, 128.5, 127.4, 122.3. Crystals suitable for X-ray analysis (identified as
19, C22H12Br N6O3Re) were obtained by liquid liquid diffusion of petroluem spirits
into a DCM solution of the complex.
fac-[Re(phen)(CO)3(TIod)]
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Yield of 20: 0.139 g, 95 %. M.p. 291.3-291.9 °C (dec.). Elemental analysis for
C22H12I N6O3Re: calculated: C 36.62, H 1.68, N 11.65; found: C 36.43 , H 1.44
, N 11.46. νmax (ATR)/cm-1: 3798 w, 3060 w, 2023 s (CO, A´(1)), 1908 br s (CO,
A´(2)/A´´ ), 1631 w, 1600 w, 1584 w, 1425 m, 1411 m, 1338 w, 1269 w, 1226 w, 1177
w, 1146 w, 1117 w, 1038 w, 1000 w, 965 w, 848 w, 825 w, 779 w, 748 w, 721 w. 1H
NMR (δ, ppm, Acetone-d6): 9.65 (2H, d, J = 5.2 Hz, phen H2,9), 8.96 (2H, d, J = 8.2
Hz, phen H4,7), 8.30 (2H, s, phen H5,6), 8.19-8.15 (2H, m, phen H3,8), 7.62 (2H, d,
J = 8.4 Hz, CN4-C6H4 -I Hmeta), 7.43 (2H, d, J = 8.8 Hz, CN4-C6H4 -I Hortho). 13C
NMR (δ, ppm, Acetone-d6): 162.9 (CN4-C6H4-I), 155.2, 148.3, 140.4, 138.4, 131.7,
130.9, 128.7, 128.6, 127.4, 93.9. Crystals suitable for X-ray analysis (identified as 20,
C22H12I N6O3Re) were obtained by liquid liquid diffusion of petroluem spirits into a
DCM solution of the complex.
2.5.3 X-ray Crystallography
Diffraction data for the complexes discussed in Chapter Two were collected by Dr.
Brian Skelton at the University of Western Australia and can be found in previously
published work; 11, 12, 13, 14, 15,16,170 17174 and 18.201
Diffraction data for fac-[Re(phen)(CO)3(TBr)] (19) and fac-[Re(phen)(CO)3(TIod)]
(20) were collected by Dr. Brian Skelton at the University of Western Australia, at
100(2) K on an Xcalibur diffractometer (20) or on an Oxford Diffraction Gemini
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diffractometer (19) both fitted with Mo Kα radiation. Following analytical absorp-
tion corrections and solution by direct methods, the structure was refined against F2
with full-matrix least-squares using the program SHELXL-97.202 All hydrogen atoms
were added at calculated positions and refined by use of a riding model with isotropic
displacement parameters based on those of the parent atom. The crystallographic data
can be found in Table A1.1, Appendix A1.1.
2.5.4 Computational Calculations
The TD-DFT and DFT calculations were performed by Dr. Paolo Raiteri. Computa-
tional details on the complexes presented in this Chapter can be found in previously
published work.170
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Chapter 3
Reversible Protonation of Metal
Tetrazolato Complexes and their
Change in Luminescence
3.1 Abstract
The reactivity of Re(I) complexes toward electrophiles was investigated to understand
their potential to be utilised as responsive probes/sensing agents. If a metal complex
is to be applied in this context, it must have a preferential and measurable response
to a specific change in the environment.62 The tetrazole ring in the Re(I) complexes
appears to act as a Brønsted-type base and was protonated by triflic acid. Upon pro-
tonation, a detectable elongation of the τ and increase in the φ was observed, as well
as a blue shift in the emission wavelength. The modulation caused by protonation of
the Re(I) complexes was completely reversible by treatment with triethylamine. The
study was extended to isoelectronic Ir(III) and Ru(II) tetrazolato complexes. Protona-
tion of [Ir(PyrTzF)] caused a red shift of the emission maxima whereas protonation of
[Ru(PyrTz)]+caused significant quenching of the emission.
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3.2 Introduction
The coordinated ligands in Ru(II), Re(I) and Ir(III) complexes play a significant role
in their photophysical output. The ligands are directly involved in the metal-to-ligand
charge transfer (MLCT) excited states and can therefore influence the emission of the
complex. If a ligand is changed or modified to become more reducible a red-shifted
emission is favoured, by stabilisation of the LUMO. Likewise, if an ancillary ligand is
altered to indirectly make the metal centre more oxidisable, then a red-shifted emission
is favoured by destabilisation of the HOMO type orbitals.
The right combination of ligands (with modified functional groups) and metal centres
has led to the development of a range of d6 metal complexes with emission spanning
from the visible to near infrared spectrum. This tunability has led to the applications of
d6 metal complexes in light emitting devices,203–205 dye sensitised solar cells,206–209
as optical imaging probes62,67,210 and as general luminescent sensors.211,212 Here, lu-
minescent sensors refer to the capacity of a compound to detect or sense changes to the
surrounding environment by exhibiting a detectable change in luminescent the output.
A range of ions and molecules are present within a cell, responsible for life pro-
cesses.213 Recently d6 metal complexes have emerged as potential in vivo and in vitro
sensing agents. Examples include the ability to sense species including O2,81,82 diva-
lent cations (eg: Zn2+, Ca2+and Hg2+),118 water,214 hypochlorous acid215 and also pH
changes.89,119 Many of these sensing agents are still being optimised for applications
specific for biology but show potential for development within this field. The com-
plexes exhibit a preferential response to external stimuli that can be monitored by a
significant change in their photophysical output. Often, a modification of the ligand
is responsible for this photophysical modulation. Modification of the ligands often
occurs through the binding of, or reactions with, specific analytes.
As discussed in Chapter Two, the tetrazolato ligands on the Re(I) diimine complexes
directly contribute to the emissive state (eg: 3MLLCT) and can therefore be used to fine
tune emission. This chapter investigates the potential for the fac-[Re(diim)(CO)3(L)]
complexes to have applications in sensing different pH environments. The rhenium
complexes described herein are outlined in Scheme 3.1.
A series of reversible protonation and deprotonation reactions have been carried out on
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(phen) (bipy)
R = H
CHO
CN
Complex = fac-[Re(diim)(CO)3(TphH)]+
(diim)
or
N N
                  fac-[Re(diim)(CO)3(TbzH)]+
                  fac-[Re(diim)(CO)3(TcyaH)]+H
CF3SO3-
+
Scheme 3.1: Codes and abbreviations for the protonated Re(I) complexes reported in
Chapter Three.
the Re(I) complexes and the change in luminescent output monitored. The study is a
proof of concept approach and the conditions used for protonation are extreme (triflic
acid). The study has also been extended to isoelectronic Ir(III) and Ru(II) tetrazolato
complexes.
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3.3 Results and Discussion: Rhenium
3.3.1 Synthesis and Spectroscopic Characterisation
A slight excess (ca. 1.2 eq) of triflic acid was added to a dichloromethane solution of
the neutral Re(I) tetrazolato complex maintained at -50 °C for 30 minutes, as shown in
Scheme 3.2. The tetrazole ring contains three free nitrogen atoms which are all poten-
tial sites for protonation. Scheme 3.2 shows the three possible protonation products.
Low temperatures were employed to favour protonation at N4 (Scheme 3.2 C).
Re
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N N
N
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N
CF3SO3H
DCM, -50 °C
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Scheme 3.2: Synthesis of the protonated rhenium tetrazolato complexes showing po-
tential protonation at N1 (A), N3 (B) or N4 (C).
Szczepura and co-workers216 carried out protonation of a hexanuclear rhenium tetra-
zolate cluster complex using HBF4. For protonation to occur, temperatures of 100 ºC
were required, unlike the reactions reported herein which occurred without heating.
The intense carbonyl bands of the complexes were monitored through solution state IR
spectroscopy. The stretching frequency of the CO bands shifted to higher wavenum-
bers upon formation of the protonated species as shown in Table 3.3.1. Protonation
causes a significant reduction in the electron density on the tetrazolato ligand and it
therefore becomes less σ donating and more pi accepting.108 This in turn reduces the
amount of electron density on the rhenium centre causing a reduction in backbonding
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to the CO ligands. These CO ligands now exhibit a higher bond order which explains
the increase in stretching frequency observed. As discussed in Chapter 2 and shown
in Figure 2.1 on page 39, the situation represented in “b” (Re→CO backbonding) is
disfavoured (even more for these cationic complexes). In all cases the facial config-
uration of the Re complexes was maintained: one band was observed at 2039-2040
cm-1 consistent with A´(1) and a broader band seen at 1936-1938 cm-1, which is the
superimposition of A´(2) and A´´ .178
Table 3.3.1: Solution state IR measurements carried out in DCM at room temperature.
Stretching frequency (cm-1) CO A´(1) CO A´(2)/A´´
fac-[Re(phen)(CO)3(Tph)] (11) 2029 1922
fac-[Re(phen)(CO)3(TphH)]+ (21) 2039 1936
fac-[Re(bipy)(CO)3(Tph)] (12) 2029 1924
fac-[Re(bipy)(CO)3(TphH)] +(22) 2039 1936
fac-[Re(phen)(CO)3(Tbz)] (13) 2029 1923
fac-[Re(phen)(CO)3(TbzH)] +(23) 2040 1938
fac-[Re(bipy)(CO)3(Tbz)] (14) 2029 1922
fac-[Re(bipy)(CO)3(TbzH)] +(24) 2040 1937
fac-[Re(phen)(CO)3(Tcya)] (17) 2030 1923
fac-[Re(phen)(CO)3(TcyaH)]+ (25) 2040 1937
fac-[Re(bipy)(CO)3(Tcya)] (18) 2029 1923
fac-[Re(bipy)(CO)3(TcyaH)]+ (26) 2040 1938
The protonated Re complexes were characterised by 1H and 13C NMR spectroscopy.
The number of peaks, chemical shifts, and integration values for each spectrum are
consistent with the proposed structure of the complexes. The addition of the H+ is
directed towards the tetrazole ligand, which behaves as a Brønsted-type base. The N-
H proton was not identified in the 1H NMR spectra of the protonated species, however,
an overall downfield shift of the resonances was observed. The signals from the phenyl
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protons of the aryl tetrazolato ligand were the most significantly shifted, as outlined
in Table 3.3.2. This shift is expected due to the reduction in electron density on the
tetrazolato ligand, upon protonation.
Table 3.3.2: Comparison of NMR chemical shift data in acetone-d6 relative to the
ortho, meta and para protons before and after protonation.
Rhenium Complex δHo δHm
fac-[Re(phen)(CO)3(Tph)] (11) 7.63 7.22-7.20a
fac-[Re(phen)(CO)3(TphH)]+ (21) 7.69 7.56-7.36a
fac-[Re(bipy)(CO)3(Tph)] (12) 7.82−7.79c 7.32-7.24
fac-[Re(bipy)(CO)3(TphH)] +(22) 7.90-7.83b 7.54-7.49a
fac-[Re(phen)(CO)3(Tbz)] (13) 7.80 7.84
fac-[Re(phen)(CO)3(TbzH)] +(23) 7.90 7.95
fac-[Re(bipy)(CO)3(Tbz)] (14) 7.87 8.01
fac-[Re(bipy)(CO)3(TbzH)] +(24) 8.07
fac-[Re(phen)(CO)3(Tcya)] (17) 7.65 7.81
fac-[Re(phen)(CO)3(TcyaH)]+ (25) 7.91
fac-[Re(bipy)(CO)3(Tcya)] (18) 7.72 7.96
fac-[Re(bipy)(CO)3(TcyaH)]+ (26) 7.94-7.88b 8.04
a; Peak range includes the resonances for Hm and Hp,b; Peak range includes the reso-
nance for bipy H5,5’, c;Peak range includes the resonance for bipy H4,4’.
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Figure 3.1: 1H NMR spectra of the neutral complex fac-[Re(phen)(CO)3(Tph)], 11
(bottom) compared to the protonated species, fac-[Re(phen)(CO)3(TphH)]+, 21 (top).
Figure 3.2: 1H NMR spectra of the neutral complex fac-[Re(phen)(CO)3(Tbz)], 13
(bottom) compared to the protonated species, fac-[Re(bipy)(CO)3(TbzH)]+, 23 (top).
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Figure 3.3: 1H NMR spectra of the neutral complex fac-[Re(phen)(CO)3(Tcya)],
17 (bottom) compared to the protonated species, fac-[Re(phen)(CO)3(TcyaH)]+ , 25
(top).
Figure 3.4: 1H NMR spectra of the neutral complex fac-[Re(bipy)(CO)3(Tph)], 12
(bottom) compared to the protonated species, fac-[Re(bipy)(CO)3(TphH)]+ , 22 (top).
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Figure 3.5: 1H NMR spectra of the neutral complex fac-[Re(bipy)(CO)3(Tbz)], 14
(bottom) compared to the protonated species, fac-[Re(bipy)(CO)3(TbzH)]+, 24 (top).
Figure 3.6: Comparison of the 1H NMR spectra of the neutral fac-
[Re(bipy)(CO)3(Tcya)], 18 (bottom) with that of the protonated species, fac-
[Re(bipy)(CO)3(TcyaH)]+, 26 (top).
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NMR measurements were carried out in acetone-d6 and Figure 3.1 to Figure 3.6 il-
lustrate the shift in the 1H NMR signals upon protonation. In particular, upon the
protonation of fac-[Re(bipy)(CO)3(Tbz)] (14) and fac-[Re(phen)(CO)3(Tcya)] (17)
the Hortho and Hmeta peaks in the corresponding protonated species (24 and 25 respec-
tively) collapse, forming a singlet (as seen in Figure 3.5 and Figure 3.3). The collapse
of Hortho and Hmeta suggests that the electron withdrawing substituent on the phenyl
ring (ie: -CHO or -CN) has equal electron withdrawing power to that of the tetrazole
ring. In the neutral complexes the -R substituent was the stronger electron withdrawing
group as the Hmeta signals were more deshielded with respect to Hortho (Table 3.3.2).
Upon protonation the Hortho becomes deshielded and collapses with the Hmeta. The
1H NMR data supports a chemoselective protonation at the tetrazole ring, making the
downfield shift of the diimine protons the result of indirect shielding. In the cases
where the Hortho and Hmeta are still resolved after protonation, a downfield shift is ob-
served. Deshielding of these peaks also suggests that the tetrazole ring has a stronger
-I effect compared to the neutral complexes (where +M from the tetrazole was domi-
nant, see section 2.3.2.2 on page 42). This is not unexpected as the tetrazolato ligand
is now neutral, with reduced electron density and therefore a reduced in +M effect.
Interestingly, reduction in +M could also be associated with a twisting of the phenyl
and tetrazole rings.
An investigation of Ru tetrazolato complexes by Stagni et al.114 observed protona-
tion at the N4 atom of the monocoordinated tetrazole ligand. Based on that study
it is assumed that the same occurs for the Re(I) complexes. Usually when there is
coordination at the N4 position on a tetrazole, there is a reduction of interannular con-
jugation due to the twisted nature acquired by the aryl and tetrazole rings (as discussed
in Chapter Two).166,167 Scheme 2.5 shows the difference in the planarity of the phenyl
and tetrazole rings when there is coordination at either the N1 or N2 site (or in this case
N4, not N1).166,167 As discussed in Chapter Two, the aryl and tetrazolato rings are pla-
nar in the neutral Re(I) complexes, as the ligand is coordinated to the rhenium via
the N2 atom,170 (Scheme 2.5). Protonation at N4 could be causing steric interactions,
leading to out of plane rotation of the rings and therefore a reduction in interannular
conjugation. There are two competing coordination sites that are both occupied and so
the studies of Butler165–167 may not be completely applicable to this case. Analysis of
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the tetrazolic carbon (Ct) can provide insight into the coordination of the tetrazolato
ligand. Unfortunately the Ct resonance was not observed in the protonated samples.
Nonetheless, protonation at N4 was observed in the solid state by analysis of the struc-
tures by X-ray diffraction, see section 3.3.2.
Figure 3.7: 1H NMR spectra of fac-[Re(phen)(CO)3(Tbz)], 13 (1), compared to the
protonated species, fac-[Re(phen)(CO)3(TbzH)]+, 23 (2) and the product from the
addition of triethylamine to a solution of fac-[Re(phen)(CO)3(TbzH)]+, 23 (3).
When triethylamine was added to an NMR solution of the protonated complex there
was an upfield shift of the 1H NMR resonances, which matched with those values
of the neutral starting complex. Figure 3.7 compares the 1H NMR spectra of fac-
[Re(phen)(CO)3(Tbz)] (13), fac-[Re(phen)(CO)3(TbzH)]+ (23) and the result of 23
+ Et3N. It is clear that the reaction is reversible as the signals in the spectrum of fac-
[Re(phen)(CO)3(Tbz)] (13) match well with those of the spectrum produced from the
addition of triethylamine to the protonated species, 23.
During NMR experiments of the protonated species (in acetone-d6) small but de-
tectable peaks were observed in the baseline over time. Some of these peaks could
be assigned to the corresponding neutral starting material, as illustrated in Figure 3.8.
No such observations were noticed for the neutral complexes, which were stable in
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solution over extended time periods. Figure 3.8 (top) also shows the presence of other
peaks in the baseline. These peaks were minor and therefore not characterised but
could be ascribed to the formation of a solvato-complex or degradation of the cationic
Re(I). For one of the cationic Re(I) complexes, a dimeric rhenium species was iso-
lated. It is discussed in section 3.3.2 but shows two Re(I) centres coordinated to one
tetrazole ligand. This suggests that the tetrazole ligand, once protonated, can become
labile and therefore degradation or solvato-complexes in solution are not unexpected.
The unstable nature of these types of complexes is also known from the methylation
experiments, discussed in Chapter Four.
Figure 3.8: 1H NMR spectra of fac-[Re(phen)(CO)3(Tph)], 11 (bottom), compared to
the spectra of the protonated species, fac-[Re(phen)(CO)3(TphH)]+, 21 (top) taken 12
hours after the sample was prepared.
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3.3.2 X-Ray Crystallography
Table 3.3.3: Torsion angles between the aryl and tetrazole rings in the protonated Re(I)
complexes.
Rhenium Complex
Deviation from
Coplanarity (°)
fac-[Re(phen)(CO)3(TphH)]+ (21) 7.65
fac-[Re(phen)(CO)3(TphH)]+ (21· 0.25Et2O) 26.23
fac-[Re(bipy)(CO)3(TphH)]+ (22) 58.12
fac-[Re(phen)(CO)3(TbzH)]+(23) 5.31
fac-[Re(bipy)(CO)3(TbzH)]+(24) 20.97
fac-[Re(phen)(CO)3(TcyaH)]+ (25) 5.95
fac-[Re(bipy)(CO)3(TcyaH)]+(26) 24.18
Single crystals of the protonated rhenium complexes were obtained by slow diffu-
sion of diethyl ether into a DCM solution of the complex, with a few drops of di-
lute triflic acid. For all of the protonated species the tetrazole ligand is coordinated
to Re via the N2 atom and protonation occurs at N4. The only exception was fac-
[Re(bipy)(CO)3(TphH)]+(24), where crystallographic analysis revealed isolation of a
dimeric rhenium species. All of the crystal structures are shown in Figure 3.9 and Fig-
ure 3.10. Interestingly, crystallisation of fac-[Re(phen)(CO)3(TphH)]+ (21) produced
two different looking crystals when visualised under a UV lamp. One set appeared yel-
low under the light and were small and flat while the other set looked more blue/green
and had a prism shape. Analysis revealed that they were both the protonated complex
however one set had crystallised with diethyl ether in the lattice.
The deviation from coplanarity observed in the solid state can aid in understanding
the degree of twisting between the aryl and tetrazole rings caused by protonation at
N4. Table 3.3.3 shows the deviation from coplanarity between the rings, calculated by
analysis of their torsion angle. The complexes vary in the level of twisting between the
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Figure 3.9: X-ray crystal structures of fac-[Re(phen)(CO)3(TphH)]+ (21, A), fac-
[Re(phen)(CO)3(TbzH)]+ (23, B), fac-[Re(phen)(CO)3(TphH)]·0.25Et2O (21, C),
and fac-[Re(phen)(CO)3(TcyaH)]+ (25, D) where thermal ellipsoids have been drawn
at 30% probability. The triflate counter ion and Et2O has been omitted for clarity.
aryl and tetrazole rings however, generally the complexes do not greatly deviate from
coplanarity. The two crystals of 21 have different torsion angles which could indicate
that the relative orientations of the aryl and tetrazole rings of the protonated complexes
in the solid state are mainly determined by crystal packing effects rather than electronic
conjugation. This makes it difficult to conclude the effect protonation has on the degree
of twisting between the two rings. Nonetheless, when comparing to the deviation
from colplanarity of the protonated complexes to the neutral species, there does not
appear to be a significant difference (see section 2.3.3). The main crystal structure
that clearly has a significant level of twisting is that of the dimeric rhenium complex
formed from crystallisation of the protonated species; fac-[Re(bipy)(CO)3(TphH)]+
(12). Figure 3.10 A, shows that there is significant twisting of the rings, especially
compared to the other protonated complexes. This is expected as the bulky rhenium
fragment is coordinated to both the N2 and the N4 atoms of the tetrazole ligand.
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Figure 3.10: X-ray crystal structures of fac-[Re(bipy)(CO)3(TphH)]+ (dimeric form,
22, A), fac-[Re(bipy)(CO)3(TbzH)]+ (24, B) and fac-[Re(bipy)(CO)3(TcyaH)]+ (26,
D) where thermal ellipsoids have been drawn at 30% probability. The triflate counter
ion has been omitted for clarity.
In all of the crystal structures, there is hydrogen bonding present between the proton
on the tetrazole ring, N4-H (which acts as a donor) and on the oxygen atoms of the
triflate anion (which acts as the acceptor). The crystal structure of complex 25 shows
weak pi stacking between the aryl rings of tetrazole ligands, with a distance of 3.8 Å
between the centroid of the two rings. The only other protonated complex exhibiting
pi-pi interactions is 25. There is moderate interaction between the centre rings of the
phenanthroline ligands with a distance of 3.5 Å.
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3.3.3 Photophysical Investigation
Table 3.3.4: Absorption data for the protonated rhenium tetrazolato complexes at 10-5
M in DCM.
Rhenium Absorption
Complex λ max/nm (ε/104M-1cm-1)
fac-[Re(phen)(CO)3(TphH)]+ (21) 254 (1.325), 335 (0.240)
fac-[Re(bipy)(CO)3(TphH)]+(22) 245 (1.556), 319 (0.520), 352 (0.185)
fac-[Re(phen)(CO)3(TbzH)]+(23) 272 (1.262), 351 (0.940)
fac-[Re(bipy)(CO)3(TbzH)]+(24) 266 (1.291), 319 (0.410), 356 (0.508)
fac-[Re(phen)(CO)3(TcyaH)]+ (25) 257 (1.650), 342 (0.180)
fac-[Re(bipy)(CO)3(TcyaH)]+(26) 254 (1.010), 319 (0.310), 350 (0.120)
Table 3.3.5: Emission data for the protonated rhenium tetrazolato complexes.
Rhenium Emission 298 K
Complexa λ max(nm) τ (µs)b τ (µs)c φ b φ c
fac-[Re(phen)(CO)3(TphH)]+ (21) 538 1.293 2.505 0.328 0.470
fac-[Re(bipy)(CO)3(TphH)]+(22) 548 0.596 0.660 0.120 0.135
fac-[Re(phen)(CO)3(TbzH)]+(23) 534 1.333 2.186 0.105 0.206
fac-[Re(bipy)(CO)3(TbzH)]+(24) 546 0.612 0.825 0.145 0.276
fac-[Re(phen)(CO)3(TcyaH)]+ (25) 534 1.819 2.948 0.296 0.540
fac-[Re(bipy)(CO)3(TcyaH)]+(26) 546 0.655 0.874 0.103 0.204
a; All data for complexes in 10-5 M DCM solutions and all quantum yields measured
against rhodamine 101, b; air-equilibrated samples, c; degassed (O2 free) samples.
The absorption profiles for the protonated rhenium complexes are relatively similar and
generally exhibit intense transitions in the high energy UV region, between 245-272
nm and lower intensity bands between 319-352 nm. To further interpret the photophys-
ical results, the energetics and absorption spectra of the complexes were simulated with
time-dependent density functional theory using GAUSSIAN09.181 The crystal isolated
for fac-[Re(bipy)(CO)3(TphH)]+ (22) was a dimeric complex and as there was no evi-
dence of the dimer in solution, DFT calculations were carried out assuming protonation
was the same as the other Re(I) complexes (monomer, with protonation on the N4). As
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discussed in Chapter Two, the lowest energy excited state for the neutral rhenium com-
plexes was characterised as an MLLCT. For the protonated rhenium species, the lowest
energy excited state seems to originate predominantly from HOMO-n→LUMO transi-
tions, where n = 0-2. Further computational detail including listed transitions can be
found in previously published work.201 Figure 3.11 and Figure 3.12 show the localisa-
tion of the HOMO and LUMO calculated for the protonated complexes. Localisation
of the HOMO-1 and HOMO-2 for all protonated rhenium complexes are included in
A2.2 and have similar localisation to the HOMO. The HOMO type orbitals are mainly
localised over the 5d orbitals of the Re center (with a small contribution from the CO
ligands) however there is no significant contribution from the tetrazole pi system. The
LUMO type orbitals are exclusively localised on the diimine ligand. Therefore, the
lowest energy transition observed in the absorption profiles is assigned to an MLCT
(Re → diimine). The high energy transitions seen in the absorption spectra around
245-272 nm can be assigned to pi −pi* IL transitions.
Figure 3.11: Localisation of the HOMO and LUMO for the protonated phen com-
plexes (left to right); 21, 23 and 25 .
Table 3.3.4 shows that the MLCT absorbance band for the bipy species are all red
shifted with respect to their phen analogues. As was observed for the neutral phen
complexes in Chapter Two, the LUMO is not delocalised over the entire diimine ligand
(Figure 3.11) and therefore mimics a 2,2’-bipyridine-3,3’-dimethyl species.
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Figure 3.12: Localisation of the HOMO and LUMO for the protonated bipy complexes
(left to right); 22, 24 and 26.
Figure 3.13: Absorption of the neutral rhenium complex, fac-[Re(phen)(CO)3(Tph)]
(11, solid line) compared to the absorption of the protonated species, fac-
[Re(phen)(CO)3(TphH)]+ (21, dashed line) in DCM.
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Figure 3.14: Absorption of the neutral rhenium complex, fac-[Re(phen)(CO)3(Tbz)]
(13, solid line) compared to the absorption of the protonated species, fac-
[Re(phen)(CO)3(TbzH)]+ (23, dashed line) in DCM.
Figure 3.15: Absorption of the neutral rhenium complex, fac-[Re(phen)(CO)3(Tcya)]
(17, solid line) compared to the absorption of the protonated species, fac-
[Re(phen)(CO)3(TcyaH)]+ (25, dashed line) in DCM.
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Figure 3.16: Absorption of the neutral rhenium complex, fac-[Re(bipy)(CO)3(Tph)]
(12, solid line) compared to the absorption of the protonated species, fac-
[Re(bipy)(CO)3(TphH)]+ (22, dashed line) in DCM.
Figure 3.17: Absorption of the neutral rhenium complex, fac-[Re(bipy)(CO)3(Tbz)]
(14, solid line) compared to the absorption of the protonated species, fac-
[Re(bipy)(CO)3(TbzH)]+ (24, dashed line) in DCM.
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Figure 3.18: Absorption of the neutral rhenium complex, fac-[Re(bipy)(CO)3(Tcya)]
(18, solid line) compared to the absorption of the protonated species, fac-
[Re(bipy)(CO)3(TcyaH)]+ (26, dashed line) in DCM.
Comparing the absorption profiles of the protonated and neutral species (Figure 3.13 to
Figure 3.18), an expected hypsochromic shift of both the IL and CT bands is observed.
This can be explained by protonation reducing the electron density around the Re metal
centre (confirmed by IR spectroscopy). The decrease in electron density experienced
by the tetrazole ring upon protonation causes indirect stabilisation of the HOMO type
orbitals on the Re centre, leading to an increase in the HOMO-LUMO energy gap.
The emission profiles of the protonated rhenium species are from a pure 3MLCT state
(disregarding the small contribution of the CO ligands to the HOMO) unlike the neutral
complexes where emission was from a mixed 3MLLCT state. The contribution of the
tetrazole to the lowest energy excited state has been removed in the protonated species.
This explains why the emission profiles for the three phen complexes (Figure 3.19) and
the three bipy complexes (Figure 3.20) are essentially the same.
The protonated rhenium complexes containing phen all have a blue shifted emission in
comparison to the bipy analogues, as observed for the neutral complexes. Table 3.3.5
shows the emissive properties of the protonated Re(I) complexes. The τ of the pro-
tonated phen complexes are longer compared to the bipy analogues and the φ are
generally higher.
This same trend was observed for the neutral complexes discussed in Chapter Two.
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Figure 3.19: Excitation and emission of fac-[Re(phen)(CO)3(TphH)]+ (21, green),
fac-[Re(phen)(CO)3(TbzH)]+ (23, red), and fac-[Re(phen)(CO)3(TcyaH)]+ (25,
blue) in DCM.
Figure 3.20: Excitation and emission of fac-[Re(bipy)(CO)3(TphH)]+ (22, green),
fac-[Re(bipy)(CO)3(TbzH)]+ (24, red), and fac-[Re(bipy)(CO)3(TcyaH)]+(26, blue)
in DCM.
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The emission of the protonated species is sensitive to the presence of molecular oxy-
gen, supporting the assignment of triplet state phosphorescence.52,54 Upon de-oxygenating
the solutions, the measured τ and φ increase (Table 3.3.5). The predominantly charge
transfer nature of the emissive state is also supported by the rigidochromic effect ob-
served upon freezing the solutions.127,192,193 Table 3.3.6 illustrates the blue shifted
λ em observed when DCM solutions are measured at 77 K.
Table 3.3.6: Emission data for the protonated rhenium tetrazolato complexes at 77 K
in DCM.
Rhenium Complex Emission 77K
λ max (nm) τ (µs)
fac-[Re(phen)(CO)3(TphH)]+ (21) 500 5.25
fac-[Re(bipy)(CO)3(TphH)]+(22) 502 3.54
fac-[Re(phen)(CO)3(TbzH)]+(23) 496 9.57
fac-[Re(bipy)(CO)3(TbzH)]+(24) 502 3.38
fac-[Re(phen)(CO)3(TcyaH)]+ (25) 508 5.42
fac-[Re(bipy)(CO)3(TcyaH)]+(26) 534 2.32 (47%), 4.74 (53%)
Unlike the comparison of the absorption profiles for the neutral and protonated com-
plexes, there is a very obvious and significant change in the emission profiles upon
protonation. The protonated complexes all still exhibit broad structureless emission
profiles however they are significantly blue shifted and have increased intensity com-
pared to the neutral precursors. Aliquots of triflic acid were sequentially added to dilute
solutions of the neutral Re(I) complexes and emission spectra recorded after each ad-
dition. The top spectra in Figure 3.21 and Figure 3.23 shows the gradual change in
emission occurring upon protonation of the complex. The bottom spectra show the
normalised emission, highlighting the blue shift.
Upon excitation of the 1MLCT band at ca. 370 nm, the neutral Re(I) tetrazolato com-
plexes display a single broad and structureless emission in the range of 584-606 nm
(see Chapter Two). After formation of their conjugate acids ([ReH]+), excitation of
the 1MLCT band at ca. 368 nm, shifts the emission to bright green, between 534-548
nm for both the phen and bipy complexes.
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Figure 3.21: (Top) Steady state emission spectra showing the change occurring upon
the sequential addition of triflic acid to fac-[Re(phen)(CO)3(Tph)] (11, Re) to form
the protonated complex, fac-[Re(phen)(CO)3(TphH)]+ (21, [ReH]+). (Bottom) Nor-
malised emission spectra to highlight the blue shift that occurs upon protonation.
Figure 3.22: Cuvettes showing the starting complex, fac-[Re(phen)(CO)3(Tph)] (11,
left), the protonated fac-[Re(phen)(CO)3(TphH)]+ (21, right) and the intermediate
mixture of the two complexes (middle).
98
Figure 3.23: (Top) Steady state emission spectra showing the change occurring upon
the sequential addition of triflic acid to fac-[Re(bipy)(CO)3(Tph)] (12, Re) to form
the protonated complex, fac-[Re(bipy)(CO)3(TphH)]+ (22, [ReH]+). (Bottom) Nor-
malised emission spectra to highlight the blue shift that occurs upon protonation.
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This change in emission could be observed in situ by visualising the solutions under a
UV lamp and sequentially adding triflic acid, Figure 3.22. The steady state emission
spectra for the remainder of the complexes are shown in Figure 3.24 to Figure 3.27.
Figure 3.24: Steady state emission spectra showing the blue shift and increase in emis-
sion intensity occurring during the sequential addition of triflic acid to the neutral rhe-
nium complex fac-[Re(phen)(CO)3(Tbz)] (13, Re) to form the protonated complex,
fac-[Re(phen)(CO)3(TbzH)]+(23, [ReH]+).
The blue shift in the emission can be rationalised by the increased HOMO-LUMO en-
ergy gap caused by protonation of the tetrazole ring. To further understand this, the
energies of the frontier molecular orbitals for fac-[Re(phen)(CO)3(Tph)] (11) and fac-
[Re(phen)(CO)3(TphH)]+ (21) were plotted.
Figure 3.28 illustrates that protonation of the tetrazole ring causes stabilisation of the
ground state (HOMO) by indirectly reducing the electron density on the Re centre.
The LUMO is not greatly effected however there is an overall increase in the HOMO-
LUMO energy gap, supporting the observed blue shifted emission.
Cationic rhenium complexes generally display greater photophysical output,57 often
rationalised by the energy gap law.47,48 The φ of the cationic protonated complexes
are 4-13 times higher than their neutral analogues and similarly, τ has been signifi-
cantly elongated. Relative to the air-equilibrated neutral Re(I) complexes, lifetimes
range from 270 to 518 ns for the phen-based and 85 to 107 ns for the bipy-based com-
plexes. Comparatively the cationic species exhibit lifetimes between 1.3 and 1.8 µs
for the phen complexes and between 595 and 655 ns and for the bipy complexes.
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Figure 3.25: Steady state emission spectra showing the blue shift and increase in emis-
sion intensity occurring during the sequential addition of triflic acid to the neutral rhe-
nium complex fac-[Re(bipy)(CO)3(Tbz)] (14, Re) to form the protonated complex,
fac-[Re(bipy)(CO)3(TbzH)]+(24, [ReH]+).
Figure 3.26: Steady state emission spectra showing the blue shift and increase in emis-
sion intensity occurring during the sequential addition of triflic acid to the neutral rhe-
nium complex fac-[Re(phen)(CO)3(Tcya)] (17, Re) to form the protonated complex,
fac-[Re(phen)(CO)3(TcyaH)]+(25, [ReH]+).
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Figure 3.27: Steady state emission spectra showing the blue shift and increase in emis-
sion intensity occurring during the sequential addition of triflic acid to the neutral rhe-
nium complex fac-[Re(bipy)(CO)3(Tcya)] (18, Re) to form the protonated complex,
fac-[Re(bipy)(CO)3(TcyaH)]+(26, [ReH]+).
Figure 3.28: Calculated energy levels and orbital contours for the HOMO and
LUMO of fac-[Re(phen)(CO)3(Tph)], 11 (A) and the protonated analogue fac-
[Re(phen)(CO)3(TphH)]+, 21 (B), obtained from DFT calculations.
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Based on the calculations of the radiative and non-radiative decay constants it appears
that the energy gap law is one factor explaining the improved luminescent output of
the protonated species. For example, fac-[Re(phen)(CO)3(Tph)] (11) exhibits a kr of
0.139×106 s-1 and knr of 1.79×106 s-1 whereas the corresponding protonated complex
(21) shows a slightly increased kr of 0.188×106 s-1 and a significantly lower knr value
of 0.212×106 s-1(see Table 3.3.7 for the kr and knr of the protonated species and Ta-
ble 2.3.8 on page 59 for the neutral species).
Table 3.3.7: Radiative and non-radiative decay constants (kr and knr) for the protonated
rhenium complexes in degassed (O2 free) DCM.
Rhenium Complex kr(106 s-1) knr(106 s-1)
fac-[Re(phen)(CO)3(TphH)]+ (21) 0.188 0.212
fac-[Re(bipy)(CO)3(TphH)]+(22) 0.205 1.311
fac-[Re(phen)(CO)3(TbzH)]+(23) 0.094 0.363
fac-[Re(bipy)(CO)3(TbzH)]+(24) 0.335 0.878
fac-[Re(phen)(CO)3(TcyaH)]+ (25) 0.183 0.156
fac-[Re(bipy)(CO)3(TcyaH)]+(26) 0.233 0.911
It was noted that after complete protonation, the addition of triethylamine caused the
photophysical output to revert back to that of the neutral complex. This was ob-
served by a red shift and decrease in emission intensity. The luminescent features
of the neutral Re(I) complexes are therefore able to undergo reversible modulation via
a protonation-deprotonation regime.
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3.4 Results and Discussion: Iridium
The results obtained from the protonation of neutral Re(I) complexes prompted us to
investigate whether the reversible luminescent modulation might be a general feature of
luminescent metal tetrazolato complexes. To explore the generality of this behaviour,
the protonation of a previously reported cyclometalated Ir(III) tetrazolato complex217
was investigated.
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Scheme 3.3: Synthesis of the protonated iridium tetrazolato complex 28.
Protonation was again performed by the addition of triflic acid to a DCM solution
of the complex, as shown in Scheme 3.3. The starting complex, [Ir(PyrTzF)] (27)
was already available at the University of Bologna. The final protonated species was
analysed by 1H NMR and ESI-MS to confirm protonation.
Table 3.4.1: Absorbance data for the Ir(III) complexes at 10-5 M in DCM.
Iridium Absorption
Complex λ max/nm (ε /104M-1cm-1)
[Ir(PyrTzF)] (27) 248 (6.09), 310 (2.23), 370 (0.78)
[Ir(PyrTzFH)]+(28) 239 (5.45) 315 (2.13), 430 (0.194)
The absorbance of the neutral iridium complex exhibits an intense transition in the
high energy UV region at 250 nm and a low intensity band at 370 nm, Table 3.4.1
and Figure 3.29. Once again, the energetics and absorption spectra of the complexes
were simulated with TD-DFT, using GAUSSIAN09.181 Computational calculations
reveal that the lowest energy transitions for [Ir(PyrTzF)] (27) appear to originate from
HOMO→LUMO+m transitions, where m = 0-2. Figure 3.30 shows the localisation
of the HOMO and LUMO on the Ir (III) complex. The lowest energy excited state
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Table 3.4.2: Emission data for the iridium tetrazolato complexes.
Iridium Emission 298 K Emission 77 K
Complexa λ (nm) τ (µs)b τ (µs)c φ b φ c λ max(nm) τ (µs)
[Ir(PyrTzF)] (27) 458, 488 0.105 0.161 0.034 0.056 450, 482 3.14 (26)
4.85 (74)
[Ir(PyrTzFH)]+ (28) 536 0.226 0.351 0.138 0.182 448, 478 4.23
a; All data for complexes in 10-5 M DCM solutions and all quantum yields measured
against rhodamine 101, b; air-equilibrated samples, c; degassed (O2 free) samples.
was therefore characterised as a mixture of MLCT and IL (pi-pi*) states, with a small
contribution from LLCT. The emission of [Ir(PyrTzF)] (27) is structured with λ em
maxima at 458 and 488 nm (Table 3.4.2). This structured profile is caused by the
close energy of the 3IL and 3MLCT emissive states and is common in these types
of iridium complexes.113 This is also supported by DFT which shows that the lowest
energy excited state has both charge transfer and intraligand character. The emission
maximum measured at 77 K for [Ir(PyrTzF)] (27) does not significantly differ from the
maximum recorded at room temperature (Table 3.4.2) suggesting dominance of the 3IL
(pi-pi*) emissive state.127,192
Figure 3.29: Absorption of the neutral iridium complex, [Ir(PyrTzF)] (27, solid line)
compared to the corresponding protonated species, [Ir(PyrTzFH)]+ (28 dashed line) in
DCM.
Figure 3.29 shows the absorbance profiles of both the neutral and protonated Ir com-
plexes. There is not a significant change in the spectrum upon protonation. The lower
energy bands are difficult to distinguish due to their broad nature however it appears
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Figure 3.30: Localisation of the HOMO and LUMO for [Ir(PyrTzF)], 27.
Figure 3.31: Localisation of the HOMO and LUMO for [Ir(PyrTzFH)]+, 28.
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there is an overall red shift of the low intensity bands. Computational calculations
of [Ir(PyrTzFH)]+(28) indicate that the lowest energy excited state originates primar-
ily from HOMO-n→LUMO+m transitions, where n = 0-1 and m = 0-3 (Figure 3.31).
Based on the localisation of these orbitals, the lowest energy transition can be assigned
to a mixture of MLCT and LLCT, with a significant reduction in the contribution from
the IL (pi −pi*) transition.
The emission of the protonated complex iridium complex is significantly different to
that of the starting neutral species. As can be seen in Figure 3.32, the neutral blue-green
emitting Ir(III) tetrazolato complex [Ir(PyrTzF)] is gradually transformed into the
corresponding protonated species [Ir(PyrTzFH)]+, displaying an increased intensity
and red shifted emission. The structured profile observed for [Ir(PyrTzF)] (27) is lost
upon protonation as evidenced in Figure 3.32, suggestive of emission from a more
dominant charge transfer state.
Figure 3.32: Steady state emission spectra showing the red shift and increase in emis-
sion intensity occurring upon addition of triflic acid to [Ir(PyrTzF)] (27), forming the
protonated complex, [Ir(PyrTzFH)]+ (28).
The loss of the IL contribution is also suggested by the blue-shifted emission maxi-
mum observed upon freezing the solution (Table 3.4.2). The rigidochromic effect is
commonly seen for purely charge transfer emissive states (ie: not pi −pi* IL transi-
tions).192,193 The localisation of the frontier orbitals, as calculated using DFT, also
shows a reduction in the IL contribution (Figure 3.31). The energies of the frontier
molecular orbitals for [Ir(PyrTzF)] (27) and the corresponding protonated analogue,
[Ir(PyrTzFH)]+ (28) have been plotted and are shown in Figure 3.33. It is apparent
107
that the tetrazole ring is directly involved in the composition of the LUMO. Protona-
tion therefore causes stabilisation of the LUMO, reducing the HOMO-LUMO energy
gap and explaining the observed red shifted emission.
Table 3.4.4: Radiative and non-radiative decay constants (kr and knr) for the iridium
complexes.
Iridium Complex kr(106 s-1) knr(106 s-1)
[Ir(PyrTzF)] (27) 0.349 5.86
[Ir(PyrTzFH)]+(28) 0.519 2.33
Figure 3.33: Calculated energy levels and orbital contours for the HOMO and LUMO
of [Ir(PyrTzF)] (27, A) and the protonated analogue [Ir(PyrTzFH)]+ (28, B), obtained
from DFT calculations.
As observed with the Re complexes, the τ and φ for the protonated Ir complex is im-
proved with respect to the corresponding neutral analogue (Table 3.4.2). The improved
output is usually described by an increased HOMO-LUMO energy gap47,48 however,
the red shifted emission and the contour plots (Figure 3.33) show that this in not the
case. Table 3.4.4 illustrates that in fact there is a significant reduction in the knr upon
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protonation which explains the improved τ and φ . The improved output of the proto-
nated complexes might be rationalised by the reduced 3IL contribution to the excited
state however this is still uncertain. The increased kr is also expected upon a reduced
contribution from the 3IL state.218 The proton-induced modulation of the photophysics
is once again reversible, with the addition of triethylamine.
3.5 Results and Discussion: Ruthenium
The final metal tetrazolato complex investigated was [Ru(PyrTz)]+ (29). Protonation
was again carried out through addition of triflic acid to a DCM solution of the complex
(Scheme 3.4). The starting material was available from the University of Bologna and
the final product was characterised by 1H NMR and ESI-MS to confirm protonation.
N
CF3SO3H
2+
Ru
N
N N
N
N N
N
+
CF3SO3-
N
Ru
N
N N
N
N N
NN
N
H
DCM, -50 °C
[Ru(PyrTz)]+ [Ru(PyrTzH)]2+
PF6-
29 30
Scheme 3.4: Synthesis of the protonated ruthenium tetrazolato complex 30.
Table 3.5.1: Absorbance data for Ru(II) complexes measured in DCM.
Ruthenium Absorption
Complex λ max/nm (ε10-4M-1cm-1)
[Ru(PyrTz)]+(29) 291 (1.701) 370 (0.272) 475 (0.311)
[Ru(PyrTzH)]2+(30) 287 (1.515) 441 (0.346)
The absorbance of the starting Ru(II) complex exhibits intense transitions in the high
energy UV region around 291 nm and a series of bands in the UV-visible range with the
main peaks at 370 nm and 475 nm. The structure of the absorbance profile, as shown
in Figure 3.34, is typical for this class of ruthenium complexes.114,219 The absorption
spectrum was simulated with TD-DFT using GAUSSIAN09.181 Computational calcu-
lations indicates that the lowest energy excited states in the unprotonated ruthenium
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Table 3.5.2: Photophysical data for the ruthenium tetrazolato complexes.
Ruthenium Emission 298 K Emission 77 K
Complexa λ max(nm) τ (µs)b τ (µs)c φ b φ c λ max(nm) τ (µs)
[Ru(PyrTz)]+ (29) 653 0.077 0.220 - 0.04 597 5.23
[Ru(PyrTzH)]2+ (30) - - - - - - -
a; measurements in acetonitrile and data from work by Stagni et al.219, b;
air-equilibrated samples, c; degassed (O2 free) samples.
complex (29) appear to originate from HOMO-n →LUMO+m transitions, where n =
0-2 and m = 0-1. The HOMO-n type orbitals predominantly localise on the 4d orbitals
of the Ru center, whereas the LUMO+m are localised on both bipyridine ligands, as
shown in Figure 3.35. The low energy transitions are therefore MLCT in character (Ru
→ bipy). The higher energy transitions can be assigned to pi −pi* IL transitions.219
Figure 3.34: Absorption of the ruthenium complex, [Ru(PyrTz)]+ (29, solid line) com-
pared to the corresponding protonated species, [Ru(PyrTzH)]2+ (30, dashed line) in
DCM.
Emission of the unprotonated ruthenium complex is broad and structureless with a
maximum at 653 nm in acetonitrile. The increased τ and φ measured for the Ru com-
plex upon de-oxygenating the solution supports the assigned emission from a triplet
MLCT state52,54 (Table 3.5.2). Ru(II) emission measured in a frozen matrix blue
shifted, suggestive of emission from a charge transfer state.192,193 DFT indicates that
there is a minor but notable contribution of 4d orbitals present in the LUMO type or-
bitals as illustrated in Figure 3.35. Their contribution is likely to be minor enough as
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there is not significant deactivation of the 3MLCT (via the MC state) and emission is
still observed.
The absorbance spectrum of the protonated species [Ru(PyrTzH)]2+ (30) shows a
broad low intensity transition at 441 nm and a sharp high intensity transition at 287
nm (Figure 3.34). Comparing the absorbance profiles of the starting and protonated
ruthenium complexes (Figure 3.34), there has been a blue shift of the two low energy
bands upon protonation. Based on TD-DFT/DFT calculations, the lowest energy ex-
cited state of 30, appears to originate from HOMO→LUMO+m transitions, where m
= 0-2. The orbitals involved are again the 4d orbitals of the Ru center (HOMO) and
the bipyridine pi* orbitals (LUMO), see Figure 3.36. Based on the localisation of the
HOMO and LUMO, the low energy transition is assigned to an MLCT. The higher
energy transitions can be assigned to pi −pi* IL transitions.219
Figure 3.35: Localisation of the HOMO and LUMO for the ruthenium complex
[Ru(PyrTz)]+ (29).
Sequential addition of triflic acid was carried out on a DCM solution of [Ru(PyrTz)]+
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(29) and the emission maximum initially seen at 635 nm, was significantly quenched
(and blue shifted) upon protonation as shown in Figure 3.37. Emission of the proto-
nated complex is originating from a 3MLCT state and again, the DFT indicates that
the LUMO+1 and LUMO+2 have a small contribution from the 4d Ru orbitals (Fig-
ure 3.36). The HOMO and LUMO contributions do not seem to change greatly be-
tween the starting and protonated ruthenium complex (Figure 3.35 and Figure 3.36).
Even though upon protonation, there is a significant reduction in the emission of the
Ruthenium complex the small blue shifted emission band observed was assigned to
emission from a 3MLCT state. The blue shift in the complex can be rationalised by
a stabilisation of the ground state (HOMO) orbitals, due to the indirect reduction in
electron density on the metal centre from the protonation of the tetrazole ring. It is
interesting that protonation of the tetrazolato ligand causes significant quenching as
previous studies which have methylated this same complex, observe extension of life-
time but a reduction in quantum yield.219
Figure 3.36: Localisation of the HOMO and LUMO for the ruthenium complex
[Ru(PyrTzH)]2+ (30).
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The quenching mechanism is still not fully understood but other studies looking at
the protonation of ruthenium azole complexes have observed similar quenching be-
haviour.220 The rationalisation used to describe their quenched emission could be used
herein. Duati et al. state that the pyridine tetrazole ligand is a good σ donor, meaning
it is a strong field ligand and can cause strong ligand field splitting of the complex.
This caused the eg level (ie; MC state) of the ruthenium to rise, increasing the energy
gap between the 3MC and 3MLCT states.220 The rationalisation could also be used
herein to describe the 3MLCT emission of [Ru(PyrTz)]+ (29). However, upon proto-
nation Duati et al. describe the azole ligand becoming a weaker sigma donor. The
ligand field splitting strength has also been reduced and therefore 3MC and 3MLCT
gap is smaller compared to the situation in the starting Ru complex. The closeness
of the 3MC and 3MLCT causes thermal population of the deactivating 3MC state.220
The low emission output observed herein, upon the formation of [Ru(PyrTzH)]2+ (30)
could also be caused by thermal population of the 3MC state. Temperature dependent
lifetime measurements would need to be conducted in order to further understand if the
theory of Duati et al. can explain the quenched emission of the ruthenium tetrazolato
complexes reported herein.
Figure 3.37: Steady state emission spectra showing the red shift and increase in emis-
sion intensity occurring upon addition of triflic acid to [Ru(PyrTz)]+(29, [RuH]+)
forming the protonated complex, [Ru(PyrTzH)]2+ (30, [RuH]2+).
An acetonitrile solution of the protonated complex with a few drops of triflic acid was
layered with diethyl ether to afford single crystals suitable for X-ray diffraction. The
resolved structure was somewhat unexpected as shown in Figure 3.38. The pyridine
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tetrazole is no longer present as a bidentate ligand but is mono-coordinating through
the N2 atom of the tetrazole ring. In this case, the crystal structure shows acetonitrile
coordinating as a sixth ligand. The proton is also shown on the pyridine ring, which
is as pyridine is the stronger base compared to the tetrazole. Potential weakening of
the Ru-N bond of the pyridine tetrazole ligand could be another reason why emission
is quenched upon formation of 30. Increased lability and movement of the tetrazole
ligand could cause increased vibrations and therefore an increased contribution from
knr . Knr could not be calculated due to the lack of τ and φ data. Understandably, the
photophysical measurements were carried out in dichloromethane, a non-coordinating
solvent. Nonetheless, protonation could make the tetrazolato ligand labile enough for
CF3SO3- to weakly coordinate (instead of solvent) however this has not been observed.
As stated above, the precise cause of the quenched emission in the protonated ruthe-
nium species is still not known and further experiments are required.
Figure 3.38: X-ray crystal structure of the protonated ruthenium complex where ther-
mal ellipsoids have been drawn at 30% probability. The triflate counter ion has been
omitted for clarity.
As a common feature discussed in Chapter Three, the emission of light from the proto-
nated Ru(II) complex can be restored through the addition of triethylamine. Protona-
tion of the Re(I), Ir(III) and Ru(II) tetrazolato complexes causes a unique modulation
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of their photophysical properties. The tetrazolato ligand, which undergoes protonation,
has a varied contribution to the excited state for each class of complex.
3.6 Conclusion
The reversible protonation reaction of Re(I) tetrazolato complexes has been investi-
gated and the change in luminescence reported. Through protonation of the tetrazole
ring, it was possible to significantly increase the intensity and blue shift the emission
of the complexes. Protonation, which occurs on the tetrazolato ligand, indirectly cre-
ates a larger energy gap between the ground and excited states of the newly formed
cationic complex. The protonated species are therefore characterised by a reduction in
the value of knr and hence improved φ and elongated τ . Addition of triethylamine to
the cationic complex causes deprotonation and the photophysical output returns to that
of the neutral analogue.
The photophysical output of the Ir(III) tetrazolato complex was also modified upon
protonation with a red shifted emission observed. The emitting excited state reversibly
passes from a mixed 3LC/3MLCT in the neutral species to a predominant 3MLCT
excited state after protonation. A completely different behaviour is observed for the
Ru(II) polypyridyl complex. Upon protonation, emission is quenched producing a
reversible on-off switch of the luminescence.
The reversible modulation of luminescence observed for the Re(I) tetrazolato com-
plexes shows they are sensitive to their environment. This fundamental study provides
the proof of concept that these complexes or modified analogues may be further inves-
tigated as sensors or responsive probes.
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3.7 Experimental
3.7.1 General Procedures
General procedures are as outlined in Chapter Two, section 2.5.1, unless otherwise
stated.
Nuclear magnetic resonance spectra (consisting of 1H and 13C experiments) were
recorded using a Varian Mercury Plus 400 instrument (400.1 MHz for 1H, 101.1 MHz
for 13C) at room temperature. 1H and 13C chemical shifts were referenced to residual
solvent resonances. The NMR referencing scheme for the assignments of peaks is as
outlined in Scheme 2.8.
Infrared spectra were recorded as DCM solutions using a NaCl (5 mm) disc on a
Perkin-Elmer Spectrum 2000 FT-IR spectrometer. The intensities of the IR bands were
reported as strong (s), medium (m) or weak (w), with broad (br) bands and shoulders
(sh) also indicated.
ESI-mass spectra were measured by Dr. Luca Zuppiroli at the University of Bologna,
using a Waters ZQ-4000 instrument (ESI-MS, acetonitrile as the solvent).
Photophysics
Absorption spectra were recorded at room temperature using a Perkin-Elmer Lambda
35 UV-vis spectrometer. Uncorrected steady-state emission and excitation spectra
were recorded on an Edinburgh FLSP920 spectrometer equipped with a 450 W xenon
arc lamp, double excitation and single emission monochromators and a Peltier-cooled
Hamamatsu R928P photomultiplier tube (185-850 nm). Emission and excitation spec-
tra were corrected for source intensity (lamp and grating) and emission spectral re-
sponse (detector and grating) by a calibration curve supplied with the instrument.
Emission lifetimes (τ) were determined with the same Edinburgh FLSP920 spectrom-
eter using pulsed picosecond LEDs (EPLED 360, FHWM <800 ps) as the excitation
source, with repetition rates between 1 kHz and 1 MHz, and the above mentioned
R928P PMT as the detector. Degassed solutions were prepared by gently bubbling
argon gas into the prepared sample for 15 minutes before measurement.
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3.7.2 Synthesis
3.7.2.1 General methodology for protonation of neutral fac-[Re(diim)(CO)3(L)]
complexes.
The preparation of the protonated fac-[Re(diim)(CO)3(L)] complexes (diim = 1,10-
phenanthroline or 2,2’-bipyridine) was carried out following procedures adapted from
previously published work.108,111
Previously synthesised fac-[Re(diim)(CO)3(L)] (1 eq) was added to DCM under argon
atmosphere and the mixture was allowed to cool using an ethyl acetate/liquid nitrogen
cool bath. Once the reaction vessel had cooled, trifluoromethanesulfonic acid (1.2 eq)
in DCM was added. The reaction was stirred under nitrogen for approximately 30
minutes in the cool bath and was then allowed to come to room temperature and stirred
overnight. The solvent was removed in vacuo to yield a yellow glassy looking solid
that was identified as the expected protonated complex.
fac-[Re(phen)(CO)3(TphH)]+
Re
CO
OC
OC
N
N N
N
H
N
N
H
+
CF3SO3-
21
Yield of compound 21: 0.051 g, 82%. ESI-MS (m/z) = 597 [M − SO3CF3]+; 149
[SO3CF3]-. νmax (IR)/cm-1, DCM, rt: 2039 s (CO, A´(1)), 1936 br (CO, A´(2)/A´´ ),
1606 w (tetrazole C=N). 1H NMR (δ, ppm, Acetone-d6): 9.75 (2H, d, J = 4.8 Hz, phen
H2,9), 9.07 (2H, d, J = 8.0 Hz, phen H4,7), 8.37 (2H, s, phen H5,6), 8.28−8.24 (2H, m,
phen H3,8), 7.69 (2H, d, J = 7.6 Hz, CN4-C6H5 Hortho), 7.56−7.54 (1H, m, CN4-C6H5
Hpara), 7.43−7.39 (2H, m, CN4-C6H5 Hmeta). 13C NMR (δ, ppm, Acetone-d6): 197.0,
156.4, 156.2, 148.8, 141.8, 134.1, 132.7, 131.0, 129.6, 128.8, 128.5. Crystals suitable
for X-ray analysis were obtained by slow diffusion of diethyl ether into a DCM solution
of the complex with a few drops of dilute triflic acid solution. By using this procedure,
two different crystals of the same complex were obtained; 21, C23H14F3N6O6ReS, and
21· 0.25Et2O, C24H16.5F3N6O6.25ReS, respectively. These were distinguished by the
absence and presence of diethyl ether in the unit cell.
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fac-[Re(bipy)(CO)3(TphH)]+
Re
CO
OC
OC
N
N N
N
H
N
N
H
+
CF3SO3-
22
Yield of compound 22: 0.045 g, 70%. ESI-MS (m/ z) = 573 [M − SO3CF3]+; 149
[SO3CF3]-. νmax (IR)/cm-1, DCM, rt: 2039 s (CO, A´(1)), 1936 br (CO, A´(2)/A´´ ),
1606 w (tetrazole C=N). 1H NMR (δ, ppm, Acetone-d6): 9.31 (2H, d, J = 5.2 Hz, bipy
H6,6’), 8.78 (2H, d, J = 8.4 Hz, bipy H3,3’), 8.43−8.39 (2H, m, bipy H4,4’), 7.90−7.83
(4H, m, bipy H5,5’ and CN4-C6H5 Hortho), 7.54−7.49 (3H, m, CN4-C6H5 Hmeta and
Hpara). 13C NMR (δ, ppm, Acetone-d6): 196.8, 194.3, 159.2, 157.5, 155.0, 141.9,
132.4, 130.1, 129.1, 127.9, 125.4, 123.3. Crystals suitable for X-ray analysis (identi-
fied as a dimeric Re species; C34H21F3N8O9Re2S) were obtained by slow diffusion of
diethyl ether into a DCM solution of the complex with a few drops of dilute triflic acid
solution.
fac-[Re(phen)(CO)3(TbzH)]+
Re
CO
OC
OC
N
N N
N
C
N
N
H
+
CF3SO3-O
H
23
Yield of compound 23: 0.042 g, 68%. ESI-MS (m/z) = 625 [M − SO3CF3]+; 149
[SO3CF3]-. νmax (IR)/cm-1, DCM, rt: 2040 s (CO, A´(1)), 1938 br (CO, A´(2)/A´´ ),
1709 s (aldehyde CO), 1607 w (tetrazole C=N). 1H NMR (δ, ppm, Acetone-d6): 10.04
(1H, s, CN4-C6H4-CHO), 9.74 (2H, d, J = 5.2 Hz, phen H2,9), 9.04 (2H, d, J = 8.2
Hz, phen H4,7), 8.36 (2H, s, phen H5,6), 8.26−8.23 (2H, m, phen H3,8), 7.95 (2H,
d, J = 8.4 Hz, CN4-C6H4 -CHO Hmeta), 7.90 (2H, d, J = 8.4 Hz, CN4-C6H4 -CHO
Hortho). 13C NMR (δ, ppm, Acetone-d6): 192.3, 155.7, 148.2, 141.0, 139.3, 132.0,
130.9, 128.9, 128.5, 127.7. Crystals suitable for X-ray analysis (identified as 23,
C24H14F3N6O7ReS) were obtained by slow diffusion of diethyl ether into a DCM so-
lution of the complex with a few drops of dilute triflic acid solution.
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fac-[Re(bipy)(CO)3(TbzH)]+
Re
CO
OC
OC
N
N N
N
C
N
N
H
+
CF3SO3-O
H
24
Yield of compound 24: 0.035g, 56%. ESI-MS (m/z) = 601 [M − SO3CF3]+; 149
[SO3CF3]-. νmax (IR)/cm-1, DCM, rt: 2040 s (CO, A´(1)), 1937 br (CO, A´(2)/A´´ ),
1709 s (aldehyde CO), 1606 w (tetrazole C=N). 1H NMR (δ, ppm, Acetone-d6): 10.11
(1H, s, CN4-C6H4-CHO), 9.34 (2H, d, J = 5.6 Hz, bipy H6,6’), 8.81 (2H, d, J = 8.2 Hz,
bipy H3,3’), 8.45−8.43 (2H, m, bipy H4,4’), 8.07 (4H, s, CN4-C6H4 -CHO H meta, ortho),
7.91−7.88 (2H, m, bipy H5,5’). 13C NMR (δ, ppm, Acetone-d6): 196.4, 192.4, 157.5,
155.1, 154.9, 142.4, 142.1, 139.9, 131.0, 129.2, 129.0, 125.3. Crystals suitable for
X-ray analysis (identified as 24, C22H14F3N6O7ReS) were obtained by slow diffusion
of diethyl ether into a DCM solution of the complex with a few drops of dilute triflic
acid solution.
fac-[Re(phen)(CO)3(TcyaH)]+
Re
CO
OC
OC
N
N N
N
CN
N
N
H
+
CF3SO3-
25
Yield of compound 25: 0.039 g, 64%. ESI-MS (m/z) = 622 [M − SO3CF3]+; 149
[SO3CF3]-. νmax (IR)/cm-1, DCM, rt: 2233 w (CN), 2040 s (CO, A´(1)), 1937 br
(CO, A´(2)/A´´ ), 1606 w (tetrazole C=N). 1H NMR (δ, ppm, Acetone-d6): 9.76 (2H,
d, J = 5.0 Hz, phen H2,9), 9.07 (2H, d, J = 8.4 Hz, phen H4,7), 8.37 (2H, s, phen
H5,6), 8.28−8.25 (2H, m, phen H3,8), 7.91 (4H, s, CN4-C6H4 -CN Hmeta, ortho). 13C
NMR (δ, ppm, Acetone-d6): 196.3, 155.8, 148.1, 141.2, 134.1, 132.0, 129.0, 128.9,
127.8, 127.6, 126.8, 118.3, 116.5. Crystals suitable for X-ray analysis (identified as
25, C24H13F3N7O6ReS) were obtained by slow diffusion of diethyl ether into a DCM
solution of the complex with a few drops of dilute triflic acid solution
fac-[Re(bipy)(CO)3(TcyaH)]+
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Yield of compound 26: 0.026 g, 42%. ESI-MS (m/z) = 598 [M − SO3CF3]+; 149
[SO3CF3]-. νmax (IR)/cm-1, DCM, rt: 2233 w (CN), 2040 s (CO, A´(1)), 1938 br
(CO, A´(2)/A´´ ), 1606 w (tetrazole C=N). 1H NMR (δ, ppm, Acetone-d6): 9.32 (2H,
d, J = 5.4 Hz, bipy H6,6’), 8.78 (2H, d, J = 8.4 Hz, bipy H3,3’), 8.44 (2H, t, J = 8.0
Hz, bipy H4,4’), 8.04 (2H, d, J = 8.8 Hz, CN4-C6H4 -CN Hmeta), 7.94−7.88 (4H, m,
CN4-C6H4 -CN Hortho and bipy H5,5’). 13C NMR (δ, ppm, Acetone-d6): 157.5, 154.9,
154.1, 141.7, 140.7, 133.7, 129.0, 128.2, 125.0, 118.8, 114.5. Crystals suitable for
X-ray analysis (identified as 26, C22H13F3N7O6ReS) were obtained by slow diffusion
of diethyl ether into a DCM solution of the complex with a few drops of dilute triflic
acid solution.
3.7.2.2 Protonation of the Ir(III) and Ru(II) Complexes.
[Ir(PyrTzFH)]+
+
CF3SO3-Ir
N
C
F
F N
N
N N
NC
N
F
F H
28
Protonation of [Ir(PyrTzF)] (27) was carried out according to previously published
methods.108,111 [Ir(PyrTzF)] (1 eq) was added to DCM and allowed to cool in an
ethyl acetate/liquid nitrogen cool bath. Once the reaction vessel had cooled, trifluo-
romethanesulfonic acid (1.2 eq) in DCM was added. The reaction was stirred under
argon for approximately 30 minutes in the cool bath and was then allowed to come to
room temperature and stirred overnight. The solvent was removed in vacuo to yield a
yellow residue that was identified as the expected protonated complex.
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Yield of compound 28: 0.048 g, 80 %. ESI-MS (m/z) = 719 [M - SO3CF3]+. 1H NMR
(δ, ppm, Acetonitrile-d3): 8.49 (1H, d, J = 7.6 Hz), 8.12-8.24 (3H, m), 8.01 (1H, d, J =
5.2 Hz), 7.92 (2H, t, J = 7.6Hz), 7.74 (1H, d, J = 5.6 Hz),7.66-7.59 (2H, m), 7.13-7.07
(2H, m), 6.72-6.65 (2H, m), 5.75-5.71 (2H, m).
[Ru(PyrTzH)]2+
2+
2CF3SO3-Ru
N
N N
N
N N
NN
N
H
30
Protonation of [Ru(PyrTz)]+(29) was carried out according to previously published
methods.108,111 [Ru(PyrTz)]+ (1 eq) was added to DCM and allowed to cool in an
ethyl acetate/liquid nitrogen cool bath. Once the reaction vessel had cooled, trifluo-
romethanesulfonic acid (1.2 eq) in DCM was added. The reaction was stirred under
nitrogen for approximately 30 minutes in the cool bath and was then allowed to come
to room temperature and stirred overnight. The solvent was removed in vacuo to yield
a red residue that was identified as the expected protonated complex.
Yield of compound 30: (0.045 g, 75%). ESI-MS (m/z) = 280 [M2+]; 145 [PF6]−, 149
[SO3CF3]−. 1H NMR (δ, ppm, Acetonitrile-d3): 8.49 (2H, t, J = 7.2 Hz), 8.44-8.41
(1H, m, 2H), 8.35 (1H, d, J = 7.6 Hz), 8.05-7.94 (5H, m), 7.87-7.83 (2H, m), 7.79 (1H,
d, J = 5.6 Hz), 7.69 (1H, d, J = 5.2 Hz), 7.62 (1H, d, J = 5.2 Hz), 7.41-7.29 (5H, m).
3.7.3 X-ray Crystallography
X-ray Crystallography for all of the complexes presented in Chapter Three were carried
out by Associate Professor Stefano Zacchini from the University of Bologna. Diffrac-
tion data for 21, 22, 23, 24, 25 and 26 can be found in previously published work.201
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3.7.4 Computational Calculations
The TD-DFT/DFT calculations were performed by Mr. Phillip Wright of Curtin Uni-
versity using GAUSSIAN09.181 The calculations were done using the B3LYP func-
tional,221 the Stuttgart-Dresden effective core potential for Re,222 and the 6-311++G**
basis set for the other atoms. The presence of solvent was then mimicked by using the
PCM implicit model223 with parameters appropriate for dichloromethane.
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Chapter 4
Methylation of Rhenium Tetrazolato
Complexes
4.1 Abstract
Methylation reactions on a series of neutral fac-[Re(diim)(CO)3(L)] complexes caused
an irreversible modulation of photophysical output, in terms of elongated lifetimes and
higher quantum yields. The emission maximum was also blue shifted upon methyla-
tion. IR studies and photophysical characterisation suggested the formation of only one
methylated rhenium species, NMR analysis revealed that two cationic rhenium species
were present in solution. X-ray crystallography was used to identify these products
as both the Re-N2 and Re-N1 linkage isomers. Although these complexes displayed
superior luminescent output, the tetrazolato ligand became labile upon methylation,
causing the overall stability of the complex to be lost.
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4.2 Introduction
The 5-substituted aryl tetrazolato ligand has been increasingly explored in a series of
organometallic complexes, spanning more than a decade.111–114,170,174,219,224–227 For
those luminescent complexes, the contribution of the tetrazole ligand can play an im-
portant role in determining the extent of the HOMO-LUMO gap which directly influ-
ences the luminescent output. As was observed in Chapter Three, the luminescence
of a series of fac-[Re(diim)(CO)3(L)] complexes was reversibly altered upon reaction
with the most simple electrophile, H+. The CH3+ group is another electrophile which
can react with the nitrogen atoms of the tetrazole ring and potentially modulate the
photophysical output of the complexes.
Previous reports on metal tetrazolato complexes have demonstrated that methylation
can significantly influence the luminescent properties of these complexes. In particu-
lar, methylation of a mono-coordinated aryl tetrazolato ligand caused a “turn-on” effect
for a Ru(II) metal complex.114 The same reaction performed on cyclometalated Ir(III)-
tetrazolate complexes caused a red shift of the emission maximum of over 50 nm,113
similar to the outcome of protonating the Ir(III)-tetrazolato complex discussed in Chap-
ter Three. Interestingly, the methylation of a deep blue emitting Pt(II)-cyclophane
complex significantly altered the emitting excited state as was evidenced by a notable
reduction in the luminescent output and an increase of the knr value.224
The results from the protonation reactions carried out in Chapter Three were encour-
aging, with the Re(I) complexes showing detectable responses to changes in their sur-
rounding environment. Methylation is an irreversible reaction and could offer a more
straight forward way to purify and isolate the positively charged rhenium complexes.
Re
CO
OC
OC
N
N N
Ct
N
R
N
N
(phen) (bipy)
R = H
CHO
COOCH3
Complex = fac-[Re(diim)(CO)3(TphCH3)]+
(diim)
or
N N
                  fac-[Re(diim)(CO)3(TbzCH3)]+
                  fac-[Re(diim)(CO)3(TmeCH3)]+CH3
PF6-
+
Scheme 4.1: Codes and abbreviations used for the methylated Re(I) complexes re-
ported in Chapter Four.
The work described in this Chapter is based around the methylation of a series of
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neutral fac-[Re(diim)(CO)3(L)] complexes. The fundamental changes occurring at
a chemical and photophysical level were investigated in response to this structural
modification. The complexes described in this Chapter are outlined in Scheme 4.1
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4.3 Results
4.3.1 Synthesis
Methylation of the neutral rhenium complexes was carried out according to previously
published methods108,111–113,219,224 as demonstrated in Scheme 4.2. The tetrazole ring
has three potential sites for methylation which are the three free nitrogen atoms of the
tetrazole ring. Scheme 4.2 shows the three possible methylation products. The reaction
was carried out at low temperatures (-50 ºC), to favour methylation at the less hindered
N4 atom, Scheme 4.2 C.
Re
CO
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Scheme 4.2: Synthesis of the methylated rhenium tetrazolato complexes showing po-
tential methylation at N1 (A), N3 (B) or N4 (C).
Following the addition of a slight excess of methyl triflate and stirring overnight at
room temperature, the cationic rhenium complexes were formed and subsequently iso-
lated as their PF6- salts. The six complexes synthesised (Scheme 4.1) were purified by
reprecipitation from dichloromethane and diethyl ether.
126
4.3.2 Infrared Spectroscopy
The formation of the expected compounds was first confirmed by solid state IR spec-
troscopy. Intense CO signals were observed between 2028 and 2032 cm-1 and broader
signals between 1897 and 1917 cm-1, Table 4.3.1. In some of the bipy complexes,
the CO A´(2) and A´´ are collapsed, which is not uncommon in these type of rhenium
complexes.178 The totally symmetric in phase stretching band A´(1), has shifted from
values of 2018-2021 cm-1 in the neutral rhenium complexes to 2028-2032 cm-1 in the
methylated species (Table 4.3.1). The A´(2) and A´´ CO bands also shift to higher
wavenumbers upon methylation due to the reduced electron density on the rhenium
metal centre caused by methylation of the tetrazolato ligand.
Table 4.3.1: Solid state FT-IR measurements comparing the CO stretching frequen-
cies (cm-1) in the neutral rhenium complexes and their corresponding methylated ana-
logues.
Stretching frequency (cm-1) CO A´(1) CO A´(2) CO A´´
fac-[Re(phen)(CO)3(Tph)] (11) 2019 1909 1881
fac-[Re(phen)(CO)3(TphCH3)]+ (31) 2032 1911 1897
fac-[Re(bipy)(CO)3(Tph)] (12) 2018 1893
fac-[Re(bipy)(CO)3(TphCH3)]+(32) 2031 1931 1898
fac-[Re(phen)(CO)3(Tbz)] (13) 2020 1916 1892
fac-[Re(phen)(CO)3(TbzCH3)]+(33) 2032 1929 1922
fac-[Re(bipy)(CO)3(Tbz)] (14) 2021 1885
fac-[Re(bipy)(CO)3(TbzCH3)]+(34) 2028 1929 1901
fac-[Re(phen)(CO)3(Tme)] (15) 2020 1912 1887
fac-[Re(phen)(CO)3(TmeCH3)]+(35) 2031 1931 1917 (1897sh)
fac-[Re(bipy)(CO)3(Tme)] (16) 2020 1902
fac-[Re(bipy)(CO)3(TmeCH3)]+(36) 2030 1908 (1925 sh)
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4.3.3 NMR
Figure 4.1: Comparison of the aromatic region in the 1H NMR spectrum of the neutral
rhenium complex 11 (bottom) and the corresponding methylated species 31 (top).
Upon 1H and 13C NMR analysis of the methylated Re(I) species (acetone-d6) two dis-
tinct signal patterns were observed. Figure 4.1 shows the aromatic region of the 1H
NMR spectra illustrating the change in the number and position of the phenanthro-
line peaks upon methylation. In the neutral species there is one set of phenanthroline
resonances (Figure 4.1, bottom) whereas after methylation, two sets are present (Fig-
ure 4.1, top). This could be suggestive of two rhenium species present in solution.
The reaction may have produced two separate rhenium complexes or, in solution an
equilibrium exists. Figure 4.2 to Figure 4.7 show the NMR spectra of the neutral and
corresponding methylated Re(I) complexes. The integration of the 1H NMR spectra
(in acetone-d6) for the methylated species, indicated the two products were occurring
in a ratio ranging from 1:0.65 to 1:0.97 (a:b; where “a” was assigned to the resonance
with the higher integration ratio). This a:b ratio is specified in each of the Figures.
The 1H NMR figures also show two new upfield singlets, suggestive of a methylated
species.
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Figure 4.2: 1H NMR spectra of the neutral complex fac-[Re(phen)(CO)3(Tph)], 11
(bottom) compared to the methylated species, fac-[Re(phen)(CO)3(TphCH3)]+, 31
(top).
Figure 4.3: 1H NMR spectra of the neutral complex fac-[Re(phen)(CO)3(Tbz)], 13
(bottom) compared to the methylated species, fac-[Re(phen)(CO)3(TbzCH3)]+, 33
(top).
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Figure 4.4: 1H NMR spectra of the neutral complex fac-[Re(phen)(CO)3(Tme)], 15,
(bottom) compared to the methylated species, fac-[Re(phen)(CO)3(TmeCH3)]+, 35
(top).
Figure 4.5: 1H NMR spectra of the neutral complex fac-[Re(bipy)(CO)3(Tph)], 12
(bottom) compared to the methylated species, fac-[Re(bipy)(CO)3(TphCH3)]+, 32
(top).
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Figure 4.6: 1H NMR spectra of the neutral complex fac-[Re(bipy)(CO)3(Tbz)], 14
(bottom) compared to the methylated species, fac-[Re(bipy)(CO)3(TbzCH3)]+, (34,
top).
Figure 4.7: Comparison of the 1H NMR spectra of the neutral fac-
[Re(bipy)(CO)3(Tme)], 16 (bottom) with that of the methylated species, fac-
[Re(bipy)(CO)3(TmeCH3)]+, 36 (top).
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Table 4.3.2 shows a comparison of the Hmeta and Hortho signals before and after methy-
lation of the Re(I) complexes. Table 4.3.2 and the corresponding Figures, show that for
the methylated complexes, the Hortho resonances for both species are collapsed, form-
ing either a singlet or a multiplet. For those complexes with an electron withdrawing
-R group in the para position, the Hmeta signals have been deshielded and two separate
signals are observed. This is consistent with the two distinct sets of resonances ob-
served for the methylated complexes. The Hortho resonances in the methylated species
have been deshielded to a lesser extent than the Hmeta signals.
Table 4.3.2: Comparison of the 1H NMR signals relative to the ortho and meta protons
before and after methylation. NMR data from acetone-d6 solutions.
Rhenium Complex Neutral
Methylated
δHo δHm
fac-[Re(phen)(CO)3(Tph)] 11 7.63 7.22-7.20a
fac-[Re(phen)(CO)3(TphCH3)]+ 31 - -
fac-[Re(bipy)(CO)3(Tph)] 12 7.82−7.79c 7.32−7.24a
fac-[Re(bipy)(CO)3(TphCH3)]+ 32 - -
fac-[Re(phen)(CO)3(Tbz)] 13 7.80 7.84
fac-[Re(phen)(CO)3(TbzCH3)]+ 33 7.72-7.69 8.18, 8.02
fac-[Re(bipy)(CO)3(Tbz)] 14 7.87 8.01
fac-[Re(bipy)(CO)3(TbzCH3)]+ 34 7.88 8.21, 8.09
fac-[Re(phen)(CO)3(Tme)] 15 7.75 7.88
fac-[Re(phen)(CO)3(TmeCH3)]+ 35 7.62 8.52, 8.19-8.06b
fac-[Re(bipy)(CO)3(Tme)] 16 7.91 7.95
fac-[Re(bipy)(CO)3(TmeCH3)]+ 36 7.80-7.78 8.26, 8.14
a; Peak range includes the resonances for Hm and Hp,b; Peak range includes the reso-
nance for phen H3,8, c;Peak range includes the resonance for bipy H4,4’, -; the Ho and
Hm signals for the methylated complexes with the phenyltetrazole ligand could not be
distinguished and have therefore been omitted.
Isolated crystals that were grown of some of the methylated complexes, were analysed
by NMR. In each case, the crystal structures indicated the presence of one system in
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the solid state (section 4.3.4) by assessing the unit cell parameters of several crystals
in the same batch. However, the 1H NMR showed the presence of the two sets of
resonances, again suggesting that in solution, two species are present.
4.3.3.1 Temperature Dependent NMR
Temperature dependent NMR studies were carried out to further understand the nature
of the two products observed for the methylated Re(I) complexes. Temperature depen-
dent NMR experiments were carried out on fac-[Re(phen)(CO)3(TbzCH3)]+ (33) in
DMSO-d6 and acetonitrile-d3. The experiment using DMSO-d6 was performed using
Figure 4.8: 1H NMR spectrum of fac-[Re(phen)(CO)3(TbzCH3)]+ (33) at 25 ºC (a),
40 ˚C (b), 55 ºC (c) and 70 ºC (d) in DMSO-d6.
the variable temperature function of the NMR. The sample was steadily heated to 70
ºC with spectra being recorded at various intervals. Figure 4.8 shows the NMR spec-
tra of 33 recorded at sequentially increasing temperatures between 25 and 70 ºC. At
40 ºC, there is the emergence of a new set of peaks which increase in intensity as the
temperature rises (marked by the * in Figure 4.8). As this new system becomes more
prevalent, the two sets of original peaks disappear. Upon reaching 70 ºC the new sys-
tem predominates, with only minor traces of any other species observed. Heating the
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sample has produced a single new product. The NMR, still containing the sample was
slowly cooled back to the starting temperature of 25 ºC. Multiple spectra were recorded
as the sample was cooled however each subsequent spectra, even the one taken at room
temperature, looked identical to that in Figure 4.8 d (at 70 ºC).
Figure 4.9: 1H NMR spectra of fac-[Re(phen)(CO)3(TbzCH3)]+ (33) at 25 ˚C (a),
after being heated at 70 ˚C for 20 minutes (b) and after being heated at 70 ˚C for 300
minutes (c) in acetonitrile-d3.
To further investigate these observations, an NMR sample of the same complex (33) in
acetonitrile-d3 was heated straight to 70 ˚C in an oil bath. NMR spectra were recorded
at different time intervals. After 20 minutes of heating the sample, the emergence of
a third, new set of peaks are observed (Figure 4.9). After heating to 70 ˚C for five
hours, the NMR spectrum only showed one set of peaks, similar to that observed in
DMSO-d6.
Although the original resonances observed at room temperature eventually disappear;
they were still present in the same ratios throughout the entire heating process (while
they could still be observed).
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4.3.3.2 Solvent effects
NMR were carried out in different solvents to analyse if there was a change in the rel-
ative integration ratios of the two systems present. The NMR spectra of
fac-[Re(phen)(CO)3(TphCH3)]+ (31) was recorded in acetone-d6. Subsequently, the
solvent was removed (without heating) and the same sample was measured in acetonitrile-
d3. The integration ratio of the two rhenium systems (a:b) in acetone-d6 was 1:0.52
whereas the same sample in acetonitrile-d3 gave an integration ratio of 1:0.72 (a:b),
see Figure 4.10.
Figure 4.10: 1H NMR spectra of fac-[Re(phen)(CO)3(TphCH3)]+, 31 in acetonitrile-
d3 (top) compared to the spectrum recorded in acetone-d6 (bottom).
The same experiment was conducted on fac-[Re(phen)(CO)3(TbzCH3)]+(33). The
integration ratio of the two systems in acetone-d6was 1:0.86 whereas when the NMR
was recorded in acetonitrile-d3, the a:b ratio was 1:0.68, see Figure 4.11.
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Figure 4.11: 1H NMR spectra of fac-[Re(phen)(CO)3(TbzCH3)]+, 33 in acetonitrile-
d3 (top) compared to the spectrum recorded in acetone-d6 (bottom).
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4.3.4 X-ray Crystallography
Single crystals of all prepared complexes were grown. In each case, the product iso-
lated from the crystallisation experiments was the one showing methylation occurring
at the N4 atom. Interestingly, coordination of the aryl tetrazolato ligand to the rhenium
centre was not always via the N2 atom as observed for the previously discussed Re(I)
complexes in Chapters Two and Three. Figure 4.12 and Figure 4.13 show the crystal
structures isolated for each of the methylated phen and bipy complexes respectively.
All of the methylated phen complexes, 31, 33 and 35 were isolated as the N1 link-
age isomer. The crystals that were isolated for the methylated bipy complexes were a
mixture of both N1 (36) and N2 (33, 32) linkage isomers, see Table 4.3.3.
Table 4.3.3: Deviation from coplanarity between the aryl and tetrazole rings in the
methylated Re(I) complexes.
Rhenium Complex/N1 or N2
Linkage Deviation from Coplanarity (˚)
Isomer (tetrazole and aryl ring)
fac-[Re(phen)(CO)3(TphCH3)]+ (31) N1 72.75
fac-[Re(bipy)(CO)3(TphCH3)]+(32) N2 48.24
fac-[Re(phen)(CO)3(TbzCH3)]+(33) N1 86.98
fac-[Re(bipy)(CO)3(TbzCH3)]+(34) N2 39.80
fac-[Re(phen)(CO)3(TmeCH3)]+(35) N1 84.55
fac-[Re(bipy)(CO)3(TmeCH3)]+(36) N1 79.46
The torsion angle between the tetrazole and aryl ring was used to calculate the devi-
ation from coplanarity (ie: deviation from 0˚ or 180˚). These calculated values are
displayed in Table 4.3.3. The N2 coordinated species have torsion angles which indi-
cate a smaller deviation from coplanarity compared to the N1 coordinated complexes.
None of the crystal structures isolated for the synthesised complexes show any hydro-
gen bonding or significant pi-pi interactions.
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Figure 4.12: X-ray crystal structures of fac-[Re(phen)(CO)3(TphCH3)]+ (31, A), fac-
[Re(phen)(CO)3(TbzCH3)]+ (33, B), and fac-[Re(phen)(CO)3(TmeCH3)]+ (35, C)
where thermal ellipsoids have been drawn at 50% probability (except for A, at 30%
probability). The hexafluorophosphate counter ion has been omitted for clarity.
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Figure 4.13: X-ray crystal structures of fac-[Re(bipy)(CO)3(TphCH3)]+ (32, A), fac-
[Re(bipy)(CO)3(TbzCH3)]+ (34, B), and fac-[Re(bipy)(CO)3(TmeCH3)]+ (36, C)
where thermal ellipsoids have been drawn at 50% probability. The hexafluorophos-
phate counter ion has been omitted for clarity.
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4.3.5 Photophysics
Table 4.3.4: Absorbance data for the methylated rhenium tetrazolato complexes at 10-5
M in DCM.
Rhenium Absorption
Complex λ max/nm (ε/104M-1cm-1)
fac-[Re(phen)(CO)3(TphCH3)]+ (31) 256 (3.93), 276 (3.83), 335 (0.87), 380 (0.60)
fac-[Re(bipy)(CO)3(TphCH3)]+(32) 242 (5.22), 319 (2.56), 350 (1.20)
fac-[Re(phen)(CO)3(TbzCH3)]+(33) 256 (4.22), 331 (0.67), 366 (0.43)
fac-[Re(bipy)(CO)3(TbzCH3)]+(34) 246 (3.98), 314 (1.5), 350 (0.5)
fac-[Re(phen)(CO)3(TmeCH3)]+(35) 230 (5.77), 254 (4.64), 333 (0.78), 380 (0.41)
fac-[Re(bipy)(CO)3(TmeCH3)]+(36) 265 (4.14), 320 (1.28), 350 (0.47)
Table 4.3.5: Photophysical data for the methylated rhenium tetrazolato complexes.
Rhenium Emission 298 K
Complexa λ max (nm) τ (µs)b τ (µs)c φ b φ c
fac-[Re(phen)(CO)3(TphCH3)]+ (31) 536 1.20 2.00 0.28 0.50
fac-[Re(bipy)(CO)3(TphCH3)]+(32) 546 0.61 1.00 0.22 0.36
fac-[Re(phen)(CO)3(TbzCH3)]+(33) 536 1.30 3.37 0.25 0.53
fac-[Re(bipy)(CO)3(TbzCH3)]+(34) 546 0.63 0.99 0.28 0.48
fac-[Re(phen)(CO)3(TmeCH3)]+(35) 538 1.40 3.20 0.23 0.57
fac-[Re(bipy)(CO)3(TmeCH3)]+(36) 546 0.64 1.02 0.20 0.34
a; All data for complexes in 10-5 M DCM solutions and all quantum yields measured
against rhodamine 101, b; air-equilibrated samples, c; degassed (O2 free) samples.
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Table 4.3.6: Emission data for the methylated rhenium tetrazolato complexes at 77 K
in DCM.
Rhenium Complex Emission 77K
λ max(nm) τ (µs)
fac-[Re(phen)(CO)3(TphCH3)]+ (31) 492 9.80
fac-[Re(bipy)(CO)3(TphCH3)]+(32) 490 4.05 (84%), 8.42 (16%)
fac-[Re(phen)(CO)3(TbzCH3)]+(33) 492 10.90
fac-[Re(bipy)(CO)3(TbzCH3)]+(34) 508 4.15
fac-[Re(phen)(CO)3(TmeCH3)]+(35) 508 9.13
fac-[Re(bipy)(CO)3(TmeCH3)]+(36) 500 4.38
Table 4.3.7: Radiative and non-radiative decay constants (kr and knr) for the methylated
rhenium complexes in degassed (O2 free) solutions of DCM.
Rhenium Complex kr (106 s-1) knr (106 s-1)
fac-[Re(phen)(CO)3(TphCH3)]+ (31) 0.250 0.250
fac-[Re(bipy)(CO)3(TphCH3)]+(32) 0.360 0.640
fac-[Re(phen)(CO)3(TbzCH3)]+(33) 0.157 0.139
fac-[Re(bipy)(CO)3(TbzCH3)]+(34) 0.485 0.525
fac-[Re(phen)(CO)3(TmeCH3)]+(35) 0.178 0.134
fac-[Re(bipy)(CO)3(TmeCH3)]+(36) 0.333 0.647
The absorption profiles for the methylated rhenium complexes generally show high
energy absorption bands in the UV region at 230 nm, tailing off around 320 nm. There
is also a lower energy band around 330-480 nm. As observed for the previously syn-
thesised Re(I) complexes, the low energy absorption bands for the methylated phen
complexes are blue shifted with respect to the bipy ones. This blue shift makes them
appear broader as they tail off into high energy transitions. The methylated species
generally have a blue shifted absorption profile when compared to the neutral ana-
logues, as seen in Figure 4.14 to Figure 4.19.
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Figure 4.14: Absorption of the neutral rhenium complex, fac-[Re(phen)(CO)3(Tph)]
(11, solid line) compared to the corresponding methylated complex, fac-
[Re(phen)(CO)3(TphCH3)]+ (31, dashed line) in DCM.
Figure 4.15: Absorption of the neutral rhenium complex, fac-[Re(bipy)(CO)3(Tph)]
(12, solid line) compared to the corresponding methylated complex, fac-
[Re(bipy)(CO)3(TphCH3)]+ (32, dashed line) in DCM.
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Figure 4.16: Absorption of the neutral rhenium complex, fac-[Re(phen)(CO)3(Tbz)]
(13, solid line) compared to the corresponding methylated complex, fac-
[Re(phen)(CO)3(TbzCH3)]+ (33, dashed line) in DCM.
Figure 4.17: Absorption of the neutral rhenium complex, fac-[Re(bipy)(CO)3(Tbz)]
(14, solid line) compared to the corresponding methylated complex, fac-
[Re(bipy)(CO)3(TbzCH3)]+ (34, dashed line) in DCM.
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Figure 4.18: Absorption of the neutral rhenium complex, fac-[Re(phen)(CO)3(Tme)]
(15, solid line) compared to the corresponding methylated complex, fac-
[Re(phen)(CO)3(TmeCH3)]+ (35, dashed line) in DCM.
Figure 4.19: Absorption of the neutral rhenium complex, fac-[Re(bipy)(CO)3(Tme)]
(16, solid line) compared to the corresponding methylated complex, fac-
[Re(bipy)(CO)3(TmeCH3)]+ (36, dashed line) in DCM.
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The emission profiles of the methylated rhenium complexes at room temperature in
dilute DCM solutions are broad and structureless. All of the complexes within the
same diimine group have the same emission maxima, see Table 4.3.5, Figure 4.20 and
Figure 4.21. The methylated phen complexes have a maximum emission wavelength
at 536-538 nm and the bipy complexes at 546 nm. The emission profiles measured
are wavelength independent suggestive of emission from a single excited state, as pre-
dicted by Kasha’s law. Again, as was observed for the absorption spectra, the emission
maxima of the phen complexes are blue shifted with respect to the bipy analogues.
Figure 4.20: Excitation and emission of fac-[Re(phen)(CO)3(TphCH3)]+ (31, green),
fac-[Re(phen)(CO)3(TbzCH3)]+ (33, red), and fac-[Re(phen)(CO)3(TmeCH3)]+ (35,
blue) in DCM.
Figure 4.21: Excitation and emission of fac-[Re(bipy)(CO)3(TphCH3)]+ (32, green),
fac-[Re(bipy)(CO)3(TbzCH3)]+ (34, red), and fac-[Re(bipy)(CO)3(TmeCH3)]+(36,
blue) in DCM.
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The luminescent properties of the methylated complexes compared to the correspond-
ing neutral precursors shows similar trends to those observed for the protonated species
discussed in Chapter Three. The emission of the methylated complexes have been sig-
nificantly blue shifted, between 48 and 60 nm. Figure 4.22 shows an example of the
blue shifted emission observed for the methylated complexes, with respect to their
neutral analogues. The quantum yields of the methylated complexes have improved
Figure 4.22: Excitation and emission of fac-[Re(phen)(CO)3(TphCH3)]+ (31, dashed
line) comapred to the neutral fac-[Re(phen)(CO)3(Tph)] (11, solid line).
23 fold and the lifetime has been elongated 4-10 times, with respect to the neutral
analogues. In line with these observations are the values calculated for kr and knr, Ta-
ble 4.3.7. There has been a significant reduction, up to 15 times, in the non radiative
decay constant upon methylation of the rhenium complexes compared to the neutral
analogues, see Table 2.3.8 on page 59, Chapter Two.
4.3.5.1 Methylation using Methyl-d3 Trifluoromethanesulfonate
Re
CO
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37
C-H vibrations and rotation around the C-N bond, are potential sources of quench-
ing in luminescent molecules. To understand if the introduction of the methyl group
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Table 4.3.8: Photophysical data of fac-[Re(phen)(CO)3(TphCH3)]+ (31) compared to
fac-[Re(phen)(CO)3(TphCD3)]+(37).
Rhenium Emission Decay
Complexa 298 K Constants (106 s-1)
λ max(nm) τ (µs)b τ (µs)c φ b φ c kr knr
CH3 (31) 536 1.18 1.83 0.14 0.26 0.142 0.404
CD3 (37) 536 1.26 1.86 0.11 0.23 0.124 0.414
a; All data for complexes in 10-5 M DCM solutions and all quantum yields measured
against quinine sulfate, b; air-equilibrated samples, c; degassed (O2 free) samples.
has caused any significant vibrational quenching, fac-[Re(phen)(CO)3(Tph)](11) was
methylated using methyl-d3 trifluoromethane sulfonate. The photophysical properties
of complex fac-[Re(phen)(CO)3(TphCD3)]+ (37) were compared to the non-deuterated
analogue (31) and are presented in Table 4.3.8. The emission maximum has not
changed upon substituting the CH3 group for a CD3. Similarly, the τ and φ observed
for the two complexes are not significantly different. This is also reflected in the knr
values which are similar for both complexes.
4.3.6 Computational Calculations
To further support the interpretation of the photophysical results, the energetics and
absorption spectra of the complexes were simulated with time-dependent density func-
tional theory using GAUSSIAN09.181 It is generally known that the high energy tran-
sitions observed in the UV-Vis spectra are from IL pi −pi∗ transitions.174 The DFT was
used to further classify the lower energy transitions.
As discussed in Chapter Two, the lowest energy excited state for the neutral rhenium
complexes was assigned to a 3MLLCT, with the HOMO localised over both the Re
5d metal orbitals and the pi orbitals on the tetrazole ligand. In the case of the methy-
lated complexes, the lowest energy excited state appears to originate predominantly
from HOMO-n→LUMO+m transitions, where n = 0-2 and m = 0-2. Figure 4.23 and
Figure 4.24 show the localisation of the HOMO and LUMO for the methylated Re(I)
complexes. Only the HOMO and LUMO are only shown here for clarity however
Figure A3.1 and Figure A3.2 show the extended orbital localisation for the HOMO-n
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and LUMO+m orbitals. The calculated low energy transitions are tabulated and can be
found in Appendix A3.3.
Figure 4.23: Localisation of the HOMO and LUMO for the methylated
phen complexes (left to right); fac-[Re(phen)(CO)3(TphCH3)]+ (31), fac-
[Re(phen)(CO)3(TbzCH3)]+ (33) and fac-[Re(phen)(CO)3(TmeCH3)]+ (35).
Based on the localisation of these orbitals (Figure 4.23 and Figure 4.24) it appears
that the lowest energy transition is an MLCT (Re→diimine) with a small contribution
of LLCT (CO→diimine). The extended HOMO and LUMO images (Figure A3.1 and
Figure A3.2 ) illustrate that there is negligible contribution of the tetrazolato ligand to
the HOMO based orbitals.
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Figure 4.24: Localisation of the HOMO and LUMO for the methylated
bipy complexes (left to right); fac-[Re(bipy)(CO)3(TphCH3)]+ 32, fac-
[Re(bipy)(CO)3(TbzCH3)]+(34) and fac-[Re(bipy)(CO)3(TmeCH3)]+(36).
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4.4 Discussion
4.4.1 Synthesis and Purification
The methylation reactions proceeded to give moderate to good yields of the final com-
plexes (51-80 %). Solid state IR spectroscopy was used to probe the outcome of
the methylation reactions. Spectra suggested the obtainment of one cationic rhenium
complex in a facial configuration, with a PF6- counter anion. The CO bands in the
methylated rhenium complexes are the main feature used to observe the formation of a
cationic complex. The CO stretching frequencies are effected by the electron density
on the rhenium metal centre. The A´(1) CO band in the methylated complexes shifts
to significantly higher wavenumbers (Table 4.3.1) compared to their neutral analogues,
which is consistent with the formation of a positively charged species.108 Increased CO
stretching frequencies is consistent with a reduction in electron density on the rhenium
centre, which therefore reduces the amount of backbonding onto the CO ligands.
The crude NMR indicated the presence of two main products but in some instances,
there was a third set of minor peaks present in the baseline. Firstly, column chromatog-
raphy was used to understand if the two main products observed in the crude NMR
were separable. fac-[Re(phen)(CO)3(TmeCH3)]+(35) was passed through an acidic
alumina column and three separate fractions were isolated. The first fraction showed
the presence of a phenanthroline system in the 1H NMR, however there was no sign
of the tetrazolato ligand attached. The specific identity of this first fraction was not
determined as the mass collected was negligible. The 1H NMR of the second fraction
looked very similar to that of the crude product, with two rhenium systems present in a
1:0.88 ratio. This fraction was recovered with a yield of approximately 60% but there
were still minor impurities present in the baseline of the NMR. The recovery of frac-
tion two also reveals the inseparable nature of the two original species observed in the
crude NMR. The final fraction appeared to contain three distinct rhenium complexes as
there was an extra set of phen signals compared to the crude product. The new signal
observed was in a comparable proportion to the other two systems. This final fraction
was passed through another column (neutral alumina) to try and identify the new sys-
tem present. Two fractions were recovered from this second column. The first fraction
eluted with ethyl acetate (100 %) and the second fraction with DCM/methanol (9:1).
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NMR revealed that the second fraction was again a mixture of three systems. The 1H
NMR of fraction one did not contain any phen signals and appeared to be mostly free,
methylated ester tetrazole (ie: benzoic acid-4-(1-methyl-1H-tetrazole-5-yl)-methyl es-
ter). Crystallisation using liquid liquid diffusion of petroleum spirits into a chloroform
solution of fraction one, isolated benzoic acid-4-(1-methyl-1H-tetrazole-5-yl)-methyl
ester, as shown in Figure 4.25.
Figure 4.25: X-ray crystal structure of benzoic acid-4-(1-methyl-1H-tetrazole-5-yl)-
methyl ester, where thermal ellipsoids have been drawn at 50% probability.
Alumina-filled column chromatography was an unsuitable method for purification, as
a third new system was formed, as observed in the 1H NMR. This third system could be
the result of ligand exchange or loss, as suggested by the recovery of a free methylated
tetrazole ligand. The alumina could be promoting ligand dissociation. Purification
was eventually achieved through reprecipitation of the crude product from DCM and
diethyl ether. Purification was unable to separate the two species observed in the NMR
but the minor baseline peaks were successfully removed.
4.4.2 Spectroscopic Characterisation
As mentioned above, upon analysis of the solid state IR spectroscopy (Table 4.3.1)
it seemed plausible to assume the obtainment of one single methylation product for
each reaction. However, in the NMR spectra two inseparable products were observed.
151
Based on the chemical shifts and integration ratios, both systems appeared to be methy-
lated rhenium complexes, not simply a mixture of neutral starting material and methy-
lated product. Figure 4.2 to Figure 4.7 highlight the changes to the NMR spectra that
occur upon methylation. Firstly, the appearance of two new singlets between 3.5 and
4.5 ppm with integration ratios of 3H, suggests that methylation has occurred but also
supports the idea that there are two methylated rhenium systems present.228 2D NMR
experiments including COSY, HMBC and HSQC were used to classify the signals into
two separate systems, a and b; where a was assigned to the set of resonances with the
relatively higher integration ratio. This also confirmed that the two systems present
were both singly methylated rather than one of the systems undergoing alkylation at
two sites on the tetrazole.
To identify the nature of the two species observed in the 1H NMR, single crystals were
grown of the final methylated products. Figure 4.12 and Figure 4.13 show the crystal
structures isolated for each of the methylated phen and bipy complexes respectively.
Coordination of the tetrazole ligand to the rhenium centre was observed through both
the N2 and N1 atoms of the tetrazole ring. N1 coordination has not been observed for
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Scheme 4.3: N1 and N2 linkage isomers of the methylated tetraozlto complexes.
any of the previously synthesised neutral or protonated rhenium complexes. Based on
the isolated crystals, it was hypothesised that the two sets of signals observed in the
NMR could belong to the N1 and N2 linkage isomers, as shown in Scheme 4.3. It was
not possible to identify which system in the NMR belonged to the N1 or N2 linkage
isomer.
Interestingly, upon methylation of iron and ruthenium tetrazolato complexes, only one
linkage isomer (N2) has ever been observed.111,229 Reports on cobalt(III) tetrazolato
complexes observe both N1 and N2 linkage isomers, however no methylation reaction
was carried out.230 The two linkage isomers in the study by Hall et al. are not in
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equilibrium with each other230 but this can not be ruled out for the methylated Re(I)
complexes reported herein.
4.4.2.1 Investigation into the Two Re(I) Systems
1H NMR of Single Crystals
1H NMR analysis was carried out on isolated crystals grown from some methylated
complexes. In each case, where the crystal structures indicated the presence of one
system in the solid state, the NMR showed the presence of the two sets of resonances.
This suggests that in solution, the Re-N1 and Re-N2 complexes both exist. This could
mean that the two isomers are in equilibrium. Their formation could also be due to
the lability of the tetrazole ligand. A possible dissociative-associative type mechanism
could be occurring where the ligand can reattach in the N2 or N1 form. It can not be
ruled out that both the N1 and N2 linkage isomers crystallise out of solution, however
even upon analysis of multiple crystals from each batch, only one linkage isomer was
ever observed in the solid state.
A study of dinuclear Re(I) systems with a tetrazolate bridging ligand has in fact ob-
served a similar situation in the NMR. In particular, Wright et al. isolated a dinuclear
species of the type [Re-L-Re]+ in which both Re(I) fragments coordinated to the tetra-
zolate ring.174 In this case, the crystals isolated showed the Re(I) metal centre binding
to the N1 and N4 atoms of the tetrazole ligand however, upon NMR analysis, both N1-
N4 and N2-N4 linkage isomers were observed, as illustrated in Figure 4.26.174 This
was ascribed to an equilibrium situation, which may also be used to describe what is
observed for the synthesised methylated Re(I) complexes.
Temperature Dependent NMR
Temperature dependent NMR studies were carried to understand if a change in the
integration ratios of the two systems could be observed. Previous studies by Butler et
al. on a series of 5-substituted aryl tetrazoles indicate that temperature can effect the
equilibrium position between the N1 and N2 tautomers (ie: the proton on the N1 or N2
atom of the tetrazole ring).167
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Figure 4.26: Equilibrium between linkage isomers of a dinuclear rhenium species.174
fac-[Re(phen)(CO)3(TbzCH3)]+ (33) was used in a series of temperature dependent
experiments in both DMSO-d6 and acetonitrile-d3 (Figure 4.8 and Figure 4.9). Upon
heating (in both solvents), the two original sets of fac-[Re(phen)(CO)3(TbzCH3)]+
resonances disappeared and a single new set of peaks were finally observed in the spec-
tra. It was found that for the acetonitrile-d3 experiments, the methylated tetrazole lig-
and had dissociated and acetonitrile coordinated in its place. Formation of the acetoni-
trile solvate was confirmed by synthesising this complex, fac-[Re(phen)(CO)3(CH3CN)]+
and comparing NMR spectra . The phenanthroline signals of fac-[Re(phen)(CO)3(TbzCH3)]+
(33) after being heated for five hours at 70 ˚C appear to match with those of the acetoni-
trile solvate, Figure 4.27. It is likely that a solvate is also forming upon heating 33 in
DMSO-d6. The methylated tetrazolato ligand is displaced by the coordinating solvent
upon heating and becomes free in the solution. It appears that the Re-N backbonding
(already fairly weak in the neutral complexes) is further reduced upon methylation,
therefore weakening the bond. The position of the tetrazole peaks also appear to shift
downfield, consistent with the free neutral ligand.170 Ligand dissociation is also sup-
ported by the fact that upon column chromatography, the free methylated ester tetrazole
ligand (benzoic acid-4-(1-methyl-1H-tetrazole-5-yl)-methyl ester) was isolated from a
column of fac-[Re(phen)(CO)3(TmeCH3)]+, as discussed earlier.
Solvent Effects
The studies of Butler et al. also looked at the effect of solvents on the tautomeric equi-
librium in a series of substituted aryl tetrazoles.167 They note that for these compounds,
the difference in ring conformations and therefore interannular conjugation should
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Figure 4.27: 1H NMR spectrum of fac-[Re(phen)(CO)3(TbzCH3)]+ (33) after be-
ing heated at 70 ˚C for 300 minutes (bottom) compared to the synthesised fac-
[Re(phen)(CO)3(CH3CN)]+(top) in acetonitrile-d3.
cause differences in energies and solvation effects between the N1 and N2 tautomeric
forms.167 Their observations show that the more polar, N1 form, is more prominent in
the polar solvent DMSO whereas the relative abundance of the N1 tautomer reduces
in the less polar solvent, dioxane.167 If the synthesised methylated Re(I) complexes
are in fact in a state of dynamic equilibrium (in solution) between the N1 and N2
isomers, then solvent changes could affect their relative abundance. The NMR of fac-
[Re(phen)(CO)3(TphCH3)]+ (31) was measured in acetonitrile-d3 (giving an integra-
tion ratio of 1:0.72, ie: 58% system a and 41% system b) and acetone-d6 (integration
of 1:0.52, ie: 65% system a and 34% system b). There was also a change observed for
fac-[Re(phen)(CO)3(TbzCH3)]+(33) with an integration ratio of 1:0.68 (60% to 40%)
in acetonitrile-d3 and 1:0.86 (54% to 46%) in acetone-d6. Although the difference
in percentage abundance of the two systems does not greatly change with the change
in solvent, the differences are within the range that Butler observed for 2-methyl-5-
phenyltetrazole upon changing from DMSO to dioxane. The abundance of the N1
tautomer was 86% in DMSO and 73% in dioxane.167 Acetonitrile is more polar than
acetone, therefore it is likely that the less abundant signals (based on integration) can
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be assigned to the less polar linkage isomer. Based on Butler’s studies this may be
ascribed to the Re-N2 complex167 however is it still not certain as to which signals
correspond to which isomer. By observing a change in the integration ratios of the two
rhenium systems upon changing solvents, the idea of having the N1 and N2 linkage
isomers in dynamic equilibrium is supported.
4.4.2.2 13 C NMR
Analysis of the 13C NMR spectra also showed two distinct sets of signals. The val-
ues of the tetraozolic carbon (Ct) in each case are in the range of 158.5-156.8 ppm
(Table 4.4.1).
The studies conducted by Butler et al. on 5-substituted aryl tetrazoles indicate that a
tetrazolic carbon value of 152-156 ppm is indicative of the N1 tautomer and values
in the range of 162-165 ppm indicate the N2 tautomer. Although it is hypothesised
that both N1 and N2 linkage isomers of the methylated Re(I) complexes are present in
solution, the fact that the methyl group is also coordinated to the tetrazole ring must
be taken into consideration. The tetrazole ring has sites occupied at two of the four N
atoms. The values of the Ct for all of the methylated species are generally the same
and in fact lie closer to those values which represent the N1 linkage isomer. This could
suggest that the methylation occurring at the N4 position is actually more responsible
for the Ct values, than whether the Re is coordinated via the N1 or N2 atom.166,167
Table 4.4.1: Linkage isomer observed in the crystal strucure and the Ct signals for the
methylated complexes in d6-acetone.
Complex
Re coordination observed Ct signal observed
in the Crystal Structure in the NMR (ppm).
fac-[Re(phen)(CO)3(TphCH3)]+ (31) N1 158.2, 157.4
fac-[Re(bipy)(CO)3(TphCH3)]+(32) N2 158.5, 157.6
fac-[Re(phen)(CO)3(TbzCH3)]+(33) N1 157.6, 156.8
fac-[Re(bipy)(CO)3(TbzCH3)]+(34) N2 157.7, 157.0
fac-[Re(phen)(CO)3(TmeCH3)]+(35) N1 157.7, 156.8
fac-[Re(bipy)(CO)3(TmeCH3)]+(36) N1 157.8, 157.0
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It is also possible that the Ct value is not useful in determining tetrazole coordination
to the rhenium (ie, through N1 or N2). In fact, the Ct value may provide more in-
sight into the sight of alkylation. Reports by Stagni et al.114 on ruthenium complexes
bearing a mono coordinated 5-substituted aryl tetrazole observed similar NMR trends
upon methylation. Even though the ruthenium is coordinated via the N2 atom on the
tetrazole, methylation causes a significant upfield shift of the Ct which they have as-
cribed to the methyl substituent being regioselective for the nitrogen atom adjacent to
the Ct .114 Their claims are supported in the solid state with the deviation from copla-
narity between the aryl and tetrazole rings being 61.4 º. Based on the study of Stagni
et al.114, the Ct resonances for our methylated Re(I) complexes, suggest the methyl is
on the N atom adjacent to the tetrazole ring, even if the rhenium is coordinated via the
N2 atom.
The deviation from colplanarity between the aryl and tetrazole rings in the methylated
complexes are discussed in section 4.4.3 and there is a significant increase in the degree
of twisting between the rings, compared to the neutral analogues. The N1 linkage
isomer or “tautomer” in the studies of Butler, usually gives rise to the aryl and tetrazole
rings taking on a twisted conformation (Scheme 2.5).165–167 The shielded nature of the
Ct in the methylated complexes compared to their neutral analogues is suggestive of
this twisted conformation as there is a reduction in the +M from the tetrazole ring,
explained by poor overlap of the p orbitals on the two rings (Scheme 2.4).
4.4.3 X-ray Crystallography
The solid state studies of the Re(I) methylated complexes show that the methyl resides
on the N4 in the solid state. This supports the observed Ct values discussed above.
The torsion angle between the aryl and tetrazole rings was calculated to assess their
degree of coplanarity. A large deviation from coplanarity correlates to an increased
twisting of the aryl and tetrazole rings. For all of the complexes that displayed the N1
linkage isomer in the solid state (31, 33, 35 and 36) a significant deviation from copla-
narity was calculated (72-87 ˚). Interestingly, for all of the complexes that displayed
the N2 linkage isomer in the solid state (32 and 34) the degree of twisting observed
between the aryl and tetrazole rings is reduced (48.24-39.8 ˚, Table 4.3.3). This is not
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unexpected as coordination of the Re to the tetrazole ligand through the N1 is sterically
unfavourable therefore causing out of plane rotation of the phenyl and tetrazole rings.
However, the degree of twisting observed in the solid state for either of the linkage
isomers is still significantly larger than what has been calculated for the neutral ana-
logues. Table 2.3.4 (Chapter Two) shows that the deviation from coplanarity for the
neutral Re(I) complexes is between 2.03 and 26.47 º. The slight twisting was suggested
to be predominantly due to a solid state effect and computational studies showed that
in solution, this angle relaxed to values closer to zero.
Interestingly, although there is an obvious comparison that can be made for the tor-
sion angles in the solid state between the Re-N1 and Re-N2, the NMR Ct values are
indiscernible. This might be rationalised by the rings becoming more relaxed in solu-
tion, irrespective of whether or not the Re is coordinated to the N1 or N2 atom of the
tetrazole. Therefore the Ct values (being closer to that indicative of N1) may be pre-
dominantly caused by the methyl group at N4. In the solid state the twisting of the aryl
and tetrazole rings appears to be a combination of the both the tetrazole coordination
to the Re (N1 or N2) and also the position of the methyl group on the tetrazole ring.
4.4.4 Photophysics
The observed blue shift in the absorption for the phen complexes compared to the
bipy can be rationalised by the fact that the 1,10-phenanthroline ligand is not fully
conjugated over the three rings (as was discussed in Chapter Two). A reduced HOMO-
LUMO energy gap also explains the blue shifted emission of the phen complexes
compared to the bipy.
When compared to the starting neutral complexes, the UV-Vis absorption spectra of
the methylated species display an expected hypsochromic shift of the MLCT transi-
tion, which is accompanied by an analogous shift of the pi −pi* absorption bands (see
Figure 4.14 to Figure 4.19). This observation can be rationalised by methylation re-
ducing the electron density on the rhenium centre (confirmed by IR spectroscopy, see
Table 4.3.1) due to a reduced σ donation of the alkylated tetrazole ligand and/or an in-
creased pi acceptance. This causes indirect stabilisation of the HOMO-n orbitals which
increases the HOMO-LUMO energy gap and therefore a blue shift in the absorption
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bands is expected. Figure 4.28 illustrates this concept and shows how the energy gap
between the HOMO and LUMO increases upon methylation.
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Figure 4.28: Energy level diagram illustrating the differences in the HOMO-LUMO
gap for the neutral and cationic rhenium complexes.
The emission of the methylated rhenium complexes at room temperature, which have
to be considered as a mixture of N1 and N2 coordination isomers, are brightly emissive.
Upon excitation at the 1MLCT, each complex displays a broad and structureless band
consistent with emission from a 3MLCT excited state. This also indicates that emission
from the two isomers is indistinguishable. Support for emission from a triplet state can
be found in Table 4.3.5 as the synthesised complexes exhibit sensitivity to molecular
oxygen. There is an observed increase in τ and φ upon de-oxygenating the solutions
before measurement. Also, there is a rigidochromic blue shift observed in the emission
bands of the complexes upon passing from room temperature to 77 K, suggestive of
emission from a charge transfer state.127,192,193 The monoexponential nature of the
lifetimes at room temperature is also suggestive that the photophysical properties of
the N1 and N2 linkage isomers are indiscernible.
Computational calculations (TD-DFT and DFT) can offer rationalisation as to why all
of the complexes within the same diimine group (phen or bipy) have the same emission
maxima. Upon alkylation, the contribution of the tetrazole ligand to the HOMO type
orbitals becomes negligible (see Figure A3.1 and Figure A3.2). The para substituent
on the tetrazole ligand is the only differentiating factor between the complexes within
the same diimine group. As the tetrazole is not involved in the HOMO-n→LUMO+m
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transitions, emission of the complexes within their respective diimine classes is the
same. This concept is also illustrated in Figure 4.28, using a simplified energy level di-
agram. There has been stabilisation of the tetrazole orbitals in the methylated complex
and therefore contribution of the LLCT to the lowest excited state is lost.
The blue shifted emission observed for the methylated complexes, with respect to
their neutral analogues can also be rationalised by stabilised HOMO type orbitals.
The luminescence output of the methylated complexes (in terms of τ and φ ) is also
greater which can again be linked with an increased HOMO-LUMO energy gap, com-
pared to the neutral starting complexes. The energy gap law is one factor that can
explain the observed improvement in luminescent output of the synthesised cationic
complexes.47,48,57 The increased HOMO-LUMO gap is also supported by a reduction
in knr upon methylation (Table 4.3.7). A similar trend was discussed for the protonated
rhenium complexes in Chapter Three.
The improved luminescence of the methylated complexes is similar to the output ob-
served for the protonated species in Chapter Three. In this case however the methyla-
tion reaction and therefore the increased luminescent output is irreversible.
4.4.4.1 Methylation using Methyl-d3 Trifluoromethanesulfonate
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It is important to consider that the addition of the methyl groups could be a potential
source of C-H vibrational quenching that was not present in the neutral analogues. The
stretching frequencies of C-D occur at lower wavenumbers than C-H, as the deuterium
is heavier than the proton. This means that higher overtones are needed to be reached
before quenching of rhenium emission can occur. The intensity of the C-D stretching
frequency is reduced as higher overtones are reached, making quenching from CD3
less likely than CH3. The photophysical properties of 37 were compared with the CH3
analogue, 31. The photophysical properties of both complexes are in fact comparable,
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indicating that the CH3 is not involved in quenching of the 3MLCT exited state of
the rhenium complexes. As mentioned above, the TD-DFT provides evidence that
the tetrazolato ligand is not directly involved in the excited state of the complexes,
reducing the likelihood of quenching from the methyl on the tetrazolato ligand.
161
4.5 Conclusion
Methylation of the neutral fac-[Re(diim)(CO)3(L)] complexes has been carried out
and the cationic PF6- complexes isolated. The product of the reaction is an inseparable
mixture of Re-N1 and Re-N2 coordinated complexes with methylation regioselective
for the N4 atom on the tetrazole. This was confirmed in solution through NMR and in
the solid state using X-ray diffraction. Methylation of the tetrazole ring is irreversible.
Upon heating the complex in a coordinating solvent, the methylated tetrazolato ligand
becomes labile and the solvent coordinates as the ancillary ligand. It is still unclear as
to whether or not the Re-N1 and Re-N2 linkage isomers exist in equilibrium however
some of the experimental data supports this conclusion.
Although two rhenium linkage isomers are observed in the NMR they do not appear to
be distinguishable by their photophysical properties. The emission of the methylated
complexes are blue shifted and the τ and φ values are increased compared to the neu-
tral analogues. Methylation, which occurs on the tetrazolato ligand, indirectly creates a
larger energy gap between the ground and excited states which has reduced the contri-
bution from knr of these complexes. Upon comparison of the CH3 and CD3 complexes,
no significant change in the photophysical properties was observed. TD-DFT supports
this observation as the contribution of the tetrazolato ligand to the HOMO type orbitals
is negligible.
This study has explored the interesting Re-N1 and Re-N2 linkage isomers that form
upon methylation of the neutral Re(I) complexes. This fundamental investigation
shows the potential for these complexes to be explored as highly emissive optical imag-
ing agents however, the increased lability of the methylated tetrazolato ligand must be
taken into account for possible “reactivity” in biological environments.
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4.6 Experimental
4.6.1 General procedures
General procedures are as outlined in Chapter Two, section 2.5.1 unless otherwise
stated.
Solid state IR measurements were carried out using an attenuated total reflectance
Perkin Elmer Spectrum 100 FT-IR with a diamond stage.
Elemental analyses were performed by Dr Thomas Rodemann at the Central Science
Laboratory, University of Tasmania or by Robert Herman at the Department of Chem-
istry, Curtin University.
Photophysics
Absorption spectra were recorded at room temperature using a Perkin-Elmer Lambda
35 UV/Vis spectrometer. Uncorrected steady-state emission and excitation spectra
were recorded on an Edinburgh FLSP920 spectrometer equipped with a 450 W xenon
arc lamp, double excitation and single emission monochromators and a Peltier-cooled
Hamamatsu R928P photomultiplier tube (185-850 nm). Emission and excitation spec-
tra were corrected for source intensity (lamp and grating) and emission spectral re-
sponse (detector and grating) by a calibration curve supplied with the instrument.
Emission lifetimes (τ) were determined with the same Edinburgh FLSP920 spectrom-
eter using pulsed picosecond LEDs ( EPLED 360, FHWM <800 ps) as the excitation
source, with repetition rates between 1 kHz and 1 MHz, and the above mentioned
R928P PMT as detector. Degassed solutions were prepared by gently bubbling argon
gas into the prepared sample for 15 minutes before measurement.
4.6.1.1 General methodology for the methylation of the neutral fac-[Re(diim)(CO)3(L)]
complexes
The preparation of the methylated fac-[Re(diim)(CO)3(L)] complexes (diim = 1,10-
phenanthroline or 2,2’-bipyridine) was carried out following procedures adapted from
previously published work.108,111–113,219,224,229
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Previously synthesised fac-[Re(diim)(CO)3(L)] (1 eq) was added to DCM and the
mixture was allowed to cool using an ethyl acetate/liquid nitrogen cool bath. Once
the reaction vessel had cooled, methyl trifluoromethanesulfonate (1.2 eq) in DCM was
added. The reaction was stirred under nitrogen for approximately 30 minutes in the
cool bath and was then allowed to come to room temperature and stirred overnight. An
excess of NH4PF6 in water was added to the reaction and stirred for 45 minutes. The
reaction was then extracted using DCM (3 × 15 mL) and the organic components com-
bined and dried over anhydrous MgSO4. The solvent was removed in vacuo to yield a
yellow glassy looking solid. Each of the complexes showed two distinct systems in the
the NMR which have been assigned to system a or b; where system a has the higher
integration ratio. Some of the signals were collapsed in the 13C NMR spectra, ie: two
signals appeared as one.
fac-[Re(phen)(CO)3(TphCH3)]+
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Compound 31 was purified by reprecipitation from DCM and diethyl ether. Yield 0.064
g (61%). M.p. 284 ºC (dec.). Elemental analysis for C23H16F6N6O3PRe·0.5H2O: cal-
culated: C 36.13, H 2.24, N 10.99; found: C 36.03 , H 1.86, N 10.85. νmax (ATR)/cm-1:
3095 w, 2032 s (CO, Aʹ(1)), 1911 s (CO, Aʹ(2)), 1897 s (CO, Aʹʹ), 1699 w, 1524 w,
1463 w, 1431 w, 1207 w, 1152 w, 832 m, 777 w, 721 w. The ratio of system a:b is
1:0.65.1H NMR (δ, ppm, Acetone-d6): 9.73 (2H, d, J = 5.2 Hz, phen H2,9)b, 9.30
(2H, d, J = 5.0 Hz, phen H2,9)a, 9.06 (2H, d, J = 8.2 Hz, phen H4,7)b, 8.99 (2H, d, J
= 8.2 Hz, phen H4,7)a, 8.37 (2H, s, phen H5,6)b, 8.33 (2H, s, phen H5,6)a , 8.28-8.24
(2H, m, phen H3,8)b, 8.09-8.06 (2H, m, phen H3,8)a , 7.85-7.80 (2H, m, CN4-C6H5),
7.68-7.64 (3H, m, CN4-C6H5)b, 7.61-7.57 (1H, m, CN4-C6H5), 7.52-7.42 (4H, m,
CN4-C6H5), 4.08 (3H, s, CH3)b, 3.73 (3H, s, CH3)a. 13C NMR (δ, ppm, Acetone-d6):
196.3 (CO), 196.0 (CO), 158.2 (CN4-C6H5), 157.4 (CN4-C6H5), 155.7, 155.4, 148.1,
147.9, 141.2, 140.9, 133.5, 133.0, 132.0 (collapsed), 130.5 (collapsed), 130.1, 129.6,
164
128.9 (collapsed), 127.8, 127.6, 122.6, 122.1, 36.9 (CH3), 35.6 (CH3). Crystals suit-
able for X-ray analysis (identified as 31, C23H16F6N6O3PRe) were obtained by liquid
liquid diffusion of diethyl ether into a DCM solution of the complex.
fac-[Re(bipy)(CO)3(TphCH3)]+
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Compound 32 was purified by reprecipitation from DCM and diethyl ether. Yield 0.79
g (79%). M.p. 230 ºC. Elemental analysis for C21H16F6N6O3PRe·0.5H2O: calculated:
C 34.06, H 2.31, N 11.35; found: C 33.84, H 1.97, N 11.12 . νmax (ATR)/cm-1: 3127
w, 2031 s (CO, Aʹ(1)), 1931 m (CO, Aʹ(2)), 1898 s (CO, Aʹʹ), 1606 w, 1550 w, 1474 w,
1447 w, 1318 w, 1247 w, 1163 w, 1111 w, 1074 w, 1027 w, 902 w, 834 s, 768 m, 732 w,
698 w. The ratio of system a:b is 1:0.79. 1H NMR (δ, ppm, Acetone-d6): 9.32 (2H, d, J
= 5.4 Hz, bipy H6,6’ )b , 8.93 (2H, d, J = 5.2 Hz, bipy H6,6’ )a , 8.78 (2H, d, J = 8.4 Hz,
bipy H3,3’ )b , 8.70 (2H, d, J = 8.4 Hz, bipy H3,3’ )a , 8.46 (2H, t, J = 8.0 Hz, bipy H4,4’
)b, 8.39 (2H, t, J = 8.0 Hz, bipy H4,4’ )a, 7.93-7.90 (2H, m, bipy H5,5’ )b, 7.84-7.80 (1H,
m, CN4-C6H5), 7.75-7.71 (2H, m, bipy H5,5’ )a, 7.69-7.55 (9H, m, CN4-C6H5), 4.22
(3H, s, -CH3)b , 3.86 (3H, s, -CH3)a. 13C NMR (δ, ppm, Acetone-d6): 158.5 ( CN4-
C6H5), 157.6 (CN4-C6H5), 157.5, 157.3, 155.1, 154.8, 142.1, 141.8, 133.5, 133.1,
130.7, 130.6, 130.2, 129.8, 129.2, 129.0, 125.2, 125.1, 122.7, 122.2, 37.1 (CH3), 35.8
(CH3). Crystals suitable for X-ray analysis (identified as 32, C23H18Cl2F3N6O6ReS)
were obtained by liquid liquid diffusion of diethyl ether into a DCM solution of the
complex.
fac-[Re(phen)(CO)3(TbzCH3)]+
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Compound 33 was purified by reprecipitation from DCM and diethyl ether. Yield 0.057
g (53%). M.p. 234 ºC (dec.). Elemental analysis for C24H16F6N6O4PRe·0.5H2O: cal-
culated: C 36.37, H 2.16, N 10.60; found: C 36.31, H 1.89, N 10.48. νmax (ATR)/cm-1:
3083 (w), 2032 s (CO, Aʹ(1)), 1929 s (CO, Aʹ(2)), 1922 s (CO, Aʹʹ), 1699 m, 1548 w,
1520 w, 1430 m, 1310 w, 1206 w, 1179 w, 1146 w, 826 m, 722 w. The ratio of sys-
tem a:b is 1:0.84.1H NMR (δ, ppm, Acetone-d6): 10.27 (1H, s, CN4-C6H4-CHO)a,
10.09 (1H, s, CN4-C6H4-CHO)b , 9.74 (2H, d, J = 5.2 Hz, phen H2,9)b, 9.34 (2H,
d, J = 6.3 Hz, phen H2,9)a, 9.07 (2H, d, J = 8.4 Hz, phen H4,7)b , 9.01 (2H, d, J =
8.2 Hz, phen H4,7)a , 8.38 (2H, s, phen H5,6 )b, 8.34 (2H, s, phen H5,6 )a, 8.28-8.25
(2H, m, phen H3,8 )b, 8.18 (2H, d, J = 8.8 Hz, CN4-C6H4-CHO Hmeta)a, 8.19-8.08
(2H, m, phen H3,8 )a , 8.02 (2H, d, J = 8.4 Hz, CN4-C6H4-CHO Hmeta)b, 7.72-7.69
(4H, m, CN4-C6H4-CHO Hortho)a,b, 4.13 (3H, s, -CH3)b, 3.77 (3H, s, -CH3)a . 13C
NMR (δ, ppm, Acetone-d6): 196.2 (CO), 196.0 (CO), 192.6 (CHO), 192.4 (CHO),
157.6 (CN4-C6H4-CHO), 156.8 (CN4-C6H4-CHO), 155.8, 155.5, 148.1, 147.9, 141.2,
141.0, 140.1, 139.6, 132.0, 131.6, 131.0, 130.7, 130.5, 129.0 (collapsed), 127.8, 127.7,
127.6, 127.4, 37.1 (CH3), 35.7 (CH3). Crystals suitable for X-ray analysis (identi-
fied as 33·CDCl3, C24H16F6N6O4PRe·CDCl3) were obtained by vapour diffusion of
petroleum spirits (40-60 ºC) into a CDCl3 solution of the complex.
fac-[Re(bipy)(CO)3(TbzCH3)]+
Re
CO
OC
OC
N
N N
N
C
N
N
CH3
+
PF6-O
H
34
Compound 34 was purified by reprecipitation from chloroform and diethyl ether. Yield
0.066 g (61%). M.p. 225 ºC (dec.). Elemental analysis for C22H16F6N6O4PRe·0.4CHCl3:
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calculated: C 33.32, H 2.05, N 10.41; found: C 33.57, H 1.73, N 10.39 (a correspond-
ing singlet for CHCl3was observed in the NMR spectrum of 34). νmax (ATR)/cm-1:
3087 w, 2841 w, 2028 s (CO, Aʹ(1)), 1929 s (CO, Aʹ(2)), 1901 s (CO, Aʹʹ), 1706 m,
1606 w, 1554 w, 1473 w, 1447 w, 1314 w, 1202 w, 834 m, 769 m, 731 w. The ratio of
system a:b is 1:0.97. 1H NMR (δ, ppm, Acetone-d6): 10.26 (1H, s, CN4-C6H4-CHO)b,
10.13 (1H, s, CN4-C6H4-CHO)a, 9.32 (2H, d, J = 5.6 Hz, bipy H6,6’ )a, 8.96 (2H, d, J
= 5.6 Hz, bipy H6,6’)b, 8.78 (2H, d, J = 7.6 Hz, bipy H3,3’ )a, 8.72 (2H, d, J = 8.4 Hz,
bipy H3,3’)b, 8.46 (2H, t, J = 8 Hz, bipy H4,4’)a, 8.41 (2H, t, J = 8 Hz, bipy H4,4’)b,
8.21 (2H, d, J = 6.4 Hz, CN4-C6H4-CHO Hmeta)b, 8.09 (2H, d, J = 6.4 Hz, CN4-
C6H4-CHO Hmeta)a, 7.94-7.90 (2H, m, bipy H5,5’ )a, 7.88 (4H, d, J = 6.8 Hz, CN4-
C6H4-CHO Hortho)a,b, 7.77-7.73 (2H, m, bipy H5,5’)b, 4.27 (3H, s, -CH3)a, 3.90 (3H,
s, -CH3)b. 13C NMR (δ, ppm, Acetone-d6): 196.3 (CO), 196.1 (CO), 192.6 (CHO),
192.4 (CHO), 157.7 (CN4-C6H4-CHO), 157.5, 157.3, 157.0 (CN4-C6H4-CHO), 155.1,
154.9, 142.2, 141.9, 140.2, 139.7, 131.8, 131.0, 130.7 (collapsed), 129.3, 129.1, 127.7,
127.5, 125.2 (collapsed), 37.3 (CH3), 35.9 (CH3). Crystals suitable for X-ray analysis
(identified as 34· CHCl3, C22H16F6N6O4PRe·CHCl3) were obtained by vapour diffu-
sion of petroleum spirits (40-60 ºC) into a CHCl3 solution of the complex.
fac-[Re(phen)(CO)3(TmeCH3)]+
Re
CO
OC
OC
N
N N
N
C
N
N
CH3
+
PF6-O
OCH3
35
Compound 35 was purified by reprecipitation from DCM and diethyl ether. Yield 0.016
g (80%). M.p.195-197 ºC (dec.). Elemental analysis for C25H18F6N6O5PRe·0.5H2O:
calculated: C 36.50, H 2.33, N 10.22; found: C 36.66 , H 1.96 , N 10.10 . νmax
(ATR)/cm-1: 3099 w, 2031 s (CO, Aʹ(1)), 1931 s (CO, Aʹ(2)), 1917 (1897 sh) s (CO,
Aʹʹ), 1713 w, 1637 w, 1604 w, 1524 w, 1465 w, 1433 m, 1286 w, 1207 w, 1150 w,
1120 w, 834 m, 721 w. The ratio of system a:b is 1:0.8. 1H NMR (δ, ppm, Acetone-
d6): 9.74 (2H, d, J = 5.0 Hz, phen H2,9)b , 9.35 (2H, d, J = 5.0 Hz, phen H2,9)a , 9.07
(2H, d, J = 8.2 Hz, phen H4,7)b , 9.02 (2H, d, J = 8.2 Hz, phen H4,7)a , 8.38 (2H,
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s, phen H5,6)b, 8.35 (2H, s, phen H5,6)a, 8.28-8.25 (2H, m, phen H3,8)b, 8.52 (2H,
d, J = 8.8 Hz, CN4-C6H4-COOCH3 Hmeta)a, 8.19-8.06 (4H, m, phen H3,8and CN4-
C6H4-COOCH3 Hmeta)a,b, 7.62 (4H, d, J = 8.6 Hz, CN4-C6H4-COOCH3 Hortho)a,b,
4.12 (3H, s, -CH3)b , 4.03 (3H, s, -OCH3)a, 3.90 (3H, s, -OCH3)b, 3.77 (3H, s, -CH3)a.
13C NMR (δ, ppm, Acetone-d6): 166.3 (COCH3), 166.1 (COCH3), 157.7 (CN4-C6H4-
COOCH3), 156.8 (CN4-C6H4-COOCH3), 155.8, 155.6, 148.1, 148.0, 141.2, 141.0,
134.8, 134.2, 132.01 (collapsed), 131.1 (collapsed), 130.8, 130.0, 129.0 (collapsed),
127.8, 127.7, 126.7, 126.4, 53.1 (-OCH3), 52.9 (-OCH3), 37.1 (CH3), 35.7 (CH3).
Crystals suitable for X-ray analysis (identified as 35, C25H18F6N6O5PRe) were ob-
tained by liquid liquid diffusion of petroleum spirits (60-80 ºC) into a DCM solution
of the complex.
fac-[Re(bipy)(CO)3(TmeCH3)]+
Re
CO
OC
OC
N
N N
N
C
N
N
CH3
+
PF6-O
OCH3
36
Compound 36 was purified by reprecipitation from DCM and diethyl ether. Yield
0.072 g (57%). M.p. 242-243 ºC. Elemental analysis for C23H18F6N6O5PRe: calcu-
lated: C 34.99, H 2.30, N 10.64; found: C 35.11 , H 2.38, N 10.45. νmax (ATR)/cm-1:
3091 w, 2952 w, 2030 s (CO, Aʹ(1)), 1908 (1925 sh) s (CO, Aʹ(2)/Aʹʹ), 1706 m, 1607
w, 1463 w, 1451 w, 1433 w, 1294 w, 1207 w, 1122 w, 834 m, 775 w, 732 w. The ratio
of system a:b is 1:0.92. 1H NMR (δ, ppm, Acetone-d6): 9.31 (2H, d, J = 4.9 Hz, bipy
H6,6’)b , 8.96 (2H, d, J = 5.6 Hz, bipy H6,6’)a , 8.77 (2H, d, J = 7.8 Hz, bipy H3,3’)b ,
8.71 (2H, d, J = 8.0 Hz, bipy H3,3’)a , 8.48-8.43 (2H, m, bipy H4,4’)b , 8.43-8.38 (2H,
bipy H4,4’)a , 8.26 (2H, d, J = 8.2 Hz, CN4-C6H4 -COOCH3 Hmeta)a , 8.14 (2H, d,
J = 8.8 Hz, CN4-C6H4-COOCH3 Hmeta)b, 7.93-7.89 (2H, m, bipy H5,5’)b, 7.80-7.78
(4H, d, J = 8.8 Hz, CN4-C6H4-COOCH3 Hortho)a,b, 7.77-7.73 (2H, m, bipy H5,5’)a,
4.25 (3H, s, -CH3)b, 4.01 (3H, s, -OCH3)a, 3.92 (3H, s, -OCH3)b, 3.89 (3H, s, -CH3)a.
13C NMR (δ, ppm, Acetone-d6): 196.3 (CO), 196.1 (CO), 166.3 (COCH3), 166.2
(COCH3), 157.8 (CN4-C6H4-COOCH3), 157.5, 157.3, 157.0 (CN4-C6H4-COOCH3),
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155.1, 154.9, 142.1, 141.9, 134.8, 134.2, 131.3, 131.1, 130.8, 130.2, 129.2, 129.0,
126.8, 126.5, 125.2 (collapsed), 53.0 (-OCH3), 52.9 (-OCH3), 37.24 (CH3), 35.91
(CH3). Crystals suitable for X-ray analysis (identified as 36, C23H18F6N6O5PRe) were
obtained by liquid liquid diffusion of petroleum spirits (60-80 ºC) into a DCM solution
of the complex.
fac-[Re(phen)(CO)3(TphCD3)]+
Re
CO
OC
OC
N
N N
N
H
N
N
CD3
+
PF6-
37
Compound 37 was synthesised according to the general procedure however, methyl-
d3 trifluoromethanesulfonate was used and purification was via neutral alumina filled
column chromatography giving a yield of 0.019 g (43%). νmax (ATR)/cm-1: 3102 w,
2925 w, 2854 w, 2032 s (CO, Aʹ(1)), 1929 s (CO, Aʹ(2)), 1894 s (CO, Aʹʹ), 1609 w,
1587 , 1522.7w, 1481 w, 1457 w, 1431 m, 1328 w, 1227 w, 1153 w, 1080 w, 1020 w,
832 m, 770 m, 752 w, 722 m, 701 w. The ratio of system a:b is 1:0.71. 1H NMR (δ,
ppm, Acetone-d6): 9.74 (2H, d, J = 5.0 Hz, phen H2,9)b , 9.31 (2H, d, J = 5.0 Hz, phen
H2,9)a , 9.07 (2H, d, J = 8.2 Hz, phen H4,7)b , 9.00 (2H, d, J = 8.2 Hz, phen H4,7)a , 8.37
(2H, s, phen H5,6)b, 8.34 (2H, s, phen H5,6)a, 8.28-8.25 (2H, m, phen H3,8)b, 8.10-8.07
(2H, m, phen H3,8)a, 7.85-7.81 (2H, m, CN4-C6H5), 7.69-7.65 (3H, m, CN4-C6H5),
7.60-7.58 (1H, m, CN4-C6H5), 7.58-7.43 (4H, m, CN4-C6H5).
4.6.2 X-ray Crystallography
X-ray Crystallography for all of the complexes presented in Chapter Four were carried
out by Dr. Brian Skelton at the University of Western Australia. Diffraction data
were collected at 100(2) K on an Oxford Diffraction Gemini diffractometer fitted with
Mo Kα radiation. Following analytical absorption corrections and solution by direct
methods, the structure was refined against F2 with full-matrix least-squares using the
program SHELXL-97.202
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For 58 the benzaldehyde group was modelled as being disordered over two sets of
sites with site occupancies constrained to 0.5 after trial refinement. For 34, the CHCl3
solvent molecule was modelled as being disordered over two sets of sites with oc-
cupancies of the two components each constrained to 0.5 after trial refinement. The
PF6- anion was also disordered over two sets of sites but with occupancies refined to
0.889(12) and its complement.
All H-atoms were added at calculated positions and refined by use of a riding model
with isotropic displacement parameters based on those of the parent atoms. Anisotropic
displacement parameters were employed throughout for the non-hydrogen atoms.
All crystallographic data can be found in Table A3.1, Table A3.2 and Table A3.3 in
Appendix 3.
4.6.3 Computational Calculations
Computational (TD-DFT/DFT) calculations were performed by Mr. Phillip Wright of
Curtin University using GAUSSIAN09.181 The TD-DFT calculations were done us-
ing the B3LYP functional,221 the Stuttgart-Dresden effective core potential for Re,222
and the 6-311++G** basis set for the other atoms. The presence of solvent was
then mimicked by using the PCM implicit model223 with parameters appropriate for
dichloromethane.
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Chapter 5
Biological Investigation of Rhenium
Complexes in HeLa Cells
5.1 Abstract
HeLa cells were incubated with a series of Re(I) complexes, to final concentrations of
20 µM and imaged on a confocal microscope using excitation at 405 nm. The three
neutral Re(I) tetrazolato complexes, fac-[Re(phen)(CO)3(Tph)] (11),
fac-[Re(phen)(CO)3(Tbz)] (13) and fac-[Re(phen-S-PEG)(CO)3(Tph)] (41) showed
good uptake and diffuse cytoplasmic localisation in the HeLa cells. The methylated
complexes fac-[Re(phen)(CO)3(TphCH3)]+ (31) and fac-[Re(phen)(CO)3(TbzCH3)]+(33)
did not exhibit observable cellular uptake. These complexes were also unsuitable imag-
ing agents due to their instability in coordinating solvents. Confocal images of the fac-
[Re(phen-RS)(CO)3(Cl)] (39) and fac-[Re(phen-S-PEG)(CO)3(Cl)] (40) suggested
that they did pass into the HeLa cells but the signal detected appeared significantly
weaker than those complexes containing the tetrazolato ancillary ligand. Phototoxic
effects were observed for some of the complexes when illuminated continuously, for
more than two minutes.
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5.2 Introduction
Live cell imaging experiments were conducted by incubating a selection of prepared
Re(I) complexes with HeLa cells. These experiments were carried out to determine the
behaviour of the complexes in a biological environment and assess how small structural
changes might affect uptake, localisation and/or toxicity within cells.
5.2.1 Cell Culture
The growth of separated cells from animal tissue (or plants) is known as cell or tis-
sue culture. Under the correct conditions, cells will grow in an artificial environment,
ie: in vitro.231 One requirement for cell sustainability is an appropriate culture media
generally containing energy sources (carbohydrates), amino acids (for nutrients), es-
sential metals and minerals, buffering agents (to maintain pH ~ 7.4) and indicators (for
pH change).232 External conditions, such as temperature and humidity levels, are also
important for cell growth. External conditions are controlled using an incubator, to
closely mimic the environment experienced by cells in vivo. The optimal temperature
for mammalian cell culturing is 37 ºC with 100% humidity (to avoid culture media
evaporation). A CO2 atmosphere (5%) is generally required to maintain the pH of the
cell culture media. It works by acting as a buffer system with the sodium bicarbon-
ate present in the media, to sustain pH ~ 7.4.232 Herein, standard conditions refer to
incubation with these particular requirements (or settings).
Primary culture refers to cells when they have been taken directly from a subject, for
example through a biopsy or from tissue/organ samples. This primary cell culture is
then grown in vitro until it reaches confluence (ie: the cells cover approximately 80-
95% of the base of the flask). Once confluent, cells are detached from their original
flask, then divided into new flasks in order to expand the culture and continue that cell
line.233
HeLa Cells
HeLa cells are a human cervical cancer cell line, that was first isolated in the 1950s
from a woman named Henrietta Lacks. HeLa are the first example of an immortal hu-
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man cell line. “Normal” cells have a finite number of divisions they can undergo before
they become senescent (stop dividing).234 This is known as they Hayflick limit.235 Im-
mortal cell lines such as HeLa can be grown outside the human body with an apparent
unlimited capacity for population doubling. HeLa cells were quickly distributed all
over the world and have been extensively used in biomedical research ever since.236
5.2.2 Light Microscopy
Light microscopy is a powerful technique used in biology to analyse cellular structure,
physiology and function. Compound microscopes contain multiple lenses. The mag-
nification of these lenses is compounded (multiplied) to increase overall magnification
of a sample, compared to simple microscopes which use only one lens. The two main
configurations of microscopes include upright (where the objective lenses are located
above the sample and light source illuminates from underneath) and inverted (where
the objective lenses are below the sample and the light source is above). The objective
lens is the first part of the microscope to collect light from the sample.237 Here, live
cell imaging experiments were carried out using MatTek glass bottom petri dishes, on
an inverted microscope. The glass coverslip at the base of the dish is necessary as the
objective lenses are positioned below the sample.
The resolution of a microscope is defined as its ability to resolve fine detail in the
sample being imaged. It can be expressed as the smallest distance between two close
points, at which they can still be recognised as two separate entities. The resolution of
a microscope is directly related to the wavelength of light used to illuminate the sample
and is inversely proportional to the numerical aperture (NA).237 This relationship is
outlined in the equation below, where d is the smallest resolvable distance (resolution).
d =0.61λNA
In these experiments, an oil immersion objective lens (60×, NA 1.4) was used where
the medium between the objective lens and the glass coverslip is oil (rather than air).
Oil is used as it has a similar refractive index (n) to the glass coverslip on the base of
the MatTek petri dish. Therefore the system has a higher NA and improved resolution
(n ∝NA).237,238
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Confocal Microscopy
In conventional light or fluorescence microscopy the entire depth of a sample is con-
stantly illuminated meaning out of focus light is still being detected ( Figure 1.12 on
page 18), which can make image detail difficult to interpret.239 Comparatively, confo-
cal microscopy allows imaging of thin optical sections as any out of focus light is not
detected, reducing the issue of out-of-focus information.240 This is possible due to the
use of two pinholes, the first located at the point of illumination, see Figure 5.1. Light
Figure 5.1: Basic schematic of a confocal microscope.241
passes through the first pinhole and is directed to the sample by a highly reflective
dichroic mirror. Light is focused onto the specimen by passing through the objective
lens which then forms an image of the specimen onto the second pinhole (located be-
fore the detector).242 In other terms, the illumination and detection systems are focused
at the same point on the sample; ie: they are confocal (Figure 5.1).240
The diameter of the pinhole can be controlled and smaller pinhole sizes lead to thinner
optical sections and high resolution along the z-axis is achieved. The z-axis is the
optical plane perpendicular to the sample (Figure 5.2), whereas the x and y axes are
parallel to the coverslip. An example of optical sectioning is shown in Figure 5.2, taken
from the research of Dan and co-workers.243 By increasing the pinhole radius, a thicker
optical section is imaged and although a brighter signal is detected, resolution along
the z-axis is reduced.240 In all imaging experiments a balance between sensitivity,
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spatial and temporal resolution needs to be considered. Confocal imaging also has
the advantage of being able to produce images in the xy and z planes allowing 3-D
images to be constructed. In z-stack imaging, multiple images are taken as the sample
is moved to different focal planes along the z-axis. This can then be viewed as a whole
stack or 3-D image. Figure 5.2 shows how optical sectioning (or z-stack imaging) can
be used to generate 3D images.
Figure 5.2: Optical sectioning of pollen grains where (a) shows a stack of optically
sectioned images and (b) shows the constructed 3D image.243
Multiphoton Microscopy
Multiphoton excitation (MPE) was discussed in Chapter One, sections 1.3.1 and 1.3.2.2.
Many microscope systems have integrated MPE capabilities where high energy pulsed
lasers (in the femtosecond range) are used to image the specimen.244 The importance
of MPE in optical imaging is that lower energy light can be used to excite the probe.
This is less damaging to the sample than high energy radiation. Generally, low energy
light has improved tissue penetration63 due to reduced scattering. Another advantage
of MPE is that it provides excitation of the sample only at the focal point of incident
light and therefore confocal type imaging is achieved without the use of pinholes.57
Also, there is usually less photobleaching as the sample is only illuminated at the
plane of focus.60
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Spectral Detection Imaging
In generic confocal imaging, filters can be used to avoid spectral bleed-through arti-
facts. However, many dye combinations can become complex to distinguish, especially
when their excitation profiles also overlap.245 Spectral imaging is a technique which al-
lows the spectral profile of fluorophores within the sample to be detected and collected
in situ, on a pixel by pixel basis. This technique is incorporated into some confocal
imaging systems and is often combined with spectral unmixing. Labels which have
overlapping excitation and/or emission profiles, making them difficult to separate with
filters alone, can be discriminated with spectral unmixing. Spectral imaging collects
many images of the same view at different wavelengths. The Nikon A1Si confocal mi-
croscope system (used in this research) contains a 32 channel spectral detector and for
the experiments reported herein, a 10 nm Si grating resolution was used. This means
that there is one signal point detected for each 10 nm step. A larger step is required
to detect a greater range of the spectrum however spectral resolution is reduced. To
improve resolution, the Si grating can be reduced (ie: 10 nm to 2.5 nm), however this
means that less of the spectrum can be collected.
In relation to this research, the spectral detection capability of the confocal microscope
was used to detect and identify the emission of the rhenium complexes incubated with
HeLa cells. It was also used to identify the rhenium signal against any autofluorescence
or noise. Autofluorescence is discussed in section 1.2.2 on page 9. Due to the very
broad emission profile of the rhenium complexes, the 10 nm grating was used to ensure
a sufficient portion of the visible spectrum could be analysed in vitro (approximately
400-700 nm).
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5.3 Results and Discussion
5.3.1 Sample preparation
fac-[Re(phen)(CO)3(Tph)] (11) and fac-[Re(phen)(CO)3(Tbz)] (13) were the first
complexes used for live cell imaging experiments. Only the phen analogues are inves-
tigated due to their superior photophysical performance (as discussed in Chapter Two).
The Re(I) complexes are not completely water soluble and therefore dimethylsulfoxide
(DMSO) was used to dissolve them into aqueous cellular media. DMSO is commonly
used in biology to make up stock solutions of powdered fluorophores.240 It is often
advised to maintain DMSO concentrations in cell samples ≤0.1 %.240 However, many
publications looking at the application of metal complexes (eg: Ir, Re and Ru) as op-
tical imaging agents use concentrations of DMSO in cell cultures anywhere between
1%99,246,247, 2%76 and even 5%.154 Herein, the concentration of DMSO used is ≤1%,
with exact concentrations specified for each experiment. Control samples, containing
the same DMSO concentrations used for each rhenium experiment, were always pre-
pared in parallel. Blank samples were also used, in which nothing was added to the
cell culture.
Figure 5.3: HeLa cells showing membrane blebbing, as indicated by the presence of
small bulges around the cells. Scale bar, 25 µM.
The first sets of experiments were conducted by adding rhenium complexes (in DMSO)
directly onto the cell culture, contained in a glass bottom MatTek petri dish with media.
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In these experiments, some cells were observed undergoing a process known as bleb-
bing of the plasma membrane. Cell blebs are irregular bulges that protrude from cell
membranes and the bulges appear like clear bubbles under the microscope.248,249 Bleb-
bing is often a sign of cells undergoing membrane damage or apoptosis (programmed
cell death) and can be in response to intracellular and extracellular damage and/or spe-
cific physiological signals.248,250–252 The loss of structural integrity is a stress response
of the cells, easily observable in transmission images, as illustrated in Figure 5.3. It
is therefore important to present both fluorescent and transmission images as the mor-
phology of cells and therefore the presence of membrane blebs is not obvious in flu-
orescent images (unless specific stains are used). Transmission imaging can include
brightfield, phase contrast or differential interference contrast (DIC) optics. DIC is
used herein, as it provides an increased contrast of the cells with high resolution.237
It was hypothesised that some cells were showing membrane blebs in response to the
highly localised concentration of DMSO being added directly onto the cells. A DMSO
control experiment was carried out to determine the cause of stress on the cells. HeLa
cells in a glass bottom MatTek petri dish were placed on the microscope and confocal
images were taken. DMSO was directly added to the centre of the cell culture dish and
further images were taken. Cells blebbed less than four minutes after DMSO addition.
Only cells directly “hit” by the DMSO showed blebbing. Figure 5.4 A and B shows
HeLa cells before and after the addition of DMSO. White arrows in image B indicate
Figure 5.4: DIC images of HeLa Cells before (A) and after (B) the direct addition of
DMSO to the culture. Arrows show the presence of blebs in image B. Scale bar, 25
µm.
the presence of blebs. Upon moving the field of view away from where DMSO was
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directly added, cells morphology appeared unchanged (similar to before the addition
of DMSO, ie: no blebs observed). The remainder of the imaging experiments were
therefore conducted by pre mixing the rhenium solutions (or DMSO) in culture media.
The homogenous solution was then added to HeLa cells. Improved cell response was
observed as the DMSO was evenly dispersed throughout the culture and cells were not
experiencing a highly localised concentration.
5.3.2 Imaging of fac-[Re(phen)(CO)3(Tph)] (11) and
fac-[Re(phen)(CO)3(Tbz)] (13)
Confocal images were collected on a Nikon Ti-E inverted motorised microscope with
a Nikon A1Si confocal microscope system to assess uptake and localisation of the
rhenium complexes in HeLa cells.
HeLa cells were incubated under standard conditions with fac-[Re(phen)(CO)3(Tph)]
(11) to a final concentration of 20 µM and 0.4% (v/v) DMSO, for three hours be-
fore imaging. HeLa cells displayed good uptake of the applied rhenium complex with
confocal imaging indicating cytoplasmic localisation. Figure 5.5 A-C shows the DIC,
fluorescence and merged images respectively. 11 appears to have entered the cells and
is localising in the cytoplasm. Bright punctate signals are observed in the fluorescence
image which could suggest organelle localisation however co-localisation experiments
would be required to support this. The black hole in the middle of the cells (Figure 5.5)
is indicative of the cell nucleus. Confocal images only take a thin optical section and
therefore Figure 5.5 B illustrates that the complex is entering cells and not just adhering
to the external cell surface.
The DIC image shows the majority of cells in culture appear comparable to cells in
the DMSO control and blank dishes. Cells show no signs of altered morphology, sug-
gesting the rhenium complexes are non-toxic within the experimental time frame. It is
unclear if specific cellular organelles are preferentially targeted. Intracellular localisa-
tion of the rhenium compound appears diffuse, suggestive of non-specific localisation.
fac-[Re(phen)(CO)3(Tbz)] (13) was incubated with HeLa cells for two hours, under
standard conditions (section 5.2.1 on page 172). For the images shown in Figure 5.6,
fac-[Re(phen)(CO)3(Tbz)] (13) was incubated to a final concentration of 20 µM and
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Figure 5.5: HeLa cells incubated with fac-[Re(phen)(CO)3(Tph)] (11). DIC (A)
shows the structural integrity of the cells where the fluorescence (B) and merged (C)
images illustrate the cellular uptake and cytoplasmic localisation of 11. Scale bar, 25
µm.
0.4% (v/v) DMSO. Diffuse cytoplasmic localisation was again observed.
HeLa cells did not show signs of stress suggesting fac-[Re(phen)(CO)3(Tbz)] (13) is
non toxic during imaging experiments.
Figure 5.6: HeLa cells incubated with fac-[Re(phen)(CO)3(Tbz)] (13). DIC (A) shows
the structural integrity of the cells where the fluorescence (B) and merged (C) images
illustrate the cellular uptake and perinuclear localisation of 13. Scale bar, 25 µm
The times of incubation quoted for each complex in HeLa cells (two to three hours) are
for the specific images shown. Uptake of both complexes 11 and 13 has clearly been
observed after incubation times of one hour.
5.3.2.1 Spectral Detection
As mentioned above, control and blank samples were always prepared to gauge the
status of cells without rhenium additives. In some instances, low levels of cellular
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autofluorescence were detected whilst imaging the DMSO control and unlabelled cell
samples. This is not unexpected due to the presence of naturally occurring fluorescent
biological compounds (eg: flavinoids, aromatic amino acids). To ensure that the lumi-
nescent signal detected for the experiments above, was in fact due to the presence of
rhenium, spectral images were collected followed by spectral analysis.
Figure 5.7: Spectral detection emission profile measured from a blank HeLa cell.
To perform spectral analysis, a spectral image of cells without additives (blank sample)
was first collected. Regions of interest were selected inside the cytoplasm of cells and
then spectrally analysed. Figure 5.7 shows the normalised emission profile generated
from a region of interest (ROI) inside the cytoplasm of a blank HeLa cell. There is a
slight maximum observed between 575 and 600 nm however the profile does not have a
Gaussian shape. This profile is representative of background noise and autofluorescent
signal.
Spectral references of the Re(I) complexes were measured on the confocal using DMSO
stock solutions. From the spectral image, a specific ROI was selected and an emission
profile generated. The emission was collected using a 32 channel spectral detector and
10 nm Si grating resolution. The spectral profiles generated from DMSO solutions
of fac-[Re(phen)(CO)3(Tph)] (11) and fac-[Re(phen)(CO)3(Tbz)] (13) are shown in
Figure 5.8. The emission spectra have Gaussian profiles which is expected, based on
the measurements made in Chapter Two (section 2.3.4 on page 49).
HeLa cells were incubated with fac-[Re(phen)(CO)3(Tph)] (11) to a final concentra-
tion of 10 µM and 0.5% (v/v) DMSO, for two hours before imaging. Spectral images
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Figure 5.8: Spectral detection emission profiles measured from DMSO solutions of
fac-[Re(phen)(CO)3(Tph)] (11, purple) and fac-[Re(phen)(CO)3(Tbz)] (13, orange).
were taken and from these, a ROI inside the cytoplasm of the cell was chosen. The
ROI selected was a circle with an approximate diameter of 7 µm. The white arrow
in Figure 5.9 indicates the area where the ROI was selected. The spectral profile was
analysed and is shown in Figure 5.10.
Figure 5.9: HeLa cells incubated with fac-[Re(phen)(CO)3(Tph)] (11). The white
arrow shows the area in which a ROI was selected for spectral analysis. DIC (A),
fluorescence (B) and merged (C) images. Scale bar, 25 µm.
Emission spectra from the confocal microscope are not as “smooth” as those taken with
a spectrofluorometer and therefore a definite emission maximum is difficult to identify.
The general shape and approximate emission maximum shown in Figure 5.10 is con-
sistent with that measured from the DMSO stock solution of 11 on the microscope
(Figure 5.8).
The same experiments were carried out incubating HeLa cells with fac-[Re(phen)(CO)3(Tbz)]
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Figure 5.10: Spectral detection emission profile taken from inside HeLa cells incu-
bated with fac-[Re(phen)(CO)3(Tph)] (11). The area in which a ROI was selected is
indicated by the white arrow in Figure 5.9.
(13) to a final concentration of 20 µM and 0.4% (v/v) DMSO, for two hours before
imaging. Spectral images were taken and from these, a ROI inside the cytoplasm of
the cell was chosen. The ROI was a circle with an approximate diameter of 7 µm and
the white arrow in Figure 5.11 indicates where the ROI was located. Spectral analysis
produced the profile shown in Figure 5.12. The emission profile is again compara-
ble to that taken from a DMSO solution of fac-[Re(phen)(CO)3(Tbz)] (13), using the
microscope (Figure 5.8). There is a slight blue shift noted for the detection of both
complexes (11 and 13), inside the HeLa cells compared to that of the DMSO solution
however this is not unexpected. Upon changing to more polar solvents, the emission
maxima of the prepared rhenium complexes are known to undergo a blue shift. The
reference spectra were recorded in DMSO but once incubated with the cells the com-
plex is in a more aqueous (polar) environment. The hypsochromic shift that occurs
upon increasing solvent polarity is illustrated in Appendix 5, Figure A5.1.
The emission profiles collected in vitro from HeLa cells incubated with rhenium com-
plexes (11 and 13) indicate that there is cellular uptake with cytoplasmic localisation.
When regions of interest were positioned outside cells or inside the nucleus, the emis-
sion profiles were significantly weaker and the shape was not comparable to the DMSO
control (Figure 5.8). Based on the similarity of the reference and in vitro emission pro-
files, it could be suggested that the Re(I) complexes remain unchanged upon incubation
with HeLa cells.
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Figure 5.11: HeLa cells incubated with fac-[Re(phen)(CO)3(Tbz)] (13). The white
arrow shows the area in which a ROI was selected for spectral analysis. DIC (A),
fluorescence (B) and merged (C) images. Scale bar, 25 µm.
Figure 5.12: Spectral detection emission profile taken from inside HeLa cells incubated
with fac-[Re(phen)(CO)3(Tbz)] (13).The area in which a ROI was selected is indicated
by the white arrow in Figure 5.11. Scale bar, 25 µm.
Further support for the stability of neutral Re(I) complexes in biological environments
is discussed in a study by Bader et al.115 The two Re(I) tetrazolato complexes used in
Bader’s study exhibit different localisation patterns attributed to the different tetrazole
ancillary ligands. Bader et al. indicate that if the structures of the complexes were to
change upon incubation, for example by detachment of the tetrazolato ligand, then it
would be unlikely for the different complexes to exhibit unique localisation.
5.3.2.2 Intensity Profiles
Intensity profile plots were used to confirm the localisation of rhenium complexes in-
side the cytoplasm of cells. FIJI (ImageJ) was used to draw a line across the cell
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and an intensity profile along this line was plotted. The profiles for cells incubated
with fac-[Re(phen)(CO)3(Tph)] (11) and fac-[Re(phen)(CO)3(Tbz)] (13) are shown
in Figure 5.13, along with the cells they were collected from. The normalised pro-
Figure 5.13: HeLa cells incubated with fac-[Re(phen)(CO)3(Tph)] (11, A) and fac-
[Re(phen)(CO)3(Tbz)] (13, B) and their corresponding integrated intensity profiles
collected along the white arrow. Intensity profiles show that the most intense signal is
originating from the cytoplasm of HeLa cells. Scale bar, 25 µm.
files are reported to demonstrate the relative luminescence intensities in various parts
of the cell culture. Figure 5.13 illustrates the increased luminescence intensity in the
cytoplasmic regions of the cells, compared to inside the nucleus or in the extracellular
space. Only one cell profile is reported for each complex however each example is rep-
resentative of all cells in culture. Confocal images of the HeLa cells incubated with the
two neutral rhenium complexes (11 and 13), as well as the emission profiles analysed
demonstrate consistent cellular uptake. The predominant cytoplasmic localisation was
supported by analysis of the intensity profile plots across the cells. These results show
the potential for 11 and 13 to be further investigated as optical imaging agents.
5.3.2.3 Multiphoton Excitation
To evaluate the ability of fac-[Re(phen)(CO)3(Tph)] (11) to undergo multiphoton ex-
citation, a thin film of the sample was imaged on a confocal microscope equipped with
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a pulsed infrared laser (700-1000 nm). The sample was excited with the infrared laser
at wavelengths between 720 and 800 nm. Figure 5.14 shows the signal from a thin film
of 11, imaged using 720 nm pulsed excitation. The white arrow in Figure 5.14 indi-
cates the edge of the thin film, illustrating that the observed luminescence is originating
from the Re(I) sample. Although no cellular images were taken using multiphoton ex-
citation, the possibility for Re(I) complexes to be excited using NIR light has been
demonstrated (Figure 5.14).
Figure 5.14: Thin film of fac-[Re(phen)(CO)3(Tph)] (11), demonstrating multiphoton
excitation. Scale bar, 25 µm.
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5.3.2.4 Photoinduced Cytotoxicity
Z-stack images were taken with the aim to produce 3D images of the rhenium con-
taining HeLa cells. Upon collection of z-stacks cells appeared to become stressed
(which was not observed during single image capture over a period of hours). fac-
[Re(phen)(CO)3(Tph)] (11) was added to HeLa cells at a concentration of 20 µM and
1% (v/v) DMSO. Cytoplasmic uptake of the complex was observed. However, upon
acquiring a z-stack series over a time of 3 minutes and 35 seconds, cells were clearly
being affected by the increased light exposure. In the z-stack images, cells progres-
sively withdraw, round up and form blebs. Figure 5.15 B shows a snap shot taken from
the illuminated area immediately after z-stack acquisition where cells have rounded up
and formed blebs. Although Figure 5.15 B was taken at the end of a 3 minute and 35
second z-stack, the cells appeared stressed even after one minute. Interestingly, when a
non-illuminated filed of view was examined cell morphology appeared unaltered with
no evidence of bleb formation.
To investigate the main cause of stress to the cells, 1% (v/v) DMSO control sample
was analysed using similar laser exposure conditions. After five minutes of illumina-
tion through acquisition of a z-stack series, a snap shot was taken of the illuminated
area, as shown in Figure 5.15 A. Overall, cellular morphology did not appear to be al-
tered with few rounded cells and no blebbing visible. Figure 5.15 shows evidence that
fac-[Re(phen)(CO)3(Tph)] (11) is having a toxic effect on cells that are continually
illuminated with 405 nm laser for one minute or more.
It is known that UV light radiation has damaging effects on cells65,66 and the 405 nm
laser source is classified as UVA radiation.253 However, it is unlikely that the 405 nm
laser is the sole cause of damage to HeLa cells as the (DMSO) control cells do not
show signs of stress. It is probable that the combination of both the laser light and
rhenium complex is causing the toxic effects to the cells.
It was rationalised that the formation of singlet oxygen (1O2) could be contributing to
the toxic response observed in the cells being illuminated. 1O2 is commonly associated
with photoinduced cytotoxicity from phosphorescent metal complexes.104 The mech-
anism of 1O2 formation is discussed in Chapter One. The diffusion distance of singlet
oxygen in cells has been calculated between 70 and 300 nm.254,255 This relatively short
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Figure 5.15: DIC images of HeLa cells after z-stack images. HeLa cells incubated with
1% (v/v) DMSO (A) and HeLa cells incubated with fac-[Re(phen)(CO)3(Tph)] (11,
B). Control cells (A) do not show signs of altered behaviour. However cells incubated
with 11 (B) have rounded up and show evidence of bleb formation. Scale bar, 25 µm.
diffusion distance is the reason that only directly illuminated cells show signs of stress.
The singlet oxygen produced upon irradiation does not travel far enough to damage sur-
rounding cells. One way to detect the production of singlet oxygen is directly through
monitoring its emission in the near infrared (NIR) region of the spectra. The spectral
detector on the confocal does not have the capacity for NIR detection. Emission stud-
ies using the FLS980 spectrofluorometer coupled to an NIR detector were carried out.
1O2 is known to exhibit an emission peak around 1270 nm254–257 and this peak has
been directly detected for a series of previously published Re(I) complexes.55
Emission of the prepared rhenium complexes, fac-[Re(phen)(CO)3(Tph)] (11) and
fac-[Re(phen)(CO)3(Tbz)] (13) in DCM, was monitored in the NIR, using an excita-
tion wavelength of 370 nm (as was determined in Chapter Two). A peak at 1274 nm
was observed for both complexes as illustrated in Figure 5.16. This is a direct indica-
tor of the ability of 11 and 13, to generate singlet oxygen. Interestingly, the 1O2 peak
was not observed for the complexes when measured in 1% (v/v) DMSO in H2O. The
measurement was also conducted in 100% DMSO and again, no 1O2 emission was ob-
served. The generation of 1O2 can not be ruled out for aqueous or DMSO solutions.
The production of 1O2 may be reduced in these solvents or the emission at 1274 nm
could be quenched. Difficulties in obtaining reliable data from aqueous solutions have
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been previously reported.258 A study by Leonidova et al. also noted that upon chang-
ing solvents from acetonitrile to water, the production of 1O2 from the Re(I) complexes
was reduced.55
Figure 5.16: Near infrared emission spectra of fac-[Re(phen)(CO)3(Tph)] (11, purple)
and fac-[Re(phen)(CO)3(Tbz)] (13, orange) in DCM. λ ex: 360 nm.
There is a correlation between the solvent (or medium in which the 1O2 is being gen-
erated) and the excited state lifetime decay (and therefore emission intensity) of 1O2.
Studies by Merkel show that the lifetime of 1O2 emission ranges from 700 µs in car-
bon tetrachloride to 12 µs in ethanol and 2 µs in water.256 The relationship is related to
the ability of the solvent to absorb at 7880 and 6280 cm-1 (1269 and 1592 nm respec-
tively), which correspond to O-H and C-H vibrations.256 These vibrational energies
also correspond to the 0-0 and 0-1 emission transitions of 1O2. The stronger the sol-
vent absorbs in these regions, the more 1O2 emission is quenched. The quenching
described by Merkel et al. could rationalise the absence of the 1O2 peak in rhenium
DMSO and water solutions.
Production of 1O2 in a biological environment is always going to be an issue for triplet
state emitters (as discussed in 1.3.1.1), such as these Re(I) phosphorescent complexes.
Further studies are required to understand the extent of 1O2 production and the damage
caused herein. During most imaging experiments no obvious phototoxic effects were
observed and it was only when the sample was continually irradiated that damage was
observed. Therefore, the neutral Re(I) complexes, fac-[Re(phen)(CO)3(Tph)] (11)
and fac-[Re(phen)(CO)3(Tbz)] (13) still show potential to be investigated as optical
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imaging agents. However, these complexes also demonstrate the ability to become
phototoxic under certain conditions.
Photodynamic Therapy
Photodynamic therapy is still a fairly new procedure that is used in the treatment
of cancerous tumours.259 It involves the administration of a photosensitising agent
which, to avoid side effects, must be non-toxic in the dark.260 This agent is then ir-
radiated with a specific wavelength of light which, through a series of photochemi-
cal, photophysical and photobiological processes (including the generation of 1O2 ),
causes cytotoxic damage.261 Selectivity comes from the ability of the photosensitiser
to localise in specific tumour cells and also from the targeted delivery of light.260
The phosphorescent Re(I) metal complexes, fac-[Re(phen)(CO)3(Tph)] (11) and fac-
[Re(phen)(CO)3(Tbz)] (13) are cytotoxic upon continuous irradiation with 405 nm
light. These rhenium complexes show potential to be further explored as mulitmodal
agents combining imaging and phototherapeutics.
5.3.3 Imaging of fac-[Re(phen)(CO)3(TphCH3)]+ (31) and
fac-[Re(phen)(CO)3(TbzCH3)]+(33)
5.3.3.1 Anion Exchange
The methylated rhenium complexes fac-[Re(phen)(CO)3(TphCH3)]+ (31) and
fac-[Re(phen)(CO)3(TbzCH3)]+(33) were used in cellular experiments as a direct
comparison to their neutral analogues. As described in Chapter Four, the methylated
complexes were isolated as their PF6- salts (exchanged from CF3SO3-). For biological
applications this anion may not be optimal in terms of size and solubility. Water solu-
bility could potentially be improved by exchanging the PF6- counter ion for Cl-. The
smaller anion may also improve cellular uptake.262
Anion exchange was trialled using a DOWEX®-Cl mesh column.263
fac-[Re(phen)(CO)3(TphCH3)]+ (31) was passed through a DOWEX®-Cl column and
an NMR taken of the product. Interestingly, instead of observing the expected two
sets of rhenium signals (see section 4.3.3 on page 128) there appeared to be a third
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system present. Separation of this mixture was attempted using acidic alumina-filled
column chromatography. IR and NMR suggested that the first product eluted was
fac-[Re(phen)(CO)3(Cl)] (7). The IR spectrum showed two intense CO stretches at
2013 and 1861 cm-1matching with 7 (see section 2.5.2.2 on page 66). The 1H NMR
spectrum also matched well with previously synthesised fac-[Re(phen)(CO)3(Cl)] (7)
as shown in Figure 5.17. There also appears to be excess free methylated tetrazole
ligand present in the NMR. The second product collected from the acidic alumina
column still showed the presence of three rhenium systems.
Based on these preliminary experiments it was concluded that the DOWEX®-Cl mesh
column was not appropriate to exchange the PF6-counter ion for Cl-. The tetrazole
ligand appears to be exchanging for the chloro as well as or instead of the PF6- anion.
This is not unexpected due to the lability of the methylated tetrazole ligand, discussed
in Chapter Four. The complexes were therefore left with the PF6- counter ion for
imaging experiments.
Figure 5.17: NMR of fac-[Re(phen)(CO)3(Cl)] (top) and fraction one recovered from
the acidic alumina column (bottom), in acetone-d6.
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5.3.3.2 Confocal Imaging and Spectral Detection
HeLa cells were incubated under standard conditions with fac-[Re(phen)(CO)3(TphCH3)]+
(31) and fac-[Re(phen)(CO)3(TbzCH3)]+(33) to final concentrations of 20 µM and
0.4% (v/v) DMSO, for one to two hours before imaging. The same general imag-
ing conditions used for the neutral Re(I) complexes were employed. Interestingly, no
obvious luminescence signal was observed in HeLa cells incubated with either 31 or
33.
It was hypothesised that there could be some ligand reactivity or exchange process
occurring due to the labile nature of the methylated tetrazolato ligand. Temperature
dependent NMR experiments carried out in Chapter Four revealed that at 40 ºC the
cationic Re(I) complexes start to undergo ligand exchange with coordinating solvents
(see Figure 4.8 on page 133). fac-[Re(phen)(CO)3(TphCH3)]+ (31) in DMSO-d6 was
heated at 37 ºC (incubation conditions) and analysed by NMR at various time intervals,
as shown in Figure 5.18.
Figure 5.18: 1H NMR spectrum of fac-[Re(phen)(CO)3(TphCH3)]+ (31) at room tem-
perature (a) and after being heated at 37 ºC for 30 minutes (b), 60 minutes (c) and 105
minutes (d) in DMSO-d6.
After 60 minutes of heating at 37 ºC in DMSO-d6, the DMSO solvate (identified by
192
the * in Figure 5.18) was the main complex present. It is therefore likely that in cell
culture media at 37 ºC the ligand could start exchanging with compounds or even wa-
ter present in cellular media. The solvato complex is even present at room temperature
(Figure 5.18). Nonetheless live cell imaging experiments were attempted at room tem-
perature as ligand exchange seemed to occur slower than at 37 ºC.
The cultured HeLa cells and media were stabilised at room temperature after which
fac-[Re(phen)(CO)3(TphCH3)]+ (31) was added to achieve a final concentration of
20 µM and 0.4% (v/v) DMSO. Cells with the complex were allowed to sit at room
temperature for 90 minutes before imaging. Some signal was detected inside HeLa
cells however it was very weak compared to the signal produced by the analogous
neutral complex fac-[Re(phen)(CO)3(Tph)] (11). Localisation was mainly observed
in the perinuclear region of cells with a focal appearance. A weak diffuse signal was
also detected, as illustrated in Figure 5.19. HeLa cells shown in Figure 5.19 A, do
not show any signs of phototoxicity and cellular morphology is consistent with the
control/blank samples (also at room temperature). This indicates that the complexes
were non-toxic towards HeLa cells within the parameters used during these imaging
experiments.
Figure 5.19: HeLa cells incubated with fac-[Re(phen)(CO)3(TphCH3)]+ (31). DIC
(A) shows the structural integrity of the cells. Fluorescence (B) and merged (C) images
illustrate the weak signal observed in the perinuclear regions of HeLa cells incubated
with 31. White arrows show areas in which ROIs were selected for spectral analysis.
Scale bar, 25 µm.
fac-[Re(phen)(CO)3(TbzCH3)]+(33) was added to HeLa cells in the same way as de-
scribed above (for complex 31). Similar results were observed. Figure 5.20 shows
a weak signal apparent in the perinuclear/cytoplasmic region of cells. The appar-
ent brighter signal of 33 compared to 31 could be attributed to the increased gain
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settings used during image acquisition. Based on the morphology of the cells, fac-
[Re(phen)(CO)3(TbzCH3)]+(33) appears to be non-toxic toward HeLa cells during
the imaging experiments.
Figure 5.20: HeLa cells incubated with fac-[Re(phen)(CO)3(TbzCH3)]+(33). DIC
(A) illustrates the structural integrity of the HeLa cells where the fluorescence (B) and
merged (C) images show the weak signal observed in the perinuclear regions of HeLa
cells incubated with 33. White arrows show areas in which ROIs were selected for
spectral analysis. Scale bar, 25 µm.
Confocal images of HeLa cells containing no complex were collected under the same
conditions used for 31. Some autofluorescent signal was observed for blank cells how-
ever it appeared weaker than the signal detected for HeLa cells containing 31. To con-
firm the signal from cell incubated with 31 or 33 was originating from a Re(I) species,
spectral imaging was trialled. Unfortunately, spectral imaging was unsuccessful due to
the very weak signal intensity from both blank and experimental cells.
It was also hypothesised that the low signal intensity from cells incubated with 31 or 33
may have been due to low molar absorptivity of fac-[Re(phen)(CO)3(TphCH3)]+(31)
and fac-[Re(phen)(CO)3(TbzCH3)]+(33) at 405 nm. Molar absorptivity directly re-
lates to the probability of a complex absorbing light (absorption cross section). As
discussed in Chapter Four, methylated Re(I) complexes have blue shifted absorbances
therefore their absorbance cross section at 405 nm may be reduced compared to the
neutral analogues. Molar absorptivity values for both neutral and methylated Re(I)
complexes in DCM are presented in Table 5.3.1. The absorbance cross sections are
comparable between the neutral and methylated species. Therefore, a low absorbance
cross section at 405 nm is unlikely to be the reason that signal from
fac-[Re(phen)(CO)3(TphCH3)]+(31) and fac-[Re(phen)(CO)3(TbzCH3)]+ (33) in HeLa
cells is extremely weak.
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Table 5.3.1: Molar Absorptivity (L mol-1 cm-1) for Re(I) complexes at 405 nm.
Rhenium Molar Absorptivity at 405 nm
Complex (L mol-1 cm-1)
fac-[Re(phen)(CO)3(Tph)] (11) 2555
fac-[Re(phen)(CO)3(Tbz)] (13) 2375
fac-[Re(phen)(CO)3(TphCH3)]+(31) 3701
fac-[Re(phen)(CO)3(TbzCH3)]+ (33) 1696
Reference spectra of the methylated rhenium complexes, fac-[Re(phen)(CO)3(TphCH3)]+
(31) and fac-[Re(phen)(CO)3(TbzCH3)]+(33) in DMSO were measured on the mi-
croscope and the spectral profiles are shown in Figure 5.21. The collection of these
Figure 5.21: Spectral detection emission profiles measured from DMSO
solutions of fac-[Re(phen)(CO)3(TphCH3)]+ (31, purple) and fac-
[Re(phen)(CO)3(TbzCH3)]+(33, orange).
profiles illustrate that the 405 nm laser is able to sufficiently excite the complexes to
produce a detectable signal. The low signal intensity observed in vitro could be due
to poor cellular uptake and/or that the identity of the methylated Re(I) complexes are
significantly changing upon incubation. If the structure of the complexes is altered the
photophysical properties, including λ ex and λ em are likely to change.
From these preliminary experiments, it is clear that fac-[Re(phen)(CO)3(TphCH3)]+
(31) and fac-[Re(phen)(CO)3(TbzCH3)]+(33) do not show potential for further inves-
tigation as optical imaging agents. The complexes are unstable in solution, even at
room temperature. The lability of the ligand could be causing structural alterations to
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the complexes once incubated into HeLa cells. Although these complexes are highly
emissive compared to their neutral analogues, their lack of stability makes them un-
suitable to be used in a biological context.
5.3.4 Imaging of fac-[Re(phen-RS)(CO)3(Cl)] (39) and
fac-[Re(phen-S-PEG)(CO)3(Cl)] (40)
Imaging experiments were carried out on fac-[Re(phen-RS)(CO)3(Cl)] (39) and fac-
[Re(phen-S-PEG)(CO)3(Cl)] (40). These complexes were synthesised as precursors
to the final tetrazolato complex, fac-[Re(phen-S-PEG)(CO)3(Tph)] (41), (section 5.3.5).
Live HeLa cell imaging experiments were performed to assess if altering the ancillary
ligand and/or functionalising the diimine group would effect the behaviour of rhenium
complexes in a biological environment.
5.3.4.1 Confocal Imaging and Spectral Detection
fac-[Re(phen-RS)(CO)3(Cl)] (39) and fac-[Re(phen-S-PEG)(CO)3(Cl)] (40) were in-
cubated with HeLa cells to a final concentration of 20 µM and 0.4% (v/v) DMSO
for 90-120 minutes under standard culture conditions (as outlined in section 5.2.1 on
page 172). Figure 5.22 shows confocal images of HeLa cells incubated with 39 (im-
ages A-C) and 40 (images D-F).
HeLa cells show uptake of the complexes with an apparent cytoplasmic localisation
for both 39 and 40. Again, the localisation was very diffuse and therefore it is unclear
if specific organelles are preferentially targeted. The localisation of 39 and 40 appears
similar to fac-[Re(phen)(CO)3(Tph)] (11) and fac-[Re(phen)(CO)3(Tbz)] (13), dis-
cussed in section 5.3.2. The main difference observed was the signal strength. Under
the same imaging conditions, complexes containing the chloro ancillary ligand ap-
peared to show a weaker signal in the cytoplasm compared to 11 and 13. The molar
absorptivity of 39 and 40 at 405 nm (3378 and 4136 L mol-1 cm-1 respectively) are
in fact comparable to 11 and 13 (see Table 5.3.1). Again, these measurements are
in DCM and could be different in aqueous solvents. DIC images in Figure 5.22 il-
lustrate that the majority of cells in culture have morphological structure comparable
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Figure 5.22: HeLa cells incubated with fac-[Re(phen-RS)(CO)3(Cl)] (39, images A-
C) and fac-[Re(phen-S-PEG)(CO)3(Cl)] (40, images D-F). DIC (A and D) images
show the structural integrity of cells where fluorescence (B and E) and merged (C and
F) images illustrate the uptake and cytoplasmic localisation of HeLa cells. Scale bar,
25 µm.
to the (DMSO) control and blank cells. They do not appear to be showing signs of
stress, indicating the non-toxic nature of fac-[Re(phen-RS)(CO)3(Cl)] (39) and fac-
[Re(phen-S-PEG)(CO)3(Cl)] (40) during imaging experiments.
To further confirm the observed signal was originating from fac-[Re(phen-RS)(CO)3(Cl)]
(39) or fac-[Re(phen-S-PEG)(CO)3(Cl)] (40) and not simply from autofluorescence/noise,
spectral imaging was carried out. Firstly, DMSO stock solutions of 39 and 40 were
measured as a reference. The spectra are shown in Figure 5.23 and have an expected
broad Gaussian shape, with maxima just above 600 nm.
Figure 5.24 shows the spectral profiles collected from circular ROIs (approximately
7 µm diameter) inside HeLa cells incubated with 39 and 40. The ROIs were located
in areas indicated by the white arrows in Figure 5.22 B and E. The emission profiles
collected in vitro are comparable with the reference DMSO solutions.
There was a significant difference in the profiles measured from regions of interest
inside the cytoplasm and in the extracellular space.
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Figure 5.23: Spectral detection emission profiles measured from DMSO solutions of
fac-[Re(phen-RS)(CO)3(Cl)] (39, purple) and fac-[Re(phen-S-PEG)(CO)3(Cl)] (40,
orange).
Figure 5.24: Spectral detection emission profile taken from inside HeLa cells incubated
with fac-[Re(phen-RS)(CO)3(Cl)] (39, purple) and fac-[Re(phen-S-PEG)(CO)3(Cl)]
(40, orange).
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The spectra lost its Gaussian-like shape and a significant reduction in intensity was
observed. Although the observed signal from HeLa cells incubated with 39 and 40
is relatively weak, spectral analysis suggests that both complexes are taken into HeLa
cells and localise in the cytoplasm.
It does not appear that modifications on the diimine ligand or the change in ancil-
lary ligand is having a significant effect on the localisation of Re(I) complexes in
HeLa cells. One difference observed for fac-[Re(phen-RS)(CO)3(Cl)] (39) and fac-
[Re(phen-S-PEG)(CO)3(Cl)] (40) is that the signal detected in the cytoplasmic region
of HeLa cells is weaker compared to the two Re(I) complexes discussed in section
5.3.2. This could be an indication of reduced cellular uptake which may be ratio-
nalised by their low lipophilicity in comparison to rhenium tetrazolato complexes (see
section ?? on page ??). The weaker signal observed for the chloro complexes (com-
pared to the tetrazolato) could also be rationalised by their relatively lower quantum
yield.
5.3.5 Imaging of fac-[Re(phen-S-PEG))(CO)3(Tph)] (41)
Motivation behind the synthesis of fac-[Re(phen-S-PEG)(CO)3(Tph)] (41) was to
improve water solubility compared to the unsubstituted rhenium phenanthroline ana-
logue. Improved water solubility may facilitate reduced DMSO concentrations during
cell culture. As discussed in Chapter Five (section ?? on page ??), the small PEG chain
was of insufficient length to modify the lipophilicity of the complexes. Nonetheless,
41 was analysed in HeLa cells.
5.3.5.1 Confocal Imaging and Spectral Detection
HeLa cells were incubated with 41 to a final concentration of 20 µM and 0.4% (v/v)
DMSO, for 40 minutes before imaging. Confocal imaging illustrates uptake of 41 into
HeLa cells, resulting in a diffuse cytoplasmic localisation. Figure 5.25 A-C shows the
DIC, fluorescence and merged images. In the fluorescence image, small bright spots
within the cytoplasm are observed. This could be indicative of preferential organelle
localisation (eg: lysosomes or mitochondria) however further experiments would be
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required to confirm this. The signal from 41 in HeLa cells does appear stronger, com-
pared to many of the other Re(I) complexes imaged herein. This might be rationalised
by the molar absorptivity calculated for fac-[Re(phen-S-PEG)(CO)3(Tph)] (41) at
405 nm (in DCM). The value is 6936 Lmol-1cm-1, which corresponds to the highest
absorption cross section out of all complexes studied in HeLa cells. The morphology
and overall appearance of cells shown in Figure 5.25 A, is comparable to the con-
trol/blank cells. This is suggestive of the non-toxic nature of 41 in HeLa cells during
the incubation period and at the time of imaging.
Figure 5.25: HeLa cells incubated with fac-[Re(phen-S-PEG)(CO)3(Tph)] (41). DIC
image (A) shows the structural integrity of HeLa cells where the fluorescence (B) and
merged (C) images illustrate the uptake and cytoplasmic localisation of the 41 in HeLa
cells. Scale bar, 25 µm.
Spectral imaging was used to probe the identity of the emitting species localised inside
the cytoplasm of the HeLa cells. First, as a reference, the DMSO stock solution of
fac-[Re(phen-S-PEG)(CO)3(Tph)] (41) was placed into a MatTek dish and a spectral
image was recorded. Spectral analysis produced the profile shown in Figure 5.26. The
broad structureless emission with a maximum around 590 nm is expected, based on
the photophysical characterisation of 41 carried out in Chapter Five, section ??.
The same HeLa cells incubated with fac-[Re(phen-S-PEG)(CO)3(Tph)] (41) were
used to collect spectral images. The white arrow in Figure 5.27 indicates the area
where a circular ROI (approximately 7 µm diameter) was positioned for spectral anal-
ysis. This particular ROI gave the profile shown in Figure 5.28. Upon moving the
ROI to other parts of the cytoplasm where signal was observed, a similar spectrum was
always generated with the emission maximum around 575 nm, comparable to that of
the DMSO reference, Figure 5.26.
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Figure 5.26: Spectral detection emission profile measured from a DMSO solution of
fac-[Re(phen-S-PEG)(CO)3(Tph)] (41).
Figure 5.27: HeLa cells incubated with fac-[Re(phen-S-PEG)(CO)3(Tph)] (41). DIC
(A), fluorescence (B) and merged (C) images. The white arrow shows the area in which
a ROIs was selected for spectral analysis. Scale bar, 25 µm.
When comparing the profile collected in vitro (Figure 5.28) to that of the DMSO ref-
erence (Figure 5.26), a slight blue shift in the maximum is observed. This can again
be rationalised by the change in solvent. When the ROI was moved to a location in
the extracellular space, the spectral profile reduced in intensity, lost the Gaussian-like
shape and therefore did not resemble typical Re(I) emission.
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Figure 5.28: Spectral detection emission profile measured from the cytoplasm of HeLa
cells incubated with fac-[Re(phen-S-PEG)(CO)3(Tph)] (41).
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5.3.5.2 Photoinduced Cytotoxicity
During live imaging of HeLa cells incubated with fac-[Re(phen-S-PEG)(CO)3(Tph)]
(41), phototoxicity was observed. For the other rhenium complexes, phototoxicity
was only observed during continuous illumination. This was also observed for HeLa
cells incubated with fac-[Re(phen-S-PEG)(CO)3(Tph)] (41). However, cytotoxic-
ity was also observed when multiple images were taken of the same area, even with
breaks/recovery time between each image.
Time lapse imaging was carried out to confirm this phototoxic effect. HeLa cells were
Figure 5.29: Merged DIC and confocal fluorescence images from a
five minute time lapse experiment of HeLa cells incubated with fac-
[Re(mercaptophenPEG)(CO)3(Tph)] (41). An image was taken every 30 seconds
for five minutes and the images shown were taken at t=0 (A), t=1 min (B), t=2 min
(C), t=3 min (D), t=4 min (E) and t=5 min (F). Blebs are apparent at t=2 min (C).
Scale bar, 25 µm.
incubated with 20 µM of fac-[Re(phen-S-PEG)(CO)3(Tph)] (41) with a 0.4% (v/v)
DMSO concentration. After incubation for one hour, the time lapse experiment was
started. The laser power and gain settings were all consistent with the images taken
previously for this and other rhenium complexes. Imaging was carried out over five
minutes with a single image captured every 30 seconds. The progress of images are
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shown in Figure 5.29. After two minutes, corresponding to a total of five scans, (Fig-
ure 5.29 C) cells start to show a stress response. This is slower than when cells are
continually illuminated, where a stress response is observed after only one minute. The
slower phototoxic effect during time lapse imaging can be ascribed to the recovery time
cells have between each image acquisition when the cells are not illuminated. Despite
this recovery time, HeLa cells still suffered from phototoxicity after the acquisition
of five images. Cells started to round up with some small membrane blebs observed.
These observations are consistent with phototoxicity.264 At completion of the time
lapse experiment, nearly all of the cells in view had blebs present and many of them
had completely rounded up. The stress response exhibited by cells was again ascribed
to the production of singlet oxygen. Further experiments would need to be carried out
to determine the exact cause of the stress response but as discussed in section 5.3.2.4,
these type of Re(I) species emit from the triplet state and can generate singlet oxygen
in solution. The NIR emission spectra of fac-[Re(phen-S-PEG)(CO)3(Tph)] (41) in
DCM was measured. A peak is observed at 1274 nm (Figure 5.30), corresponding to
Figure 5.30: Near infrared emission spectra of fac-[Re(phen-S-PEG)(CO)3(Tph)]
(41) in DCM.
1O2. As the complexes show uptake into the cells, it is not unlikely that the production
of this cytotoxic species (1O2) would cause an apoptotic response.
The same time lapse settings were used on a dish of HeLa cells where no complex
was added. This was done as a control to gauge if the cause of the cells distress was
the complex. The images shown in Figure 5.31 are from scans taken at time zero
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(A), 2 min 30 sec (B) and 5 min (C). These cells do not illustrate any morphological
changes over time suggesting that 41 is likely playing a direct role in causing the HeLa
cells to bleb and round up upon illumination. These observations are consistent with
continuous illumination effects shown in section 5.3.2.4.
Figure 5.31: DIC images from a five minute time lapse of HeLa cells without any
rhenium complex or DMSO additives. Images were acquired every 30 seconds for five
minutes. DIC images show the structural integrity of HeLa cells where: t=0 (A), t=2.5
min (B) and t=5 min (C). Scale bar, 25 µm.
Time lapse experiments were also carried out on cells incubated with fac-[Re(phen)(CO)3(Tph)]
(11), fac-[Re(phen)(CO)3(Tbz)] (13), fac-[Re(phen-RS)(CO)3(Cl)] (39) or fac-[Re(phen-
S-PEG)(CO)3(Cl)] (40). For each of these experiments phototoxic effects, with bleb
formation were observed. However, the response was slower and less pronounced
compared to 41. This could be attributed to a greater uptake of fac-[Re(phen-S-
PEG)(CO)3(Tph)] (41) into the HeLa cells compared to the other complexes or simply
a greater production of 1O2. Further experiments are required to completely under-
stand the different phototoxic effects exhibited by each of the complexes. All of the
neutral Re(I) complexes studied in HeLa cells are phototoxic upon extended illumi-
nation, however it appears that fac-[Re(phen-S-PEG)(CO)3(Tph)] (41) is having the
greatest phototoxic effect.
As seen with many of the Re(I) complexes studied in this Chapter,
fac-[Re(phen-S-PEG)(CO)3(Tph)] (41) shows potential as an imaging agent however
its phototoxic nature could lead to potential applications as a multi-modal luminescent
imaging and phototherapeutic agent.
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5.4 Conclusion
Neutral Re(I) tetrazolato complexes, fac-[Re(phen)(CO)3(Tph)] (11),
fac-[Re(phen)(CO)3(Tbz)] (13) and fac-[Re(phen-S-PEG)(CO)3(Tph)] (41), showed
cellular uptake and exhibited a diffuse perinuclear localisation in HeLa cells without
apparent localisation to any particular organelles. Spectral imaging and analysis of
cells incubated with the Re(I) complexes confirmed the signal observed in the cyto-
plasm, was originating from the Re(I) species. Further investigation could employ
techniques such as ICP-MS and/or GF-AAS to quantify the uptake of Re(I) complexes
in HeLa cells.
Apparent toxicity of the Re(I) complexes is very dependent on imaging protocol. When
taking multiple images over extended time periods with breaks between each scan, the
cells appeared to resemble the morphology of those cells in the control and blank
samples. Under these experimental conditions, the rhenium complexes are non-toxic.
However, HeLa cells did exhibit an observable phototoxic response during acquisition
of z-stacks, where the sample is illuminated, almost continuously. Phototoxicity was
attributed to the excessive production of singlet oxygen, a cytotoxic species. The non-
toxic nature of the Re(I) complexes observed during “normal” image acquisition can
be ascribed to the significant recovery time the cells have between each scan.
Weak luminescent signals were identified in the perinuclear regions of HeLa cells in-
cubated with fac-[Re(phen-RS)(CO)3(Cl)] (39) and fac-[Re(phen-S-PEG)(CO)3(Cl)]
(40). This weaker signal could be attributed to reduced uptake of 39 and 40 which
might be explained by the reduced lipophilicity of these complexes.
Methylated complexes fac-[Re(phen)(CO)3(TphCH3)]+ (31) and
fac-[Re(phen)(CO)3(TbzCH3)]+(33) were originally designed to be highly emissive
optical imaging labels. Uptake and localisation patterns were unclear as a luminescent
signal was not detected and spectral analysis was unsuccessful due to the weak signal.
These methylated Re(I) complexes were not stable enough to be utilised in a biological
context.
Further studies using fac-[Re(phen)(CO)3(Tph)] (11), fac-[Re(phen)(CO)3(Tbz)] (13)
and fac-[Re(phen-S-PEG)(CO)3(Tph)] (41) are required to grasp their full potential
as optical imaging agents.
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5.5 Experimental
5.5.1 Cell Culture
Human cervical carcinoma cells, HeLa, (company, location) were cultured in DMEM
cell medium (Gibco, Australia), 10% Fetal Bovine Serum (Gibco, Australia), and 1%
penicillin-streptomycin at 37 °C under a 5% CO2 atmosphere, in T75 culture flasks.
When the cells were ready to be split for imaging, they were done so using 1 mL of
trypsin (0.25 %) and seeded into 35 mm diameter MatTek glass bottom petri dishes for
24 hours before imaging, to give a cell confluency of 50-60% unless otherwise stated.
DMSO solutions of the prepared complexes were added to 2 mL of culture media.
This solution was then added to cell culture to give final concentrations of the rhenium
complexes between 10-20 µM. The DMSO concentration for each experiment was
0.4-1% in culture media, as specified.
5.5.2 Confocal Imaging
All confocal imaging and spectral detection experiments were carried out on a Nikon
Ti-E inverted motorised microscope with a Nikon A1Si confocal microscope system.
Köhler alignment was carried out before each imaging experiment and differential
interference contrast (DIC) imaging was always employed.
The Nikon A1Si confocal microscope system was equipped with four PMT detectors,
a spectral detector and 50mW solid state lasers of the following wavelengths: 405
nm, 488 nm, 561 nm and 638 nm. The 405 nm laser was used for excitation and the
images were collected in channels 2, 3 and 4 with spectral ranges of 500-550 nm, 570-
620 nm and 633-738 nm respectively. For live cell imaging experiments, a Tokai Hit
stage top incubation system was used, unless otherwise stated. Images were collected
using a Nikon PlanApo 60× oil immersion objective (NA 1.4). In cases where spectral
detection was carried out, 32-channel spectral images were collected using a 10 nm Si
grating resolution and the 405 nm laser for excitation. All images were collected at a
resolution of 0.21 µm/pixel (1024×1024 pixels) or 0.41µm/pixel (512×512 pixels).
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5.5.2.1 Image Processing
Confocal images were exported from the Nikon software NIS-Elements as 16 bit mono
colour images. FIJI (ImageJ, http://fiji.sc/Fiji) was used to add channels 2, 3 and 4 to-
gether. The resultant image was imported into Adobe Photoshop and converted to an
RGB image. The contrast and brightness of the image was increased. Colour was
added by altering the relative values of the each RGB channel. Each fluorescence im-
age was processed using the same brightness/contrast and RGB values for consistency.
The DIC image was also imported into Adobe Photoshop and the brightness/contrast
adjusted. The DIC and fluorescence images were overlaid. The fluorescent layer (top)
was converted to “color” using the blending options which gave the final merged im-
age. The final images were converted to 8 bit and saved as TIFF files.
5.5.3 Multiphoton Excitation Confocal Imaging
All multiphoton microscopy was carried out on a Nikon Ti-E inverted motorised mi-
croscope with a Nikon A1R confocal microscope system equipped with four PMT
detectors and 20mW solid state lasers of the following wavelengths: 405 nm, 488 nm,
561 nm and 638 nm. The system also contained a Coherent Chameleon II infrared
laser (700-1000 nm) for two photon excitation.
5.5.4 Near-Infrared Luminescence
The photophysical measurements were carried out as described in Chapter Two, sec-
tion 2.5.1. Singlet oxygen analysis was measured using the Hamamatsu R5509-42
photomultiplier detector for detection of NIR radiation (spectral range 800-1400 nm).
5.5.5 Anion Exchange
DOWEX®-Cl (1×8, 200-400 mesh, Cl- form) was swollen in ethanol and packed
into a column. An acetonitrile solution of fac-[Re(phen)(CO)3(TphCH3)]+ (59) was
passed through the column and eluted with acetonitrile until all the yellow solution
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had eluted. The yellow solution was concentrated in vacuo to yield a mixture of rhe-
nium complexes as characterised by 1H NMR. This mixture was passed through an
acidic alumina-filled column. Fraction one was eluted with ethyl acetate (100%) and
fraction two eluted with an ethyl acetate/methanol (9.5:0.5) solvent system. IR and 1H
NMR revealed fraction one was fac-[Re(phen)(CO)3(Cl)] (7) and fraction two was a
mixture.
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Chapter 6
Conclusions and Future Work
This study reports on the design, synthesis and investigation of a library of rhenium
tetrazolato complexes for applications in optical imaging. Small structural changes
were made to assess how the chemical, photophysical and biological properties of
the complexes would be effected. The neutral complexes were of the form; fac-
[Re(diim)(CO)3(L)], where diim is either 1,10-phenanthroline (phen) or 2,2’-bipyridine
(bipy) and L is one of a series of 5-substituted aryl tetrazoles. The first set of struc-
tural changes involved altering the diimine ligand from bipy to phen as well as mod-
ification of the para substituent on the aryl tetrazolato ligand. NMR, IR and X-ray
crystallographic analysis indicated the chemical similarity between the synthesised
neutral Re(I) complexes; each complex was in a facial configuration and the tetra-
zolato ligand was coordinated to rhenium via the N2 atom. The photophysical output
of the Re(I) phen complexes demonstrated longer τ and higher φ compared to the
bipy analogues. The photophysical output could be fine tuned by altering the para
substituent on the tetrazolato ligand. Computational calculations (DFT) indicated that
as the electron withdrawing strength of the para substituent increased, the contribution
of the aryl ring to the HOMO reduced; rationalising the minor photophysical change
observed. Therefore these tetrazolato ligands can be further functionalised without
significantly altering the photophysical output. When fac-[Re(phen)(CO)3(Tph)] (11)
and fac-[Re(phen)(CO)3(Tbz)] (13) were incubated with HeLa cells, live imaging ex-
periments revealed their good uptake and perinuclear localisation. There was no ob-
vious difference in the behaviour of 11 and 13 in HeLa cells, despite the difference in
para substituents. These complexes were also found to be non-toxic during incubation
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and imaging however upon acquisition of z-stacks (continuous imaging, <4 min), cells
showed signs of blebbing. It is likely that fac-[Re(phen)(CO)3(Tph)] (11) and fac-
[Re(phen)(CO)3(Tbz)] (13) are phototoxic due to the production of singlet oxygen.
Protonation of the neutral Re(I) tetrazolato complexes with triflic acid produced a blue
shifted and increased emission intensity as well as elongated τ and higher φ . These
experiments provide proof of concept that Re(I) tetrazolato complexes demonstrate a
detectable response to a change in environment and may therefore be further explored
as sensing agents/responsive probes. Protonation of [Ir(PyrTzF)](60) lead to a change
in the composition of the excited state. The neutral Ir(III) complex has a structured
emission profile and upon protonation emission red shifts and becomes structureless.
The emission of [Ru(PyrTzH)]2+(61) was significantly quenched with respect to the
unprotonated species. Photophysical modulation of the metal tetrazolato complexes
was completely reversible through addition of triethylamine.
The improved photophysical output of the Re(I) complexes was harnessed in an irre-
versible way by carrying out methylation on the tetrazolato ligand. The photophysical
output increased in a similar way as observed for the protonated species, however the
chemical stability of the complexes decreased. In coordinating solvents, the methy-
lated ligand became labile and a solvato-complex was formed, even at 37 ºC (cell
incubation temperature). Live cell imaging experiments were conducted with HeLa
cells incubated with fac-[Re(phen)(CO)3(TphCH3)]+
(59) and fac-[Re(phen)(CO)3(TbzCH3)]+(33) however limited uptake was observed.
The lack of cellular uptake and the instability of the methylated Re(I) complexes, sug-
gests they are unsuitable for biological imaging.
fac-[Re(phen-S-PEG)(CO)3(Tph)] (41) was synthesised in an attempt to improve the
water solubility of the Re(I) tetrazolato complexes. Analysis of the n-octanol/water
distribution coefficient suggests the addition of a small PEG chain was insufficient to
significantly improve water solubility. Although the concentration of DMSO used dur-
ing the live cell imaging experiments was generally kept below 0.5%, it is important
to minimise cytotoxic effects and alterations to “normal” physiological state. Future
modifications to the complexes will aim to reduce DMSO to below 0.1% (as recom-
mended). This may involve the attachment of a longer and/or more PEG chains to
the diimine ligand. Functionalisation of the diimine ligand with PEG did not lead to
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significant structural changes nor significant photophysical changes at room tempera-
ture. 41 was incubated with HeLa cells and live cell imaging showed good uptake with
diffuse perinuclear localisation. Functionalisation did not appear to effect localisation
however 41 did exhibit increased phototoxicity. This could be attributed to increased
singlet oxygen production and/or increased cellular uptake.
This study has gained fundamental insight into how structural changes to Re(I) tetrazo-
lato complexes can influence their chemical, photophysical and biological properties.
The photophysical properties are conserved upon functionalisation of both the diimine
ligand (with a thioether chain) and the para substituted tetrazolato ligand. This pro-
vides opportunities for conjugation to molecules aiming to improve or direct cellular
uptake and localisation without altering emission properties.
Future work will focus on live cell imaging in a range of other cell lines, including
normal human cells. This will extend understanding of uptake, localisation and toxic-
ity. To reveal the Re(I) complexes preferential organelle localisation or simply confirm
their non-specific nature co-localisation experiments will be carried out using labels
known to stain cytoplasmic organelles. A recent publication by Bader et al.115 studied
the uptake and localisation of two Re(I) complexes, 17 and 62 in Drosophila larval
adipose tissues and human adipose 3T3-L1 cells.
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The cellular uptake and localisation suggested a relationship between the structure of
the Re(I) tetrazolato complexes and their behaviour in a biological environment. Col-
laborations with this research group at the University of South Australia are continuing.
Investigations will look at cellular uptake and localisation of other Re(I) complexes re-
ported in this work.
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The toxicity of the Re(I) comlpexes can be further explored through a range of tests.
MTT testing as well as the utilisation of flow cytometry can quantify the relative toxi-
city of Re(I) complexes against a range of cell lines. The production of singlet oxygen
by phosphorescent metal complexes is not commonly addressed in the literature, with
only a few studies reporting on this issue.80,104 Therefore, it is important that the pho-
totoxic nature of the Re(I) complexes be further explored. The quantum yield of singlet
oxygen production is a way to quantify the efficiency of a photodynamic probe and will
be a necessary parameter to calculate for the Re(I) complexes. The photodynamic effi-
ciency of the Re(I) complexes will assess their potential to be explored as therapeutic
agents. Selectivity of the complex could be conferred through functionalisation with
a compound exhibiting specificity towards cancerous or diseased cells. A range of
strategies exist to form targeted imaging or therapeutic agents with examples includ-
ing conjugation of antibody conjugates, tumour surface proteins (ie: receptor binding
ligands) and peptides.265 Conjugation to either the tetrazolato or diimine ligand of the
Re(I) complexes would offer specificity without significantly altering photophysical
and therefore the phototoxic properties.
The sensing abilities of Re(I) complexes (which was fundamentally studied in Chapter
Three) should be further investigated. It is important to be able to monitor the levels
of certain molecules and cations within cells. A range of metals within the body are
responsible for life processes and their levels can be used as a marker for the health
status of cells.213 The Re(I) complexes should be analysed by UV-visible and emission
spectrophotometric titrations with metal cations such zinc, calcium and cadmium. If
no selective response is noted structural changes to the Re(I) tetrazolato complex can
improve the coordination site for cations. If the aryl group on the ligand is substi-
tuted for a pyridine to form fac-[Re(phen)(CO)3(TPyr)] (63), cations may coordinate
between the nitrogen on the pyridine.
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If fac-[Re(phen)(CO)3(TPyr)] (63) exhibits a selective and detectable response to any
cation(s), the investigation can be extended to in vitro studies.
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Despite the numerous studies of phosphorescent metal complexes in bio-imaging, their
specific design is not trivial. To advance their use in optical imaging, systematic stud-
ies need to continue, to gauge an understanding of what structural changes govern their
chemical, photophysical and biological properties. Heavy metal complexes generally
exhibit chemical stability and advantageous photophysical properties. These proper-
ties are tunable through simple synthetic modifications. The variety of optical imaging
experiments available has been greatly expanded with the employment of phospho-
rescent heavy metal complexes. This study, along with many others, has shown the
potential of metal complexes to be applied in optical imaging in both a diagnostic and
therapeutic context.
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A1.1 Appendix: Chapter Two
Table A1.1: Crystallographic data for fac-[Re(phen)(CO)3(TIod)] (20) and fac-
[Re(phen)(CO)3(TBr)] (19).
Identification code 20 19
Empirical formula C22H12I N6O3Re C22H12Br N6O3Re
Formula weight 721.48 674.49
Temperature 100(2) K 100(2)K
Wavelength 0.71073 Å 1.54178 Å
Crystal system Monoclinic Monoclinic
Space group P21/n P21/c
Unit cell dimensions a = 7.0191(3) Å
b = 18.0476(8) Å
c = 16.9652(6) Å
β = 99.850(3)°
a = 6.8071(3) Å
b = 18.4161(8) Å
c = 17.0264(7) Å
β =102.607(3)°
Volume 2117.44(15) Å3 2082.97(15) Å3
Z 4 4
Density (calculated) 2.263 Mg/m3 2.151 Mg/m3
µ 7.236 mm−1 7.792 mm−1
Crystal size 0.46 x 0.31 x 0.02 mm3 0.53 x 0.24 x 0.035 mm3
θ range for data collection 2.99 to 30.00° 3.66 to 28.00°
Index ranges -19<=h<=9, -25<=k<=25,
-23<=l<=23
-8<=h<=8, -23<=k<=24,
-22<=l<=18
Reflections collected 21406 20685
Independent reflections 6157 [R(int) = 0.0448] 5005 [R(int) = 0.0585]
Completeness to θ max 99.9 % 99.8 %
Absorption correction Analytical Analytical
Max. and min. transmission 0.855 and 0.219 0.758 and 0.217
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares on F2
Data / restraints / parameters 6157 / 0 / 298 5005 / 0 / 298
Goodness-of-fit on F2 1.129 1.069
Final R indices [I>2σ (I)] R1 = 0.0372, wR2 = 0.0787 R1 = 0.0340, wR2 = 0.0800
R indices (all data) R1 = 0.0448, wR2 = 0.0815 R1 = 0.0399, wR2 = 0.0827
Largest diff. peak and hole 2.204 and -0.802 e.Å-3 2.862 and -2.081 e.Å-3
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A2.2 Appendix: Chapter Three
Figure A2.1: Localisation of the HOMO and LUMO for fac-
[Re(phen)(CO)3(TphH)]+ (21).
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Figure A2.2: Localisation of the HOMO and LUMO for fac-[Re(bipy)(CO)3(TphH)]+
(22).
Figure A2.3: Localisation of the HOMO and LUMO for fac-
[Re(phen)(CO)3(TbzH)]+ (23).
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Figure A2.4: Localisation of the HOMO and LUMO for fac-[Rebipy)(CO)3(TbzH)]+
(24).
Figure A2.5: Localisation of the HOMO and LUMO for fac-
[Re(phen)(CO)3(TcyaH)]+ (25).
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Figure A2.6: Localisation of the HOMO and LUMO for fac-
[Re(bipy)(CO)3(TcyaH)]+(26).
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A3.3 Appendix: Chapter Four
Table A3.1: Crystallographic data for fac-[Re(phen)(CO)3(TphCH3)]+ (31) and fac-
[Re(bipy)(CO)3(TphCH3)]+(32).
Identification code 31 32
Empirical formula C23H16F6N6O3PRe C23H18Cl2F3N6O6ReS
Formula weight 755.59 820.59
Temperature 298(2) K 100(2)K
Wavelength 0.71073 Å 1.54178 Å
Crystal system Monoclinic Monoclinic
Space group P21/c P21/n
Unit cell dimensions a = 12.1607(13) Å
b = 14.9974(17) Å
c = 14.0496(16) Å
α=90.00
β = 90.0710(10)°
γ=90.00
a = 9.2488(13) Å
b = 22.212(3) Å
c = 14.293(2) Å
α=90.00
β = 90.906(2)°
γ=90.00
Volume 2562.3(5) Å3 2934.8(7) Å3
Z 4 4
Density (calculated) 1.959 Mg/m3 2.991 Mg/m3
F(000) 1456 1592
µ 4.887 mm−1 4.461 mm−1
Crystal size 0.16 x 0.13 x 0.11 mm3 0.223 x 0.14 x 0.12 mm3
θ range for data collection 1.36 to 26.00° 1.83 to 25.02 °
Index ranges -15<=h<=15, -18<=k<=18,
-17<=l<=17
-11<=h<=11, -26<=k<=26,
-17<=l<=17
Reflections collected 5037 5166
Independent reflections 4189 [R(int) = 0.0519] 4353 [R(int) = 0.0508]
Completeness to θ max 99.9 % 99.8 %
Absorption correction Empirical Empirical
Max. and min. transmission 0.5085 and 0.6154 0.4403 and 0.6166
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares on F2
Data / restraints / parameters - -
Goodness-of-fit on F2 1.1021 1.100
Final R indices [I>2σ (I)] R1 = 0.0519, wR2 = 0.0539 R1 = 0.0582, wR2 = 0.1246
R indices (all data) R1 = 0.0369, wR2 = 0.0493 R1 = 0.0469, wR2 = 0.1183
Largest diff. peak and hole
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Table A3.2: Crystallographic data for fac-[Re(phen)(CO)3(TbzCH3)]+(33) and fac-
[Re(bipy)(CO)3(TbzCH3)]+(34).
Identification code 33 34
Empirical formula C24H16F6N6O4PRe·CDCl3 C22H16F6N6O4PRe·CHCl3
Formula weight 902.97 878.95
Temperature 100(2) K 100(2)K
Wavelength 0.71073 Å 1.54178 Å
Crystal system Monoclinic Monoclinic
Space group C2/c C2/c
Unit cell dimensions a = 20.7999(12) Å
b = 11.1806(5) Å
c = 26.1866(14) Å
β = 99.901(5)°
a = 23.0576(9) Å
b = 16.6963(5) Å
c = 15.9749(6) Å
β = 97.077(4)°
Volume 5999.1(5) Å3 6103.1(4) Å3
Z 8 8
Density (calculated) 2.000 Mg/m3 1.913 Mg/m3
F(000) 1512 3392
µ 4.454 mm−1 3.375 mm−1
Crystal size 0.22 x 0.12 x 0.03 mm3 0.4321 x 0.1910 x 0.0878mm3
θ range for data collection 3.36 to 28.43° 2.88 to 30.00 °
Index ranges -23<=h<=26, -14<=k<=14,
-34<=l<=2
-28<=h<=32, -23<=k<=23,
-22<=l<=19
Reflections collected 17010 38648
Independent reflections 6501 [R(int) = 0.0965] 8891 [R(int) = 0.0763]
Completeness to θ max 98.8 % 99.9 %
Absorption correction Analytical Analytical
Max. and min. transmission 0.884 and 0.623 0.688 and 0.277
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares on F2
Data / restraints / parameters 6501/ 84/ 479 8891 / 19 / 459
Goodness-of-fit on F2 0.937 1.197
Final R indices [I>2σ (I)] R1 = 0.0548, wR2 = 0.0876 R1 = 0.0598, wR2 = 0.1206
R indices (all data) R1 = 0.1115, wR2 = 0.0969 R1 = 0.0771, wR2 = 0.1263
Largest diff. peak and hole 3.124 and -1.739 e.Å-3 2.474 and -0.960 e.Å-3
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Table A3.3: Crystallographic data for fac-[Re(phen)(CO)3(TmeCH3)]+(35) and fac-
[Re(bpiy)(CO)3(TmeCH3)]+(36).
Identification code 35 36
Empirical formula C25H18F6N6O5PRe C23H18F6N6O5PRe
Formula weight 813.62 789.60
Temperature 100(2) K 100(2)K
Wavelength 0.71073 Å 0.71073Å
Crystal system Monoclinic Monoclinic
Space group P21/c P21/c
Unit cell dimensions a = 18.0672(6) Å
b =9.8480(2) Å
c = 16.8781(6) Å
β = 114.201(4)°
a =10.6468(1) Å
b = 13.1055(1) Å
c = 19.4480(1) Å
β = 91.955(1)°
Volume 2739.12(17)Å3 2712.03(4) Å3
Z 4 4
Density (calculated) 1.973 Mg/m3 1.934 Mg/m3
F(000) 1576 1528
µ 4.585 mm−1 4.628 mm−1
Crystal size 0.27 x 0.23 x 0.20mm3 0.28 x 0.24 x 0.16 mm3
θ range for data collection 3.85 to 36.45° 2.88 to 30.00 °
Index ranges -29<=h<=29, -16<=k<=15,
-27<=l<=27
-28<=h<=32, -23<=k<=23,
-22<=l<=19
Reflections collected 81206 181307
Independent reflections 12974 [R(int) = 0.0403]] 23179 [R(int) = 0.0401]
Completeness to θ max 99.0 % 99.8 %
Absorption correction Analytical Analytical
Max. and min. transmission 0.483 and 0.405 0.535 and 0.398
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares on F2
Data / restraints / parameters 12974 / 0 / 400 23179 / 0 / 381
Goodness-of-fit on F2 0.967 0.874
Final R indices [I>2σ (I)] R1 = 0.0360, wR2 = 0.0914 R1 = 0.0197, wR2 = 0.0392
R indices (all data) R1 = 0.0599, wR2 = 0.0960 R1 = 0.0340, wR2 = 0.0400
Largest diff. peak and hole 2.000 and -1.326 e.Å-3 1.390 and -0.646 e.Å-3
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Figure A3.1: Localisation of the HOMO-n and and LUMO+m orbitals, where
n and m = 0-2, for the methylated Re(I) phen complexes (left to right);
fac-[Re(phen)(CO)3(TphCH3)]+ 31, fac-[Re(phen)(CO)3(TbzCH3)]+(33) and fac-
[Re(phen)(CO)3(TmeCH3)]+(35).
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Figure A3.2: Localisation of the HOMO-n and and LUMO+m orbitals, where
n and m = 0-2, for the methylated Re(I) bipy complexes (left to right);
fac-[Re(bipy)(CO)3(TphCH3)]+ 32, fac-[Re(bipy)(CO)3(TbzCH3)]+(34) and fac-
[Re(bipy)(CO)3(TmeCH3)]+(36).
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Table A3.4: Calculated low energy transitions for fac-[Re(phen)(CO)3(TphCH3)]+
(31).
Wavelength Intensity Levels Character
423.94 nm 0.0014 HOMO -> LUMO 98.70%
398.67 nm 0.0219 HOMO-2 -> LUMO 33.30%
HOMO-1 -> LUMO 60.90%
HOMO -> LUMO+1 4.70%
388.06 nm 0.0203 HOMO-2 -> LUMO 54.20%
HOMO-1 -> LUMO 15.40%
HOMO -> LUMO+1 29.50%
373.51 nm 0.0787 HOMO-2 -> LUMO 11.40%
HOMO-1 -> LUMO 22.00%
HOMO -> LUMO+1 64.80%
362.16 nm 0.0124 HOMO-2 -> LUMO+1 5.10%
HOMO-1 -> LUMO+1 91.40%
351.35 nm 0.0055 HOMO-2 -> LUMO+1 93.70%
HOMO-1 -> LUMO+1 4.20%
315.15 nm 0.0023 HOMO-6 -> LUMO+1 7.80%
HOMO-4 -> LUMO 26.70%
HOMO-3 -> LUMO 62.20%
Table A3.5: Calculated low energy transitions for fac-
[Re(bipy)(CO)3(TphCH3)]+(32).
Wavelength Intensity Levels Character
395.25 nm 0.0098 HOMO -1 -> LUMO 38.50%
HOMO -> LUMO 60.50%
386.82 nm 0.0836 HOMO-2 -> LUMO 12.00%
HOMO-1 -> LUMO 54.40%
HOMO -> LUMO 32.60%
375.88 nm 0.0487 HOMO-2 -> LUMO 86.80%
HOMO-1 -> LUMO 6.10%
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HOMO -> LUMO 6.00%
304.65 nm 0.1357 HOMO-5 -> LUMO 44.80%
HOMO-1 -> LUMO+1 23.30%
HOMO-1 -> LUMO+2 3.00%
HOMO -> LUMO+1 14.80%
HOMO -> LUMO+2 6.80%
300.66 nm 0.0767 HOMO-5 -> LUMO 17.40%
HOMO-1 -> LUMO+1 38.00%
HOMO-1 -> LUMO+2 9.40%
HOMO-1 -> LUMO+3 4.30%
HOMO-1 -> LUMO+4 14.40%
HOMO -> LUMO+1 4.30%
HOMO -> LUMO+2 6.20%
HOMO -> LUMO+4 2.60%
Table A3.6: Calculated low energy transitions for fac-
[Re(phen)(CO)3(TbzCH3)]+(33).
Wavelength Intensity Levels Character
390.60 nm 0.0035 HOMO -> LUMO 98.20%
372.04 nm 0.1107 HOMO-2 -> LUMO 10.80%
HOMO-1 -> LUMO 83.80%
HOMO -> LUMO+1 3.40%
362.27 nm 0.0392 HOMO-2 -> LUMO 85.20%
HOMO-1 -> LUMO 7.80%
HOMO -> LUMO+1 4.90%
348.32 nm 0.0884 HOMO-2 -> LUMO 2.50%
HOMO-1 -> LUMO 6.40%
HOMO -> LUMO+1 75.60%
HOMO -> LUMO+2 13.10%
343.92 nm 0.0000 HOMO-4 -> LUMO 2.10%
HOMO-4 -> LUMO+1 18.20%
HOMO-4 -> LUMO+2 73.10%
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336.98 nm 0.019 HOMO -> LUMO+1 14.30%
HOMO -> LUMO+2 81.30%
336.48 nm 0.0423 HOMO-5 -> LUMO 2.70%
HOMO-2 -> LUMO+1 2.30%
HOMO-1 -> LUMO+1 82.30%
HOMO-1 -> LUMO+2 7.80%
HOMO -> LUMO+2 2.60%
327.25 nm 0.0044 HOMO-2 -> LUMO+1 3.20%
HOMO-1 -> LUMO+1 7.80%
HOMO-1 -> LUMO+2 84.40%
325.88 nm 0.011 HOMO-2 -> LUMO+1 84.60%
HOMO-2 -> LUMO+2 9.90%
HOMO-1 -> LUMO+1 2.90%
316.09 nm 0.0016 HOMO-2 -> LUMO+1 8.40%
HOMO-2 -> LUMO+2 85.90%
HOMO-1 -> LUMO+2 2.80%
314.29 nm 0.0009 HOMO-5 -> LUMO+1 4.90%
HOMO-3 -> LUMO 88.90%
297.06 nm 0.0004 HOMO-5 -> LUMO 34.60%
HOMO-3 -> LUMO+1 53.20%
HOMO-3 -> LUMO+2 10.70%
Table A3.7: Calculated low energy transitions for fac-
[Re(bipy)(CO)3(TbzCH3)]+(34).
Wavelength Intensity Levels Character
401.02 nm 0.0057 HOMO -> LUMO 99.00%
378.20 nm 0.0288 HOMO-2 -> LUMO 29.50%
HOMO-1 -> LUMO 69.40%
366.84 nm 0.111 HOMO-2 -> LUMO 69.40%
HOMO-1 -> LUMO 29.40%
348.16 nm 0.0002 HOMO-3 -> LUMO+1 90.60%
HOMO-3 -> LUMO+8 4.00%
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343.20 nm 0.0215 HOMO -> LUMO+1 98.30%
328.61 nm 0.0004 HOMO-1 -> LUMO+1 97.20%
HOMO-1 -> LUMO+3 2.10%
320.17 nm 0.0011 HOMO-2 -> LUMO+1 97.10%
HOMO-2 -> LUMO+3 2.30%
305.75 nm 0.093 HOMO-4 -> LUMO 36.30%
HOMO -> LUMO+2 57.50%
304.65 nm 0.2815 HOMO -> LUMO+3 83.90%
HOMO -> LUMO+4 4.30%
HOMO -> LUMO+6 3.80%
303.16 nm 0.0086 HOMO-4 -> LUMO 4.20%
HOMO-2 -> LUMO+3 4.00%
HOMO-1 -> LUMO+3 78.30%
HOMO-1 -> LUMO+4 3.20%
HOMO-1 -> LUMO+6 4.50%
295.86 nm 0.281 HOMO-4 -> LUMO 44.10%
HOMO-2 -> LUMO+3 18.60%
HOMO-2 -> LUMO+4 2.50%
HOMO-1 -> LUMO+4 3.30%
HOMO -> LUMO+2 26.90%
Table A3.8: Calculated low energy transitions for fac-
[Re(phen)(CO)3(TmeCH3)]+(35).
Wavelength Intensity Levels Character
391.89 nm 0.0033 HOMO -> LUMO 98.50%
373.05 nm 0.1043 HOMO-2 -> LUMO 11.80%
HOMO-1 -> LUMO 83.20%
HOMO -> LUMO+1 3.60%
363.19 nm 0.0418 HOMO-2 -> LUMO 84.10%
HOMO-1 -> LUMO 8.50%
HOMO -> LUMO+1 6.20%
349.56 nm 0.0899 HOMO-2 -> LUMO 2.90%
232
HOMO-1 -> LUMO 6.60%
HOMO -> LUMO+1 88.40%
337.46 nm 0.0442 HOMO-4 -> LUMO 2.60%
HOMO-2 -> LUMO+1 2.80%
HOMO-1 -> LUMO+1 92.60%
326.88 nm 0.0123 HOMO-2 -> LUMO+1 95.90%
HOMO-1 -> LUMO+1 2.00%
314.48 nm 0.0009 HOMO-4 -> LUMO+1 5.80%
HOMO-3 -> LUMO 81.50%
HOMO -> LUMO+2 8.90%
313.09 nm 0.0247 HOMO-3 -> LUMO 8.40%
HOMO -> LUMO+2 87.50%
305.15 nm 0.0098 HOMO-2 -> LUMO+2 2.90%
HOMO-1 -> LUMO+2 89.80%
HOMO-1 -> LUMO+3 2.20%
297.18 nm 0.0005 HOMO-4 -> LUMO 33.90%
HOMO-3 -> LUMO+1 62.70%
Table A3.9: Calculated low energy transitions for fac-
[Re(bpiy)(CO)3(TmeCH3)]+(36).
Wavelength Intensity Levels Character
396.42 nm 0.0054 HOMO -> LUMO 99.10%
374.97 nm 0.0557 HOMO-2 -> LUMO 19.10%
HOMO-1 -> LUMO 79.80%
362.84 nm 0.1065 HOMO-2 -> LUMO 79.80%
HOMO-1 -> LUMO 19.10%
312.33 nm 0.0222 HOMO -> LUMO+1 95.30%
304.29 nm 0.1595 HOMO-3 -> LUMO 52.70%
HOMO -> LUMO+2 42.00%
302.80 nm 0.0131 HOMO-1 -> LUMO+1 90.30%
HOMO-1 -> LUMO+4 3.40%
294.68 nm 0.2847 HOMO-3 -> LUMO 36.80%
233
HOMO-2 -> LUMO+1 4.90%
HOMO-1 -> LUMO+3 3.20%
HOMO -> LUMO+2 47.10%
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A4.4 Appendix: Chapter Five
Table A4.1: Crystallographic data for fac-[Re(mercaptophen)(CO)3(Cl)] (39) and
fac-[Re(mercaptophenPEG)(CO)3(Cl)] (40).
Identification code 39 40
Empirical formula C17H12Cl N2O4SRe·CH2Cl2 C22H20Cl N2O7SRe
Formula weight 616.92 678.11
Temperature 100(2) K 100(2)K
Wavelength 0.71073 Å 1.54178 Å
Crystal system Monoclinic Triclinic
Space group P21/c P¯1
Unit cell dimensions a = 10.1763(5) Å
b = 20.8369(4) Å
c = 10.3782(3) Å
β = 110.147(4)°
a = 11.5291(11) Å
b = 13.1863(12) Å
c = 16.323(2) Å
α= 90.450(8)
β =92.944(8)°
γ=110.770(9)°
Volume 2065.97(12) Å3 2316.3(4) Å3
Z 4 4
Density (calculated) 2.080 Mg/m3 1.945 Mg/m3
µ 6.399 mm−1 12.585 mm−1
Crystal size 0.15 x 0.06 x 0.05 mm3 0.25 x 0.05 x 0.015 mm3
θ range for data collection 2.86 to 33.00° 3.59 to 67.36°
Index ranges -15<=h<=15, -31<=k<=31,
-15<=l<=15
-13<=h<=13, -10<=k<=15,
-19<=l<=19
Reflections collected 56790 23868
Independent reflections 7775 [R(int) = 0.0525] 8213 [R(int) = 0.0464]
Completeness to θ max 99.9 % 98.6 %
Absorption correction Analytical Analytical
Max. and min. transmission 0.775 and 0.538 0.808 and 0.188
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares on F2
Data / restraints / parameters 7775 / 3 / 279 8213 / 0 / 615
Goodness-of-fit on F2 1.110 1.044
Final R indices [I>2σ (I)] R1 = 0.0383, wR2 = 0.0679 R1 = 0.0466, wR2 = 0.1131
R indices (all data) R1 = 0.0497, wR2 = 0.0710 R1 = 0.0569, wR2 = 0.1229
Largest diff. peak and hole 1.743 and -1.625 e.Å-3 3.640 and -0.944e.Å-3
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A4.5 Appendix: Chapter Six
Figure A5.1: Normalised emission spectra of fac-[Re(phen)(CO)3(Tbz)] (13) in DCM
(red), DMSO (green) and 1% (v/v) DMSO in water (blue).
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